Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Einleitung und Definitionen Kapitel lesen Erstes Kapitel lesen

2022 | OriginalPaper | Buchkapitel

3. Behandlung von riskantem, schädlichem und abhängigem Alkoholgebrauch

verfasst von : Falk Kiefer, Sabine Hoffmann, Julia Arens, Martin Beutel, Oliver Bilke-Hentsch, Gallus Bischof, Udo Bonnet, Jan Malte Bumb, Ralf Demmel, Silke Diestelkamp, Patric Driessen, Isabel Englert, Ursula Fennen, Heribert Fleischmann, Jennis Freyer-Adam, Wilma Funke, Dieter Geyer, Euphrosyne Gouzoulis-Mayfrank, Renate Hannak-Zeltner, Barbara Hansen, Ursula Havemann-Reinecke, Derik Hermann, Eva Hoch, Werner Höhl, Susann Hößelbarth, Kristin Hupfer, Julia Jückstock, Marianne Klein, Andreas Koch, Joachim Köhler, Michael Köhnke, Anne Koopmann, Oliver Kreh, Monika Krönes, Dietmar Kramer, Georg Kremer, Timo Krüger, Nikolaus Lange, Bodo Lieb, Johannes Lindenmeyer, Mathias Luderer, Karl Mann, Peter Missel, Sebastian Mueller, Michael Müller-Mohnssen, Corinna Nels-Lindemann, Tim Neumann, Thomas Polak, Ulrich W. Preuss, Olaf Reis, Gerhard Reymann, Monika Ridinger, Hans-Jürgen Rumpf, Peter-Michael Sack, Ingo Schäfer, Martin Schäfer, Norbert Scherbaum, Ariane Schulte, Welf Schroeder, Manfred Singer, Michael Soyka, Rainer Thomasius, Clemens Veltrup, Monika Vogelgesang, Irmgard Vogt, Marc Walter, Tillmann Weber, Georg Weil, Bernd Wessel, Tina Wessels, Klaudia Winkler, Nadja Wirth, Arnold Wieczorek, Norbert Wodarz, Dirk Wolter

Erschienen in: S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Kurzinterventionen sind ein Weg, Menschen mit problematischem Alkoholkonsum in nicht-spezialisierten Settings zu einer Trinkmengenreduktion oder ggf. zur Abstinenz zu motivieren. Unter Kurzinterventionen werden gewöhnlich Interventionen verstanden, die eine Dauer bis 60 Minuten bei bis zu fünf Sitzungen nicht überschreiten (Kaner et al., 2018). Die Interventionen zielen auf eine Verringerung des Alkoholkonsums und alkoholassoziierter Probleme und integrieren u. a. 1) personalisiertes Feedback, 2) individuelle Zielfindung sowie 3) konkrete Ratschläge. Sie können durch schriftliches Infomaterial ergänzt oder auch computergestützt dargeboten werden.
Fußnoten
1
Im Original ist SS/SeSa auf 25 Sitzungen angelegt. Hien et al. (<CitationRef CitationID="CR359" >2009</Citation Ref>, <CitationRef CitationID="CR363" >2015a</Citation Ref>) haben das Programm auf 12 Sitzungen verkürzt. Auf die Abbruchraten gehen wir im Folgenden noch genauer ein.
 
2
COPE wird in den USA vergleichsweise oft zur Behandlung von Veteranen eingesetzt, die unter PTBS und Alkohol-bzw. Substanzkonsumstörungen leiden (Back et al., <CitationRef CitationID="CR44" >2019</Citation Ref>; Norman et al., <CitationRef CitationID="CR629" >2019</Citation Ref>; Straus et al., <CitationRef CitationID="CR832" >2019</Citation Ref>; vgl. die Empfehlung 38 VA/DOD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder, Version 3.0 – 2017, S. 73 f.).
 
3
Die Untersuchungen zu unerwünschten Ereignissen in verschiedenen Studien haben gezeigt, dass diese selten sind (vgl. Persson et al., <CitationRef CitationID="CR661" >2017</Citation Ref>) und nicht häufiger vorkommen als in (unbehandelten) Kontrollgruppen.
 
4
Das New York State Department of Health hat in seinen Leitlinien (New York State Dept. Of Health <CitationRef CitationID="CR619" >2009</Citation Ref>) empfohlen, in den Eingangsuntersuchungen alle Frauen mit AUD/SUD systematisch nach aktuellen Gewalterfahrungen zu befragen (vgl. Fowler & Faulkner, <CitationRef CitationID="CR283" >2011</Citation Ref>).
 
5
Interpersonale Gewalt in Partnerschaften steht hier stellvertretend für interpersonale Gewalttätigkeiten in Beziehungen und für häusliche Gewalt. Es geht also stets um Gewalttätigkeiten zwischen Menschen, die in den meisten Fällen zusammenleben oder jedenfalls in einer engen emotionalen Beziehung zueinander stehen, hier um diejenige zwischen Menschen die 18 Jahre und älter sind.
 
6
Die Schwangerschaft ist eine Phase, in der Frauen besonders vulnerable sind hinsichtlich Gewalttätigkeiten in Beziehungen/Partnerschaften (vgl. Parkinson et al., <CitationRef CitationID="CR656" >2017</Citation Ref>). Aber auch in dieser Phase sind sie nicht nur Opfer, sondern in etlichen Fällen ebenfalls aktiv in die Kämpfe involviert (z. B. Shneyderman & Kiely, <CitationRef CitationID="CR783" >2013</Citation Ref>).
 
Literatur
Addolorato, G., Leggio, L., Abenavoli, L., Agabio, R., Caputo, F., Capristo, E., et al. (2006). Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. The American journal of medicine, 119(3), 276.e13–276.e18.PubMedCrossRef
Addolorato, G., Leggio, L., Ferrulli, A., Cardone, S., Vonghia, L., Mirijello, A., et al. (2007). Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. The Lancet, 370(9603), 1915–1922.CrossRef
Agabio, R., Trogu, E., & Pani, P. P. (2018). Antidepressants for the treatment of people with co-occurring depression and alcohol dependence. Cochrane database of systematic reviews, (4) CD008581.
Agelink, M. W., Malessa, R., Weisser, U., Lemmer, W., Zeit, T., Majewski, T., & Klieser, E. (1998). Alcoholism, peripheral neuropathy (PNP) and cardiovascular autonomic neuropathy (CAN). Journal of the neurological sciences, 161(2), 135–142.PubMedCrossRef
Akerele, E., & Levin, F. R. (2007). Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia. American Journal on Addictions, 16(4), 260–268.PubMedCrossRef
Akison, L. K., Kuo, J., Reid, N., Boyd, R. N., & Moritz, K. M. (2018). Effect of choline supplementation on neurological cognitive and behavioral outcomes in offspring arising from alcohol exposure during development: A quantitative systematic review of clinical and preclinical studies. Alcoholism: Clinical and Experimental Research, 42(9), 1591–1611.
Aletraris, L., Paino, M., Edmond, M. B., Roman, P. M., & Bride, B. E. (2014). The use of art and music therapy in substance abuse treatment programs. Journal of addictions nursing, 25(4), 190.PubMedPubMedCentralCrossRef
Altintoprak, A. E., Zorlu, N., Coskunol, H., Akdeniz, F., & Kitapcioglu, G. (2008). Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. Human Psychopharmacology: Clinical and Experimental, 23(4), 313–319.PubMedCrossRef
Alvarez-Bueno, C., Rodriguez-Martin, B., Garcia-Ortiz, L., Gómez-Marcos, M. Á., & Martinez-Vizcaino, V. (2015). Effectiveness of brief interventions in primary health care settings to decrease alcohol consumption by adult non-dependent drinkers: a systematic review of systematic reviews. Preventive medicine, 76, S33–S38.PubMedCrossRef
Amato, L., Minozzi, S., Vecchi, S., & Davoli, M. (2010). Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews, 3.
Amato, L., Minozzi, S., & Davoli, M. (2011). Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome. Cochrane database of systematic reviews, 6, 1–26.
American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (5. Aufl.). American Psychiatric Publishing.CrossRef
American Psychiatric Association, Kleber, H. D., Weiss, R. D., Anton, R. F., George, T. P., Greenfield, S. F., Kosten, T. R., et al. (2006). Treatment of patients with substance use disorders, American Psychiatric Association. The American journal of psychiatry, 164(4 Suppl), 5–123.
American Psychiatric Association, Kleber, H. D., Weiss, R. D., Anton, R. F., Rounsaville, B. J., George, T. P., Strain, E. C., et al. (2006). Treatment of patients with substance use disorders, American Psychiatic Association. American Journal of Psychiatry, 163(8 Suppl), 5–82.
American Psychiatric Association, Kleber, H. D., & McIntyre, J. S. (2006). Practice guideline for treatment of patients with substance use disorders (S. 1–276). American Psychiatric Association.
Ammann, R. W., Akovbiantz, A., Largiader, F., & Schueler, G. (1984). Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology, 86(5 Pt 1), 820–828.PubMed
Ammendola, A., Gemini, D., Iannaccone, S., Argenzio, F., Ciccone, G., Ammendola, E., et al. (2000). Gender and peripheral neuropathy in chronic alcoholism: A clinical–electroneurographic study. Alcohol and Alcoholism, 35(4), 368–371.PubMedCrossRef
Ammendola, A., Tata, M. R., Aurilio, C., Ciccone, G., Gemini, D., Ammendola, E., et al. (2001). Peripheral neuropathy in chronic alcoholism: a retrospective cross-sectional study in 76 subjects. Alcohol and Alcoholism, 36(3), 271–275.PubMedCrossRef
Ang, C. D., Alviar, M. J. M., Dans, A. L., Bautista-Velez, G. G. P., Villaruz-Sulit, M. V. C., Tan, J. J., et al. (2008). Vitamin B for treating peripheral neuropathy. Cochrane Database of Systematic Reviews, (3), CD004573.
Anthenelli, R. M., Heffner, J. L., Wong, E., Tibbs, J., Russell, K., Isgro, M., et al. (2017). A randomized trial evaluating whether topiramate aids smoking cessation and prevents alcohol relapse in recovering alcohol-dependent men. Alcoholism: Clinical and Experimental Research, 41(1).
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., et al. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. Jama, 295(17), 2003–2017.PubMedCrossRef
Anton, R. F., Myrick, H., Baros, A. M., Latham, P. K., Randall, P. K., Wright, T. M., et al. (2009). Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. Journal of clinical psychopharmacology, 29(4), 334–342.PubMedCrossRef
Anton, R. F., Latham, P. K., Voronin, K. E., Randall, P. K., Book, S. W., Hoffman, M., & Schacht, J. P. (2018). Nicotine-use/smoking is associated with the efficacy of naltrexone in the treatment of alcohol dependence. Alcoholism: Clinical and Experimental Research, 42(4), 751–760.PubMedCrossRef
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF). (2001). S2-Leitlinie Akutbehandlung Alkoholbezogener Störungen (AWMF-Register-Nr. 076-001).
Areán, P. A., Ayalon, L., Jin, C., McCulloch, C. E., Linkins, K., Chen, H., et al. (2008). Retracted: Integrated specialty mental health care among older minorities improves access but not outcomes: Results of the PRISMe study. International Journal of Geriatric Psychiatry: A Journal of the Psychiatry of Late Life and Allied Sciences, 23(10).
Armstrong, M. A., Kaskutas, L. A., Witbrodt, J., Taillac, C. J., Hung, Y. Y., Osejo, V. M., & Escobar, G. J. (2009). Using drink size to talk about drinking during pregnancy: A randomized clinical trial of Early Start Plus. Social Work in Health Care, 48(1), 90–103.
Arranz, B., Garriga, M., García-Rizo, C., & San, L. (2018). Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review. European Neuropsychopharmacology, 28(2), 227–242.PubMedCrossRef
Bachmeier, R., Bick-Dresen, S., Dreckmann, I., Feindel, H., Funke, W., Kemmann, D., et al. (2019). Effektivität der stationären Suchtrehabilitation – FVS-Katamnese des Entlassjahrgangs 2016 von Fachkliniken für Alkohol- und Medikamentenabhängige. Sucht Aktuell, 26(1), 34–50.
Back, S. E. (2014).Concurrent treatment of PTSD and substance use disorders using prolonged exposure (COPE): Therapist guide. Treatments That Work.
Back, S. E., Brady, K. T., Sonne, S. C., & Verduin, M. L. (2006). Symptom improvement in co-occurring PTSD and alcohol dependence. The Journal of Nervous and Mental Disease, 194(9), 690–696.PubMedCrossRef
Back, S. E., Killeen, T., Badour, C. L., Flanagan, J. C., Allan, N. P., Santa Ana, E., et al. (2019). Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addictive behaviors, 90, 369–377.PubMedCrossRef
Backmund, M. (2007). Drogennotfälle im Jugendalter. In C. Möller (Hrsg.), Sucht im Jugendalter. Vandenhoeck & Ruprecht.
Bailey, K., Trevillion, K., & Gilchrist, G. (2019). What works for whom and why: A narrative systematic review of interventions for reducing post-traumatic stress disorder and problematic substance use among women with experiences of interpersonal violence. Journal of substance abuse treatment, 99, 88–103.PubMedCrossRef
Baker, A., Lewin, T., Reichler, H., Clancy, R., Carr, V., Garrett, R., et al. (2002a). Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatrica Scandinavica, 106(3), 233–240.PubMedCrossRef
Baker, A., Lewin, T., Reichler, H., Clancy, R., Carr, V., Garrett, R., et al. (2002b). Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction, 97(10), 1329–1337.PubMedCrossRef
Baker, A., Bucci, S., Lewin, T. J., Kay-Lambkin, F., Constable, P. M., & Carr, V. J. (2006). Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: randomised controlled trial. The British Journal of Psychiatry, 188(5), 439–448.PubMedCrossRef
Baker, A., Turner, A., Kay-Lambkin, F. J., & Lewin, T. J. (2009a). The long and the short of treatments for alcohol or cannabis misuse among people with severe mental disorders. Addictive behaviors, 34(10), 852–858.PubMedCrossRef
Baker, A. L., Kavanagh, D. J., Kay-Lambkin, F. J., Hunt, S. A., Lewin, T. J., Carr, V. J., & Connolly, J. (2009b). Randomized controlled trial of cognitive–behavioural therapy for coexisting depression and alcohol problems: short-term outcome. Addiction, 105(1), 87–99.PubMedCrossRef
Baker, A. L., Hiles, S. A., Thornton, L. K., Hides, L., & Lubman, D. I. (2012a). A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders. Acta Psychiatrica Scandinavica, 126(4), 243–255.
Baker, A. L., Thornton, L. K., Hiles, S., Hides, L., & Lubman, D. I. (2012b). Psychological interventions for alcohol misuse among people with co-occurring depression or anxiety disorders: a systematic review. Journal of affective disorders, 139(3), 217–229.PubMedCrossRef
Ball, S. A. (1998). Manualized treatment for substance abusers with personality disorders: Dual focus schema therapy. Addictive Behaviors, 23(6), 883–891.PubMedCrossRef
Ball, S. A., Cobb-Richardson, P., Connolly, A. J., Bujosa, C. T., & O’Neall, T. W. (2005). Substance abuse and personality disorders in homeless drop-in center clients: symptom severity and psychotherapy retention in a randomized clinical trial. Comprehensive Psychiatry, 46(5), 371–379.PubMedCrossRef
Ball, S. A., Maccarelli, L. M., LaPaglia, D. M., & Ostrowski, M. J. (2011). Randomized trial of dual-focused versus single-focused individual therapy for personality disorders and substance dependence. The Journal of Nervous and Mental Disease, 199(5), 319–328.PubMedPubMedCentralCrossRef
Barata, I. A., Shandro, J. R., Montgomery, M., Polansky, R., Sachs, C. J., Duber, H. C., et al. (2017). Effectiveness of SBIRT for alcohol use disorders in the emergency department: a systematic review. Western journal of emergency medicine, 18(6), 1143–1152.PubMedPubMedCentralCrossRef
Barrowclough, C., Haddock, G., Wykes, T., Beardmore, R., Conrod, P., Craig, T., et al. (2010). Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ, 341, c6325.PubMedPubMedCentralCrossRef
Bartels, S. J., Coakley, E. H., Zubritsky, C., Ware, J. H., Miles, K. M., Areán, P. A., et al. (2004). Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use. American Journal of Psychiatry, 161(8), 1455–1462.PubMedCrossRef
Batki, S. L., Dimmock, J. A., Wade, M., Gately, P. W., Cornell, M., Maisto, S. A., et al. (2007). Monitored naltrexone without counseling for alcohol abuse/dependence in schizophrenia-spectrum disorders. American Journal on Addictions, 16(4), 253–259.PubMedCrossRef
Bauer, U., & Hasenöhrl, A. (2000). Therapieerfolg Alkoholabhängiger nach qualifizierter Entzugsbehandlung und konventioneller Entgiftung (vergleichende 28-Monats-Katamnese). Sucht, 46(4), 250–259.CrossRef
Baumann, S., Gaertner, B., Haberecht, K., Bischof, G., John, U., & Freyer-Adam, J. (2018). How alcohol use problem severity affects the outcome of brief intervention delivered in-person versus through computer-generated feedback letters. Drug and alcohol dependence, 183, 82–88.PubMedCrossRef
Becker, T., Riedel-Heller, S., & Weinmann, S. (2013). S3-Leitlinie Psychosoziale Therapien bei schweren psychischen Erkrankungen (S3-Praxisleitlinien in Psychiatrie und Psychotherapie). Springer.
Beckmann, U., & Naumann, B. (2012). Suchtrehabilitation durch die Rentenversicherung. Jahrbuch Sucht, 241–256. Pabst
Beesdo-Baum, K., Zaudig, M., & Wittchen, H. U. (Hrsg.). (2019). SCID-5-PD. Strukturiertes Klinisches Interview für DSM-5 – Persönlichkeitsstörungen. Hogrefe.
Bekdash, R. A., Zhang, C., & Sarkar, D. K. (2013). Gestational choline supplementation normalized fetal alcohol-induced alterations in histone modifications, DNA methylation, and proopiomelanocortin (POMC) gene expression in β-endorphin-producing POMC neurons of the hypothalamus. Alcoholism: Clinical and Experimental Research, 37(7), 1133–1142.
Bell, H., Tallaksen, C. M., Try, K., & Haug, E. (1994). Carbohydrate-deficient transferrin and other markers of high alcohol consumption: A study of 502 patients admitted consecutively to a medical department. Alcoholism: Clinical and Experimental Research, 18(5), 1103–1108.PubMedCrossRef
Bennett, M. E., Bradshaw, K. R., & Catalano, L. T. (2017). Treatment of substance use disorders in schizophrenia. The American Journal of Drug and Alcohol Abuse, 43(4), 377–390.PubMedCrossRef
Benshoff, J. J., Harrawood, L. K., & Koch, D. S. (2003). Substance abuse and the elderly: Unique issues and concerns. Journal of rehabilitation, 69(2), 43–48.
Berg, K. M., Piper, M. E., Smith, S. S., Fiore, M. C., & Jorenby, D. E. (2015). Defining and predicting short-term alcohol use changes during a smoking cessation attempt. Addictive Behaviors, 48, 52–57.PubMedPubMedCentralCrossRef
Berner, M. M., Wahl, S., Brueck, R., Frick, K., Smolka, R., Haug, M., et al. (2014). The place of additional individual psychotherapy in the treatment of alcoholism: a randomized controlled study in nonresponders to anticraving medication—results of the PREDICT study. Alcoholism: Clinical and Experimental Research, 38(4), 1118–1125.PubMedCrossRef
Bernstein, J., Heeren, T., Edward, E., Dorfman, D., Bliss, C., Winter, M., & Bernstein, E. (2010). A brief motivational interview in a pediatric emergency department, plus 10-day telephone follow-up, increases attempts to quit drinking among youth and young adults who screen positive for problematic drinking. Academic Emergency Medicine, 17(8), 890–902.PubMedPubMedCentralCrossRef
Bertholet, N., Daeppen, J. B., Wietlisbach, V., Fleming, M., & Burnand, B. (2005). Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Archives of internal medicine, 165(9), 986–995.PubMedCrossRef
Beyer, F., Lynch, E., & Kaner, E. (2018). Brief interventions in primary care: an evidence overview of practitioner and digital intervention programmes. Current addiction reports, 5(2), 265–273.PubMedPubMedCentralCrossRef
Bhat, A., & Hadley, A. (2015). The management of alcohol withdrawal in pregnancy—case report, literature review and preliminary recommendations. General hospital psychiatry, 37(3), 273.e1–273.e3.PubMedCrossRef
Bick-Dresen, S., Bachmeier, R., Deichler, M.-L., Forschner, L., Funke, W., Herder, F., et al. (2019). Effektivität der Ganztätig ambulanten Suchtehabilitation – FVS-Katamnese des Entlassjahrgangs 2016 aus Einrichtungen Alkohol- und Medikamentenabhängiger. Sucht Aktuell, 26(1), 84–95.
Bird, R. D., & Makela, E. H. (1994). Alcohol withdrawal: what is the benzodiazepine of choice? Annals of Pharmacotherapy, 28(1), 67–71.PubMedCrossRef
Birkeland, B., Foster, K., Selbekk, A. S., Høie, M. M., Ruud, T., & Weimand, B. (2018). The quality of life when a partner has substance use problems: a scoping review. Health and quality of life outcomes, 16(1).
Biroscak, B. J., Pantalon, M. V., Dziura, J. D., Hersey, D. P., & Vaca, F. E. (2019). Use of non–face-to-face modalities for emergency department screening, brief intervention, and referral to treatment (ED-SBIRT) for high-risk alcohol use: A scoping review. Substance abuse, 40(1), 20–32.PubMedCrossRef
Bischof, G., Iwen, J., & Müller, C. W. (2016). Efficacy of the community reinforcement and family training for treatment-resistant individuals with alcohol use disorders: A randomized controlled trial. Drug and Alcohol Dependence, 163, 179–185.PubMedCrossRef
Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D., Charney, D. S., & Keane, T. M. (1995). The development of a clinician-administered PTSD scale. Journal of Traumatic Stress, 8(1), 75–90.PubMedCrossRef
Blankers, M., Koeter, M. W., & Schippers, G. M. (2011). Internet therapy versus internet self-help versus no treatment for problematic alcohol use: A randomized controlled trial. Journal of consulting and clinical psychology, 79(3), 330.PubMedCrossRef
Blodgett, J. C., Del Re, A. C., Maisel, N. C., & Finney, J. W. (2014). A meta-analysis of topiramate’s effects for individuals with alcohol use disorders. Alcoholism: Clinical and Experimental Research, 38(6), 1481–1488.PubMedCrossRef
Bobo, J. K., Walker, R. D., Lando, H. A., & McIlvain, H. E. (1995). Enhancing alcohol control with counseling on nicotine dependence: Pilot study findings and treatment implications. In J. B. Fertig & J. P. Allen (Hrsg.), Alcohol and tobacco: From basic science to clinical practice (Research Monograph No. 30, S. 225–238). National Institute on Alcohol and Alcoholism.
Bobo, J. K., Mcilvain, H. E., Lando, H. A., Walker, R. D., & Leed-Kelly, A. (1998). Effect of smoking cessation counseling on recovery from alcoholism: findings from a randomized community intervention trial. Addiction, 93(6), 877–887.PubMedCrossRef
Boden, J. M., & Fergusson, D. M. (2011). Alcohol and depression. Addiction, 106(5), 906–914.PubMedCrossRef
Boffo, M., Zerhouni, O., Gronau, Q. F., van Beek, R. J., Nikolaou, K., Marsman, M., & Wiers, R. W. (2019). Cognitive bias modification for behavior change in alcohol and smoking addiction. Bayesiana meta-analysis of individual participant data. Neuropsychology Review, 29(1), 52–78.PubMedPubMedCentralCrossRef
Böhm, K., Mardorf, S., Nöthen, M., Schelhase, T., Hoffmann, E., Hokema, A., … & Wurm, S. (2009). Gesundheit und Krankheit im Alter. Robert-Koch Institut.
Boniface, S., Malet-Lambert, I., Coleman, R., Deluca, P., Donoghue, K., Drummond, C., & Khadjesari, Z. (2018). The effect of brief interventions for alcohol among people with comorbid mental health conditions: a systematic review of randomized trials and narrative synthesis. Alcohol and Alcoholism, 53(3), 282–293.PubMedCrossRef
Bonnet, U., & Scherbaum, N. (2017). How addictive are gabapentin and pregabalin? A systematic review. European neuropsychopharmacology, 27(12), 1185–1215.PubMedCrossRef
Bonnet, U., Banger, M., Leweke, F. M., Specka, M., Müller, B. W., Hashemi, T., et al. (2003). Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial. Journal of clinical psychopharmacology, 23(5), 514–519.PubMedCrossRef
Bonnet, U., Schäfer, M., Richter, C., Milkereit, J., Wiltfang, J., Scherbaum, N., & Lieb, B. (2009a). Anticonvulsants in the treatment of alcoholism. Fortschritte der Neurologie-psychiatrie, 77(4), 192–202.PubMedCrossRef
Bonnet, U., Specka, M., Abedi, R. H., Wiltfang, J., & Scherbaum, N. (2009b). Severe protracted alcohol withdrawal syndrome: prevalence and pharmacological treatment at an inpatient detoxification unit-a naturalistic study. Pharmacopsychiatry, 42(2), 76–78.PubMedCrossRef
Bonnet, U., Hamzavi-Abedi, R., Specka, M., Wiltfang, J., Lieb, B., & Scherbaum, N. (2010). An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol. Alcohol & Alcoholism, 45(2), 143–145.CrossRef
Booth, B. M., & Blow, F. C. (1993). The kindling hypothesis: further evidence from a US national study of alcoholic men. Alcohol and Alcoholism, 28(5), 593–598.PubMed
Bottlender, M., Köhler, J., & Soyka, M. (2006). Effektivität psychosozialer Behandlungsmethoden zur medizinischen Rehabilitation alkoholabhängiger Patienten. Fortschritte der Neurologie· Psychiatrie, 74(01), 19–31.PubMedCrossRef
Bradizza, C. M., Stasiewicz, P. R., & Paas, N. D. (2006). Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. Clinical Psychology Review, 26(2), 162–178.PubMedCrossRef
Bradley, K. A., Rubinsky, A. D., Sun, H., Bryson, C. L., Bishop, M. J., Blough, D. K., et al. (2011). Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. Journal of general internal medicine, 26(2), 162–169.PubMedCrossRef
Brady, K. T., Myrick, H., Henderson, S., & Coffey, S. F. (2002). The use of divalproex in alcohol relapse prevention: a pilot study. Drug and Alcohol Dependence, 67(3), 323–330.PubMedCrossRef
Brady, K. T., Sonne, S., Anton, R. F., Randall, C. L., Back, S. E., & Simpson, K. (2005). Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcoholism: Clinical and Experimental Research, 29(3), 395–401.PubMedCrossRef
Braun, B., Behrendt, S., Piontek, D., Kraus, L., & Bühringer, G. (2019). Therapie alkoholbezogener Störungen im Alter: Ergebnisse der deutschen Stichprobe der randomisiert-kontrollierten ELDERLY-Studie1 bis zum 12-Monats-Follow-up. Sucht, 65(2), 101–114.CrossRef
Brenner, L. M., Karper, L. P., & Krystal, J. H. (1994). Short-term use of disulfiram with clozapine. Journal of Clinical Psychopharmacology, 14(3), 213–214.PubMedCrossRef
Breslau, N., Peterson, E., Schultz, L., Andreski, P., & Chilcoat, H. (1996). Are smokers with alcohol disorders less likely to quit? American Journal of Public Health, 86(7), 985–990.PubMedPubMedCentralCrossRef
Breslow, R. A., Faden, V. B., & Smothers, B. (2003). Alcohol consumption by elderly Americans. Journal of Studies on Alcohol, 64(6), 884–892.PubMedCrossRef
British Medical Association. (1995). Guidelines on sensible drinking. British Medical Association.
Brown, M. E., Anton, R. F., Malcolm, R., & Ballenger, J. C. (1988). Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biological psychiatry, 23(5), 507–514.PubMedCrossRef
Brown, R. A., Evans, D. M., Miller, I. W., Burgess, E. S., & Mueller, T. I. (1997). Cognitive–behavioral treatment for depression in alcoholism. Journal of Consulting and Clinical Psychology, 65(5), 715–726.PubMedPubMedCentralCrossRef
Brown, R. A., Ramsey, S. E., Kahler, C. W., Palm, K. M., Monti, P. M., Abrams, D., et al. (2011). A randomized controlled trial of cognitive-behavioral treatment for depression versus relaxation training for alcohol-dependent individuals with elevated depressive symptoms. Journal of Studies on Alcohol and Drugs, 72(2), 286–296.PubMedPubMedCentralCrossRef
Brown, S. A., Inaba, R. K., Gillin, J. C., Schuckit, M. A., Stewart, M. A., & Irwin, M. R. (1995). Alcoholism and affective disorder: clinical course of depressive symptoms. The American journal of psychiatry, 152(1), 45–52.PubMedCrossRef
Brunette, M. F., Drake, R. E., Xie, H., McHugo, G. J., & Green, A. I. (2006). Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophrenia Bulletin, 32(4), 637–643.PubMedPubMedCentralCrossRef
Brunette, M. F., Dawson, R., O’Keefe, C. D., Narasimhan, M., Noordsy, D. L., Wojcik, J., & Green, A. I. (2011). A randomized trial of clozapine versus other antipsychotics for cannabis use disorder in patients with schizophrenia. Journal of Dual Diagnosis, 7(1–2), 50–63.PubMedPubMedCentralCrossRef
Bschor, T., Henssler, J., Müller, M., & Baethge, C. (2018). Baclofen for alcohol use disorder—a systematic meta-analysis. Acta Psychiatrica Scandinavica, 138(3), 232–242.PubMedCrossRef
Buckingham, T. A., Kennedy, H. L., Goenjian, A. K., Vasilomanolakis, E. C., Shriver, K. K., Sprague, M. K., & Lyyski, D. (1985). Cardiac arrhythmias in a population admitted to an acute alcoholic detoxification center. American heart journal, 110(5), 961–965.PubMedCrossRef
Buckman, J. F., Bates, M. E., & Cisler, R. A. (2007). Social networks and their influence on drinking behaviors: differences related to cognitive impairment in clients receiving alcoholism treatment. Journal of Studies on Alcohol and Drugs, 68(5), 738–747.PubMedCrossRef
Buechler, C., Schäffler, A., Johann, M., Neumeier, M., Köhl, P., Weiss, T., et al. (2009). Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal. Journal of gastroenterology and hepatology, 24(4), 558–563.PubMedCrossRef
Burleson, J. A., Kaminer, Y., & Burke, R. H. (2012). Twelve-month follow-up of aftercare for adolescents with alcohol use disorders. Journal of substance abuse treatment, 42(1), 78–86.PubMedCrossRef
Burling, T. A., Marshall, G. D., & Seidner, A. L. (1991). Smoking cessation for substance abuse inpatients. Journal of Substance Abuse, 3(3), 269–276.PubMedCrossRef
Burling, T. A., Seidner Burling, A., & Latini, D. (2001). A controlled smoking cessation trial for substance-dependent inpatients. Journal of Consulting and Clinical Psychology, 69(2), 295–304.PubMedCrossRef
Burnam, M. A., Morton, S. C., McGlynn, E. A., Petersen, L. P., Stecher, B. M., Hayes, C., & Vaccaro, J. V. (1996). An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases, 14(4), 111–134.CrossRef
Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Archives of internal medicine, 158(16), 1789–1795.PubMedCrossRef
Byrne, S. A., & Petry, N. M. (2011). Concurrent alcohol dependence among methadone-maintained cocaine abusers is associated with greater abstinence. Experimental and clinical psychopharmacology, 19(2), 116.PubMedPubMedCentralCrossRef
Cafferky, B. M., Mendez, M., Anderson, J. R., & Stith, S. M. (2018). Substance use and intimate partner violence: A meta-analytic review. Psychology of Violence, 8(1), 110–131.CrossRef
Calabria, B., Shakeshaft, A. P., & Havard, A. (2011). A systematic and methodological review of interventions for young people experiencing alcohol-related harm. Addiction, 106(8), 1406–1418.PubMedCrossRef
Campbell, B. K., Wander, N., Stark, M. J., & Holbert, T. (1995). Treating cigarette smoking in drug-abusing clients. Journal of Substance Abuse Treatment, 12(2), 89–94.PubMedCrossRef
Capone, C., Kahler, C. W., Swift, R. M., & O’Malley, S. S. (2011). Does family history of alcoholism moderate naltrexone’s effects on alcohol use? Journal of Studies on Alcohol and Drugs, 72(1), 135–131.PubMedCrossRef
Carey, K. B., Carey, M. P., Henson, J. M., Maisto, S. A., & DeMartini, K. S. (2011). Brief alcohol interventions for mandated college students: Comparison of face-to-face counseling and computer-delivered interventions. Addiction, 106(3), 528–537.PubMedCrossRef
Cargiulo, T. (2007). Understanding the health impact of alcohol dependence. American Journal of Health-System Pharmacy, 64(5 Suppl 3), 5–11.CrossRef
Carmody, T. P., Delucchi, K., Duncan, C. L., Banys, P., Simon, J. A., Solkowitz, S. N., et al. (2012). Intensive intervention for alcohol-dependent smokers in early recovery: A randomized trial. Drug and Alcohol Dependence, 122(3), 186–194.PubMedCrossRef
Carney, T., Myers, B. J., Louw, J., & Okwundu, C. I. (2016). Brief school-based interventions and behavioural outcomes for substance-using adolescents. Cochrane database of systematic reviews, (1).
Carroll, K. M., Nich, C., Ball, S. A., McCance, E., & Rounsavile, B. J. (1998). Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction, 93(5), 713–727.PubMedCrossRef
Cassidy, C. M., Schmitz, N., & Malla, A. (2008). Validation of the alcohol use disorders identification test and the drug abuse screening test in first episode psychosis. The Canadian Journal of Psychiatry, 53(1), 26–33.PubMedCrossRef
Cassidy, F., Ahearn, E. P., & Carroll, B. J. (2001). Substance abuse in bipolar disorder. Bipolar Disorders, 3(4), 181–188.PubMedCrossRef
Cerullo, M. A., & Strakowski, S. M. (2007). The prevalence and significance of substance use disorders in bipolar type I and II disorder. Substance Abuse Treatment, Prevention, and Policy, 2(1), 29.PubMedPubMedCentralCrossRef
Chandler, D. W., & Spicer, G. (2006). Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders. Community Mental Health Journal, 42(4), 405–425.PubMedCrossRef
Chang, G., Wilkins-Haug, L., Berman, S., & Goetz, M. A. (1999). Brief intervention for alcohol use in pregnancy: a randomized trial. Addiction, 94(10), 1499–1508.PubMedCrossRef
Chang, G., Goetz, M. A., Wilkins-Haug, L., & Berman, S. (2000). A brief intervention for prenatal alcohol use an in-depth look. Journal of Substance Abuse Treatment, 18(4), 365–369.PubMedCrossRef
Chang, G., McNamara, T. K., Orav, E. J., Koby, D., Lavigne, A., Ludman, B., et al. (2005). Brief intervention for prenatal alcohol use: a randomized trial. Obstetrics and gynecology, 105(5 Pt 1), 991–998.PubMedCrossRef
Chang, G., McNamara, T. K., Orav, E. J., & Wilkins-Haug, L. (2006). Brief intervention for prenatal alcohol use: the role of drinking goal selection. Journal of substance abuse treatment, 31(4), 419–424.PubMedCrossRef
Chang, G., McNamara, T., Wilkins-Haug, L., & Orav, E. J. (2007). Stages of change and prenatal alcohol use. Journal of substance abuse treatment, 32(1), 105–109.PubMedCrossRef
Chang, P. H., & Steinberg, M. B. (2001). Alcohol withdrawal. Medical Clinics of North America, 85(5), 1191–1212.PubMedCrossRef
Chang, Z., Lichtenstein, P., Halldner, L., D’Onofrio, B., Serlachius, E., Fazel, S., et al. (2014). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55(8), 878–885.PubMedCrossRef
Chaparro, L. E., Wiffen, P. J., Moore, R. A., & Gilron, I. (2012). Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database of Systematic Reviews, (7), CD008943.
Charney, D. A., Heath, L. M., Zikos, E., Palacios-Boix, J., & Gill, K. J. (2015). Poorer drinking outcomes with citalopram treatment for alcohol dependence: A randomized, double-blind, placebo-controlled trial. Alcoholism: Clinical and Experimental Research, 39(9), 1756–1765.PubMedCrossRef
Chen, H., Coakley, E. H., Cheal, K., Maxwell, J., Costantino, G., Krahn, D. D., et al. (2006). Satisfaction with mental health services in older primary care patients. The American journal of geriatric psychiatry, 14(4), 371–379.PubMedCrossRef
Chen, I. C., Chie, W. C., Hwu, H. G., Chou, S. Y., Yeh, Y. C., Yu, C. Y., & Tan, H. K. L. (2011). Alcohol use problem among patients in methadone maintenance treatment in Taiwan. Journal of substance abuse treatment, 40(2), 142–149.PubMedCrossRef
Chermack, S. T., Bonar, E. E., Ilgen, M. A., Walton, M. A., Cunningham, R. M., Booth, B. M., & Blow, F. C. (2017). Developing an integrated violence prevention for men and women in treatment for substance use disorders. Journal of interpersonal violence, 32(4), 581–603.PubMedCrossRef
Choenni, V., Hammink, A., & van de Mheen, D. (2017). Association between substance use and the perpetration of family violence in industrialized countries: A systematic review. Trauma, Violence, & Abuse, 18(1), 37–50.CrossRef
Ciraulo, D. A., & Shader, R. I. (Hrsg.). (1991). Clinical manual of chemical dependence. American Psychiatric Press.
Cleary, M., Hunt, G. E., Matheson, S. L., Siegfried, N., & Walter, G. (2008a). Psychosocial treatment programs for people with both severe mental illness and substance misuse. Schizophrenia Bulletin, 34(2), 226–228.PubMedPubMedCentralCrossRef
Cleary, M., Hunt, G. E., Matheson, S. L., Siegfried, N., & Walter, G. (2008b). Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews, (1), CD001088.
Coatsworth, J. D., Santisteban, D. A., McBride, C. K., & Szapocznik, J. (2001). Brief strategic family therapy versus community control: Engagement, retention, and an exploration of the moderating role of adolescent symptom severity. Family Process, 40(3), 313–332.PubMedCrossRef
Cobain, K., Owens, L., Kolamunnage-Dona, R., Fitzgerald, R., Gilmore, I., & Pirmohamed, M. (2011). Brief interventions in dependent drinkers: a comparative prospective analysis in two hospitals. Alcohol and Alcoholism, 46(4), 434–440.PubMedCrossRef
Coffey, S. F., Stasiewicz, P. R., Hughes, P. M., & Brimo, M. L. (2006). Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: Revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychology of Addictive Behaviors, 20(4), 425.PubMedCrossRef
Coffey, S. F., Schumacher, J. A., Nosen, E., Littlefield, A. K., Henslee, A. M., Lappen, A., & Stasiewicz, P. R. (2016). Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: A randomized controlled trial. Psychology of Addictive Behaviors, 30(7), 778–790.PubMedPubMedCentralCrossRef
Cohen, L. R., Field, C., Campbell, A. N., & Hien, D. A. (2013). Intimate partner violence outcomes in women with PTSD and substance use: A secondary analysis of NIDA Clinical Trials Network „Women and Trauma“ Multi-site Study. Addictive behaviors, 38(7), 2325–2332.PubMedPubMedCentralCrossRef
Cohen, P., Chen, H., Crawford, T. N., Brook, J. S., & Gordon, K. (2007). Personality disorders in early adolescence and the development of later substance use disorders in the general population. Drug and Alcohol Dependence, 88, 71–84.CrossRef
Conklin, C. A., & Tiffany, S. T. (2002). Applying extinction research and theory to cue-exposure addiction treatments. Addiction, 97(2), 155–167.PubMedCrossRef
Cooney, J. L., Cooper, S., Grant, C., Sevarino, K., Krishnan-Sarin, S., Gutierrez, I. A., & Cooney, N. L. (2017). A randomized trial of contingency management for smoking cessation during intensive outpatient alcohol treatment. Journal of Substance Abuse Treatment, 72, 89–96.PubMedCrossRef
Cooney, N. L., Litt, M. D., Cooney, J. L., Pilkey, D. T., Steinberg, H. R., & Oncken, C. A. (2007). Concurrent brief versus intensive smoking intervention during alcohol dependence treatment. Psychology of Addictive Behaviors, 21(4), 570–575.PubMedPubMedCentralCrossRef
Cooney, N. L., Cooney, J. L., Perry, B. L., Carbone, M., Cohen, E. H., Steinberg, H. R., et al. (2009). Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum. Addiction, 104(9), 1588–1596.PubMedPubMedCentralCrossRef
Cooney, N. L., Litt, M. D., Sevarino, K. A., Levy, L., Kranitz, L. S., Sackler, H., & Cooney, J. L. (2015). Concurrent alcohol and tobacco treatment: Effect on daily process measures of alcohol relapse risk. Journal of Consulting and Clinical Psychology, 83(2), 346–358.PubMedPubMedCentralCrossRef
Cornelius, J. R., Salloum, I. M., Ehler, J. G., Jarrett, P. J., Cornelius, M. D., Perel, J. M., et al. (1997). Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial. Archives of General Psychiatry, 54(8), 700–705.PubMedCrossRef
Cornelius, J. R., Perkins, K. A., Salloum, I. M., Thase, M. E., & Moss, H. B. (1999). Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients. Journal of Clinical Psychopharmacology, 19(2), 183–184.PubMedCrossRef
Cornelius, J. R., Chung, T., Douaihy, A. B., Kirisci, L., Glance, J., Kmiec, J., et al. (2016). Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial. Psychiatry Research, 242, 326–330.PubMedPubMedCentralCrossRef
Corrao, G., Bagnardi, V., Zambon, A., & Torchio, P. (1998). Meta-analysis of alcohol intake in relation to risk of liver cirrhosis. Alcohol and Alcoholism, 33(4), 381–392.PubMedCrossRef
Corrao, G., Bagnardi, V., Zambon, A., & La Vecchia, C. (2004). A meta-analysis of alcohol consumption and the risk of 15 diseases. Preventive medicine, 38(5), 613–619.PubMedCrossRef
Craft, P. P., Foil, M. B., Cunningham, P. R., Patselas, P. C., Long-Snyder, B. M., & Collier, M. S. (1994). Intravenous ethanol for alcohol detoxification in trauma patients. Southern medical journal, 87(1), 47–54.PubMedCrossRef
Craig, T. K., Johnson, S., McCrone, P., Afuwape, S., Hughes, E., Gournay, K., et al. (2008). Integrated care for co-occurring disorders: psychiatric symptoms, social functioning, and service costs at 18 months. Psychiatric Services, 59(3), 276–282.PubMedCrossRef
Crockford, D., & Addington, D. (2017). Canadian schizophrenia guidelines: schizophrenia and other psychotic disorders with coexisting substance use disorders. The Canadian Journal of Psychiatry, 62(9), 624–634.PubMedCrossRef
Croissant, B., Loeber, S., Diehl, A., Nakovics, H., Wagner, F., Kiefer, F., & Mann, K. (2009). Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal-a RCT. Pharmacopsychiatry, 42(05), 175–181.
Crunelle, C. L., Van Den Brink, W., Moggi, F., Konstenius, M., Franck, J., Levin, F. R., et al. (2018). International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder. European Addiction Research, 24(1), 43–51.PubMedCrossRef
Cummings, A. M., Gallop, R. J., & Greenfield, S. F. (2010). Self-efficacy and substance use outcomes for women in single-gender versus mixed-gender group treatment. Journal of groups in addiction & recovery, 5(1), 4–16.CrossRef
Curtis, J. R., Geller, G., Stokes, E. J., Levine, D. M., & Moore, R. D. (1989). Characteristics, diagnosis, and treatment of alcoholism in elderly patients. Journal of the American Geriatrics Society, 37(4), 310–316.PubMedCrossRef
Daeppen, J. B., Gache, P., Landry, U., Sekera, E., Schweizer, V., Gloor, S., & Yersin, B. (2002). Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Archives of internal medicine, 162(10), 1117–1121.PubMedCrossRef
Dahlgren, L., & Willander, A. (1989). Are special treatment facilities for female alcoholics needed? A controlled 2-year follow-up study from a specialized female unit (EWA) versus a mixed male/female treatment facility. Alcoholism: Clinical and Experimental Research, 13(4), 499–504.PubMedCrossRef
Daigre, C., Roncero, C., Rodríguez-Cintas, L., Ortega, L., Lligoña, A., Fuentes, S., et al. (2015). Adult ADHD screening in alcohol-dependent patients using the Wender–Utah Rating Scale and the adult ADHD Self-Report Scale. Journal of Attention Disorders, 19(4), 328–334.PubMedCrossRef
Dalsgaard, S., Leckman, J. F., Mortensen, P. B., Nielsen, H. S., & Simonsen, M. (2015a). Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study. The Lancet Psychiatry, 2(8), 702–709.PubMedCrossRef
Dalsgaard, S., Østergaard, S. D., Leckman, J. F., Mortensen, P. B., & Pedersen, M. G. (2015b). Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. The Lancet, 385(9983), 2190–2196.CrossRef
van Dam, D., Vedel, E., Ehring, T., & Emmelkamp, P. M. (2012). Psychological treatments for concurrent posttraumatic stress disorder and substance use disorder: A systematic review. Clinical psychology review, 32(3), 202–214.PubMedCrossRef
Dar, K. (2006). Alcohol use disorders in elderly people: fact or fiction? Advances in Psychiatric Treatment, 12(3), 173–181.CrossRef
Darker, C. D., Sweeney, B., Keenan, E., Whiston, L., Anderson, R., & Barry, J. (2016). Screening and brief interventions for illicit drug use and alcohol use in methadone maintained opiate-dependent patients: Results of a pilot cluster randomized controlled trial feasibility study. Substance Use & Misuse, 51(9), 1104–1115.CrossRef
Dass-Brailsford, P., & Myrick, A. C. (2010). Psychological trauma and substance abuse: The need for an integrated approach. Trauma, Violence, & Abuse, 11(4), 202–213.CrossRef
Dauber, H., Pogarell, O., Kraus, L., & Braun, B. (2018). Older adults in treatment for alcohol use disorders: service utilisation, patient characteristics and treatment outcomes. Substance abuse treatment, prevention, and policy, 13(40).
Davey, C. J., Landy, M. S., Pecora, A., Quintero, D., & McShane, K. E. (2015). A realist review of brief interventions for alcohol misuse delivered in emergency departments. Systematic reviews, 4(1), 45.PubMedPubMedCentralCrossRef
Davies, G. A., Maxwell, C., McLeod, L., Gagnon, R., Basso, M., Bos, H., et al. (2010). SOGC Clinical Practice Guidelines: Obesity in pregnancy. No. 239, February 2010. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 110(2), 167–173.
Dawson, D. A., Grant, B. F., Stinson, F. S., & Zhou, Y. (2005). Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcoholism: Clinical and Experimental Research, 29(5), 844–854.PubMedCrossRef
Day, E., Bentham, P., Callaghan, R., Kuruvilla, T., & George, S. (2004). Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse. Cochrane Database of Systematic Reviews, (1) CD004033.
De Beaurepaire, R., Sinclair, J., Heydtmann, M., Addolorato, G., Aubin, H. J., Beraha, E. M., et al. (2019). The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective. Frontiers in psychiatry, 9, 708.PubMedPubMedCentralCrossRef
Deady, M., Teesson, M., Kay-Lambkin, J., & F. (2014). Treatments for co-occurring depression and substance use in young people: a systematic review. Current drug abuse reviews, 7(1), 3–17.PubMedCrossRef
Deas, D., Randall, C. L., Roberts, J. S., & Anton, R. F. (2000). A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study. Human Psychopharmacology: Clinical and Experimental, 15(6), 461–469.PubMedCrossRef
Debell, F., Fear, N. T., Head, M., Batt-Rawden, S., Greenberg, N., Wessely, S., & Goodwin, L. (2014). A systematic review of the comorbidity between PTSD and alcohol misuse. Social psychiatry and psychiatric epidemiology, 49(9), 1401–1425.PubMedCrossRef
DeBellis, R., Smith, B. S., Choi, S., & Malloy, M. (2005). Management of delirium tremens. Journal of intensive care medicine, 20(3), 164–173.PubMedCrossRef
Dedert, E. A., McDuffie, J. R., Stein, R., McNiel, J. M., Kosinski, A. S., Freiermuth, C. E., et al. (2015). Electronic interventions for alcohol misuse and alcohol use disorders: a systematic review. Annals of internal medicine, 163(3), 205–214.PubMedPubMedCentralCrossRef
Dermody, S. S., Tidey, J. W., Denlinger, R. L., Pacek, L. R., al’Absi, M., Drobes, D. J., et al. (2016). The impact of smoking very low nicotine content cigarettes on alcohol use. Alcoholism: Clinical and Experimental Research, 40(3), 606–615.PubMedCrossRef
Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde e. V. (DGPPN) (Hrsg.). (2006). S3-Praxisleitlinien in Psychiatrie und Psychotherapie (Band 1: Schizophrenie) (S. 43–109). Steinkopff.
Deutsche Gesellschaft für Suchtforschung und Suchttherapie (DGSS). (2001). Dokumentationsstandards III für die Evaluation der Behandlung von Abhängigen. Sucht, 47(8), 3–94.
Deutsche Hauptstelle für Suchtfragen e.V (Hrsg.). (2013). Jahrbuch Sucht 2013. Lengerich, 2013, 227–241.
Deutsche Rentenversicherung. (2016). Reha-Therapiestandards Alkoholabhängigkeit – Leitlinie für die medizinische Rehabilitation der Rentenversicherung. Stand: 01.2016.
Deutschen Gesellschaft für Psychiatrie Psychotherapie und Nervenheilkunde e. V. (DGPPN) (Hrsg.). (2018). S3-Leitlinie Psychosoziale Therapien bei schweren psychischen Erkrankungen. S3-Praxisleitlinien in Psychiatrie und Psychotherapie. (2. Aufl) Springer Berlin.
Devries, K. M., Child, J. C., Bacchus, L. J., Mak, J., Falder, G., Graham, K., et al. (2014). Intimate partner violence victimization and alcohol consumption in women: A systematic review and meta-analysis. Addiction, 109(3), 379–391.PubMedCrossRef
Diestelkamp, S., Drechsel, M., Baldus, C., Wartberg, L., Arnaud, N., & Thomasius, R. (2016). Brief in person interventions for adolescents and young adults following alcohol-related events in emergency care: a systematic review and European evidence synthesis. European Addiction Research, 22(1), 17–35.PubMedCrossRef
Dingle, G. A., Dingle, G. A., Gleadhill, L., & Baker, F. A. (2008). Can music therapy engage patients in group cognitive behaviour therapy for substance abuse treatment? Drug and Alcohol Review, 27(2), 190–196.PubMedCrossRef
Dockendorf, S., Joas, U., & Missel, P. (2013). Biofeedback–ein zusätzliches verhaltenstherapeutisches Angebot in der stationären Rehabilitation psychosomatisch und suchterkrankter Menschen. Suchttherapie, 14(S 01), S_25_1.CrossRef
Doggett, C., Burrett, S. L., & Osborn, D. A. (2005). Home visits during pregnancy and after birth for women with an alcohol or drug problem. Cochrane Database of Systematic Reviews, (4).
Dom, G., D’haene, P., Hulstijn, W., & Sabbe, B. G. C. C. (2006). Impulsivity in abstinent early-and late-onset alcoholics: differences in self-report measures and a discounting task. Addiction, 101(1), 50–59.PubMedCrossRef
Dom, G., De Wilde, B., Hulstijn, W., & Sabbe, B. (2007). Traumatic experiences and posttraumatic stress disorders: differences between treatment-seeking early-and late-onset alcoholic patients. Comprehensive Psychiatry, 48(2), 178–185.PubMedCrossRef
D’Onofrio, G., & Degutis, L. C. (2002). Preventive care in the emergency department: screening and brief intervention for alcohol problems in the emergency department: a systematic review. Academic Emergency Medicine, 9(6), 627–638.PubMedCrossRef
D’Onofrio, G., Rathlev, N. K., Ulrich, A. S., Fish, S. S., & Freedland, E. S. (1999). Lorazepam for the prevention of recurrent seizures related to alcohol. New England Journal of Medicine, 340(12), 915–919.PubMedCrossRef
Donoghue, K., Patton, R., Phillips, T., Deluca, P., & Drummond, C. (2014). The effectiveness of electronic screening and brief intervention for reducing levels of alcohol consumption: a systematic review and meta-analysis. Journal of medical Internet research, 16(6), e142.PubMedPubMedCentralCrossRef
Dorus, W., Ostrow, D. G., Anton, R., Cushman, P., Collins, J. F., Schaefer, M., et al. (1989). Lithium treatment of depressed and nondepressed alcoholics. JAMA, 262(12), 1646–1652.PubMedCrossRef
Dragan, M., & Lis-Turlejska, M. (2007). Prevalence of posttraumatic stress disorder in alcohol dependent patients in Poland. Addictive Behaviors, 32(5), 902–911.PubMedCrossRef
Drake, R. E., Yovetich, N. A., Bebout, R. R., Harris, M., & McHugo, G. J. (1997). Integrated treatment for dually diagnosed homeless adults. The Journal of Nervous and Mental Disease, 185(5), 298–305.PubMedCrossRef
Drake, R. E., McHugo, G. J., Clark, R. E., Teague, G. B., Xie, H., Miles, K., & Ackerson, T. H. (1998). Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. American journal of orthopsychiatry, 68(2), 201–215.PubMedCrossRef
Drake, R. E., Xie, H., McHugo, G. J., & Green, A. I. (2000). The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophrenia Bulletin, 26(2), 441–449.PubMedCrossRef
Drake, R. E., O’Neal, E. L., & Wallach, M. A. (2008). A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of substance abuse treatment, 34(1), 123–138.PubMedCrossRef
Drapkin, M. L., McCrady, B. S., Swingle, J. M., & Epstein, E. E. (2005). Exploring bidirectional couple violence in a clinical sample of female alcoholics. Journal of Studies on Alcohol, 66(2), 213–219.PubMedCrossRef
Driessen, M., Veltrup, C., Junghanns, K., Przywara, A., & Dilling, H. (1999). Cost-efficacy analysis of clinically evaluated therapeutic programs. An expanded withdrawal therapy in alcohol dependence. Der Nervenarzt, 70(5), 463–470.PubMedCrossRef
Driessen, M., Meier, S., Hill, A., Wetterling, T., Lange, W., & Junghanns, K. (2001). The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol and Alcoholism, 36(3), 249–255.PubMedCrossRef
Driessen, M., Schulte, S., Luedecke, C., Schaefer, I., Sutmann, F., Ohlmeier, M., et al. (2008). Trauma and PTSD in patients with alcohol, drug, or dual dependence: A multi-center study. Alcoholism: Clinical and Experimental Research, 32(3), 481–488.PubMedCrossRef
Du, J., Wang, Z., Xie, B., & Zhao, M. (2012). Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China. The American journal of drug and alcohol abuse, 38(3), 228–232.PubMedPubMedCentralCrossRef
Duka, T., Townshend, J. M., Collier, K., & Stephens, D. N. (2002). Kindling of withdrawal: a study of craving and anxiety after multiple detoxifications in alcoholic inpatients. Alcoholism: Clinical and Experimental Research, 26(6), 785–795.PubMedCrossRef
Duka, T., Townshend, J. M., Collier, K., & Stephens, D. N. (2003). Impairment in cognitive functions after multiple detoxifications in alcoholic inpatients. Alcoholism: Clinical and Experimental Research, 27(10), 1563–1572.PubMedCrossRef
Duka, T., Gentry, J., Malcolm, R., Ripley, T. L., Borlikova, G., Stephens, D. N., et al. (2004). Consequences of multiple withdrawals from alcohol. Alcoholism: Clinical and Experimental Research, 28(2), 233–246.PubMedCrossRef
Duke, A. A., Smith, K. M., Oberleitner, L., Westphal, A., & McKee, S. A. (2018). Alcohol, drugs, and violence: A meta-meta-analysis. Psychology of violence, 8(2), 238–249.CrossRef
Durbec, J. P., & Sarles, H. (1978). Relationship between the relative risk of developing chronic pancreatitis and alcohol, protein and lipid consumption. Digestion, 18, 337–350.PubMedCrossRef
Eberl, C., Wiers, R. W., Pawelczack, S., Rinck, M., Becker, E. S., & Lindenmeyer, J. (2013). Approach bias modification in alcohol dependence: do clinical effects replicate and for whom does it work best? Developmental cognitive neuroscience, 4, 38–51.PubMedCrossRef
Echeburúa, E., De Medina, R. B., & Aizpiri, J. (2005). Alcoholism and personality disorders: An exploratory study. Alcohol and Alcoholism, 40(4), 323–326.PubMedCrossRef
Echeburúa, E., De Medina, R. B., & Aizpiri, J. (2007). Comorbidity of alcohol dependence and personality disorders: A comparative study. Alcohol & Alcoholism, 42(6), 618–622.CrossRef
Egholm, J. W., Pedersen, B., Møller, A. M., Adami, J., Juhl, C. B., & Tønnesen, H. (2018). Perioperative alcohol cessation intervention for postoperative complications. Cochrane Database of Systematic Reviews, 11.
Elzerbi, C., Donoghue, K., & Drummond, C. (2015). A comparison of the efficacy of brief interventions to reduce hazardous and harmful alcohol consumption between European and non-European countries: a systematic review and meta-analysis of randomized controlled trials. Addiction, 110(7), 1082–1091.PubMedCrossRef
Elzerbi, C., Donoghue, K., Boniface, S., & Drummond, C. (2017). Variance in the efficacy of brief interventions to reduce hazardous and harmful alcohol consumption between injury and noninjury patients in emergency departments: a systematic review and meta-analysis of randomized controlled trials. Annals of emergency medicine, 70(5), 714–723.PubMedCrossRef
van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., & Schoevers, R. A. (2012). Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug and Alcohol Dependence, 122(1-2), 11–19.CrossRef
van Emmerik-van Oortmerssen, K., van de Glind, G., Koeter, M. W., Allsop, S., Auriacombe, M., Barta, C., et al. (2014). Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction, 109(2), 262–272.CrossRef
van Emmerik-van Oortmerssen, K., Vedel, E., Kramer, F. J., Koeter, M. W., Schoevers, R. A., & van den Brink, W. (2017). Diagnosing ADHD during active substance use: Feasible or flawed? Drug and Alcohol Dependence, 180, 371–375.CrossRef
van Emmerik-van Oortmerssen, K., Vedel, E., Kramer, F. J., Blankers, M., Dekker, J. J., van den Brink, W., & Schoevers, R. A. (2019). Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: results of a randomized clinical trial. Drug and Alcohol Dependence, 197, 28–36.CrossRef
Engle, B., & Macgowan, M. J. (2009). A critical review of adolescent substance abuse group treatments. Journal of evidence-based social work, 6(3), 217–243.PubMedCrossRef
Epstein, E. E., McCrady, B. S., Hallgren, K. A., Cook, S., Jensen, N. K., & Hildebrandt, T. (2018a). A randomized trial of female-specific cognitive behavior therapy for alcohol dependent women. Psychology of Addictive Behaviors, 32(1), 1–15.PubMedCrossRef
Epstein, E. E., McCrady, B. S., Hallgren, K. A., Gaba, A., Cook, S., Jensen, N., et al. (2018b). Individual versus group female-specific cognitive behavior therapy for alcohol use disorder. Journal of substance abuse treatment, 88, 27–43.PubMedPubMedCentralCrossRef
Ernst, C. C., Grant, T. M., Streissguth, A. P., & Sampson, P. D. (1999). Intervention with high-risk alcohol and drug-abusing mothers: II. Three-year findings from the Seattle model of paraprofessional advocacy. Journal of Community Psychology, 27(1), 19–38.
Essock, S. M., Mueser, K. T., Drake, R. E., Covell, N. H., McHugo, G. J., Frisman, L. K., et al. (2006). Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatric Services, 57(2), 185–196.PubMedCrossRef
Ettrich, K. U., & Fischer-Cyrulies, A. (2005). Substanzmissbrauch im mittleren und höheren Erwachsenenalter—Alltagsdrogen Alkohol und Nikotin: Gebrauch und Missbrauch. Zeitschrift für Gerontologie und Geriatrie, 38(1), 47–59.PubMedCrossRef
Euler, S., Dammann, G., Endtner, K., Leihener, F., Perroud, N. A., Reisch, T., et al. (2018). Borderline-Störung: Behandlungsempfehlungen der SGPP. Swiss archives of neurology, psychiatry and psychotherapy, 169(05), 135–143.
European Association for the Study of the Liver. (2012). EASL clinical practical guidelines: management of alcoholic liver disease. Journal of hepatology, 57(2), 399–420.CrossRef
European Association for the Study of the Liver. (2018). EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. Journal of hepatology, 69(1), 154–181.CrossRef
Evert, D. L., & Oscar-Berman, M. (1995). Alcohol-related cognitive impairments: An overview of how alcoholism may affect the workings of the brain. Alcohol Health and Research World, 19(2), 89.PubMedPubMedCentral
Evren, C., Sar, V., Dalbudak, E., Cetin, R., Durkaya, M., Evren, B., & Celik, S. (2011). Lifetime PTSD and quality of life among alcohol-dependent men: impact of childhood emotional abuse and dissociation. Psychiatry Research, 186(1), 85–90.PubMedCrossRef
Executive Council of the Society of Obstetricians and Gynaecologists of Canada. (Hrsg.). (2010). Alcohol use and pregnancy consensus clinical guidelines. Journal of Obstetrics and Gynaeocology, 32(8), 1–27.
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., Murray, C. J., & Comparative Risk Assessment Collaborating Group. (2002). Selected major risk factors and global and regional burden of disease. The Lancet, 360(9343), 1347–1360.CrossRef
Fals-Stewart, W., Birchler, G. R., & Kelley, M. L. (2006). Learning sobriety together: A randomized clinical trial examining behavioral couples therapy with alcoholic female patients. Journal of Consulting and Clinical Psychology, 74(3), 579–591.PubMedCrossRef
Farren, C. K., & Mc Elroy, S. (2008). Treatment response of bipolar and unipolar alcoholics to an inpatient dual diagnosis program. Journal of Affective Disorders, 106(3), 265–272.PubMedCrossRef
Farren, C. K., & McElroy, S. (2010). Predictive factors for relapse after an integrated inpatient treatment programme for unipolar depressed and bipolar alcoholics. Alcohol and Alcoholism, 45(6), 527–533.PubMedCrossRef
Farren, C. K., Scimeca, M., Wu, R., & Malley, S. O. (2009). A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence. Drug and alcohol dependence, 99(1-3), 317–321.PubMedCrossRef
Farren, C. K., Snee, L., & McElroy, S. (2011). Gender differences in outcome at 2-year follow-up of treated bipolar and depressed alcoholics. Journal of Studies on Alcohol and Drugs, 72(5), 872–880.PubMedCrossRef
Fassoulaki, A., Farinotti, R., Servin, F., & Desmonts, J. M. (1993). Chronic alcoholism increases the induction dose of propofol in humans. Anesthesia and analgesia, 77(3), 553–556.PubMedCrossRef
Feldman, N., Chatton, A., Khan, R., Khazaal, Y., & Zullino, D. (2011). Alcohol-related brief intervention in patients treated for opiate or cocaine dependence: a randomized controlled study. Substance Abuse Treatment, Prevention, and Policy, 6(1), 22.PubMedPubMedCentralCrossRef
Fergie, L., Campbell, K. A., Coleman-Haynes, T., Ussher, M., Cooper, S., & Coleman, T. (2019). Identifying effective behavior change techniques for alcohol and illicit substance use during pregnancy: a systematic review. Annals of Behavioral Medicine, 53(8), 769–781.PubMedCrossRef
Ferguson, J. A., Suelzer, C. J., Eckert, G. J., Zhou, X. H., & Diffus, R. S. (1996). Risk factors for delirium tremens development. Journal of general internal medicine, 11(7), 410–414.PubMedCrossRef
Fernandez, A. C., Waller, R., Walton, M. A., Bonar, E. E., Ignacio, R. V., Chermack, S. T., et al. (2019). Alcohol use severity and age moderate the effects of brief interventions in an emergency department randomized controlled trial. Drug and alcohol dependence, 194, 386–394.PubMedCrossRef
Fernández-Montalvo, J., López-Goñi, J. J., Arteaga, A., & Haro, B. (2020). Gender differences in unidirectional and bidirectional intimate partner violence in addictions. The American journal of drug and alcohol abuse, 46(2), 194–202.
Ferreira, J. A., Wieruszewski, P. M., Cunningham, D. W., Davidson, K. E., & Weisberg, S. F. (2017). Approach to the complicated alcohol withdrawal patient. Journal of intensive care medicine, 32(1), 3–14.PubMedCrossRef
Feuerlein, W., Küfner, H., & Flohrschütz, T. (1994). Mortality in alcoholic patients given inpatient treatment. Addiction, 89(7), 841–849.PubMedCrossRef
Field, C., & Caetano, R. (2010). The role of ethnic matching between patient and provider on the effectiveness of brief alcohol interventions with Hispanics. Alcoholism: Clinical and Experimental Research, 34(2), 262–271.PubMedCrossRef
Finfgeld-Connett, D. (2009). Web-based treatment for rural women with alcohol problems: preliminary findings. CIN: Computers, Informatics, Nursing, 27(6), 345–353.
Fink, A., Elliott, M. N., Tsai, M., & Beck, J. C. (2005). An evaluation of an intervention to assist primary care physicians in screening and educating older patients who use alcohol. Journal of the American Geriatrics Society, 53(11), 1937–1943.PubMedCrossRef
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., et al. (2015). Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. The Lancet Neurology, 14(2), 162–173.PubMedPubMedCentralCrossRef
Fiore, M. C., Jaén, C. R., Baker, T. B., Bailey, W. C., Benowitz, N. L., Curry, S. J., et al. (2008). Treating tobacco use and dependence: 2008 update. US Department of Health and Human Services.
Fishman, H. C., Andes, F., & Knowlton, R. (2001). Enhancing family therapy: The addition of a community resource specialist. Journal of Marital and Family Therapy, 27(1), 111–116.PubMedCrossRef
Flanagan, J. C., Korte, K. J., Killeen, T. K., & Back, S. E. (2016). Concurrent treatment of substance use and PTSD. Current psychiatry reports, 18(8).
Fleischmann, H. (2002). Positionspapier» Krankenhausbehandlung Alkoholkranker «Hier: Qualifizierte Entzugsbehandlung. Sucht, 48(6), 462–475.CrossRef
Fleming, M. F., Barry, K. L., Manwell, L. B., Johnson, K., & London, R. (1997). Brief physician advice for problem alcohol drinkers: a randomized controlled trial in community-based primary care practices. Jama, 277(13), 1039–1045.PubMedCrossRef
Foa, E. B., Yusko, D. A., McLean, C. P., Suvak, M. K., Bux, D. A., Oslin, D., et al. (2013). Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: A randomized clinical trial. JAMA, 310(5), 488–495.PubMedCrossRef
Foran, H. M., & O’Leary, K. D. (2008). Alcohol and intimate partner violence: A meta-analytic review. Clinical psychology review, 28(7), 1222–1234.PubMedCrossRef
Förg, A., Hein, J., Volkmar, K., Winter, M., Richter, C., Heinz, A., & Müller, C. A. (2012). Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial. Alcohol and Alcoholism, 47(2), 149–155.PubMedCrossRef
Foulds, J. A., Adamson, S. J., Boden, J. M., Williman, J. A., & Mulder, R. T. (2015). Depression in patients with alcohol use disorders: systematic review and meta-analysis of outcomes for independent and substance-induced disorders. Journal of affective disorders, 185, 47–59.PubMedCrossRef
Fowler, D. N., & Faulkner, M. (2011). Interventions targeting substance abuse among women survivors of intimate partner abuse: a meta-analysis. Journal of substance abuse treatment, 41(4), 386–398.PubMedCrossRef
Foxcroft, D. R., Moreira, M. T., Santimano, N. M. A., & Smith, L. A. (2015). Social norms information for alcohol misuse in university and college students. Cochrane database of systematic reviews, (12) CD006748.
Foxcroft, D. R., Coombes, L., Wood, S., Allen, D., Santimano, N. M. A., & Moreira, M. T. (2016). Motivational interviewing for the prevention of alcohol misuse in young adults. Cochrane Database of Systematic Reviews, (7) CD007025.
Foy, A., & Kay, J. (1995). The incidence of alcohol-related problems and the risk of alcohol withdrawal in a general hospital population. Drug and Alcohol Review, 14(1), 49–54.PubMedCrossRef
Frey, H., & Wertgen, A. (Hrsg.). (2012). Pädagogik bei Krankheit: Konzeptionen, Methodik, Didaktik, Best-Practice-Beispiele. Pabst Science Publ.
Freynhagen, R., Backonja, M., Schug, S., Lyndon, G., Parsons, B., Watt, S., & Behar, R. (2016). Pregabalin for the treatment of drug and alcohol withdrawal symptoms: a comprehensive review. CNS drugs, 30(12), 1191–1200.PubMedPubMedCentralCrossRef
Friedman, A. S. (1989). Family therapy vs. parent groups: Effects on adolescent drug abusers. American Journal of Family Therapy, 17(4), 335–347.CrossRef
Fu, S. S., Kodl, M., Willenbring, M., Nelson, D. B., Nugent, S., Gravely, A. A., & Joseph, A. M. (2008). Ethnic differences in alcohol treatment outcomes and the effect of concurrent smoking cessation treatment. Drug and alcohol dependence, 92(1–3), 61–68.PubMedCrossRef
Galambos, J. T., & Shapira, R. (1973). Natural history of alcoholic hepatitis. IV. Glycosaminoglycuronans and collagen in the hepatic connective tissue. The Journal of clinical investigation, 52(11), 2952–2962.PubMedPubMedCentralCrossRef
Galvin, R., Bråthen, G., Ivashynka, A., Hillbom, M., Tanasescu, R., & Leone, M. A. (2010). EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. European Journal of Neurology, 17(12), 1408–1418.PubMedCrossRef
Gamble, S. A., Conner, K. R., Talbot, N. L., Yu, Q., Tu, X. M., & Connors, G. J. (2010). Effects of pretreatment and posttreatment depressive symptoms on alcohol consumption following treatment in Project MATCH. Journal of Studies on Alcohol and Drugs, 71(1), 71–77.PubMedPubMedCentralCrossRef
Garbutt, J. C. (2010). Efficacy and tolerability of naltrexone in the management of alcohol dependence. Current pharmaceutical design, 16(19), 2091–2097.PubMedCrossRef
García-Pugés, A. M., Navarro, S., Ros, E., Elena, M., Ballesta, A., Aused, R., & Vilar-Bonet, J. (1986). Reversibility of exocrine pancreatic failure in chronic pancreatitis. Gastroenterology, 91(1), 17–24.PubMedCrossRef
Gariti, P., Alterman, A., Mulvaney, F., Mechanic, K., Dhopesh, V., Yu, E., et al. (2002). Nicotine intervention during detoxification and treatment for other substance use. The American Journal of Drug and Alcohol Abuse, 28(4), 671–679.PubMedCrossRef
Gebara, C. F. d. P., de Castro Bhona, F. M., Ronzani, T. M., Lourenço, L. M., & Noto, A. R. (2013). Brief intervention and decrease of alcohol consumption among women: a systematic review. Substance Abuse Treatment, Prevention, and Policy, 8(1), 31.PubMedPubMedCentralCrossRef
Geller, B., Cooper, T. B., Sun, K. A. I., Zimerman, B., Frazier, J., Williams, M., & Heath, J. (1998). Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of the American Academy of Child & Adolescent Psychiatry, 37(2), 171–178.CrossRef
Gerke, P., Hapke, U., Rumpf, H. J., & John, U. (1997). Alcohol-related diseases in general hospital patients. Alcohol and Alcoholism, 32(2), 179–184.PubMedCrossRef
Geyer, D. (2016). Alkoholgebrauchsstörungen bei älteren Menschen. In T. Supprian & C. Hauke (Hrsg.), Störungsspezifische Psychotherapie im Alter. Das Praxisbuch (S. 146–160). Schattauer.
Geyer, D., Batra, A., Beutel, M., Funke, W., Görlich, P., Günthner, A., et al. (2006). AWMF Leitlinie: Postakutbehandlung alkoholbezogener Störungen. Sucht, 52(1), 8–34.
Ghavanini, A. A., & Kimpinski, K. (2014). Revisiting the evidence for neuropathy caused by pyridoxine deficiency and excess. Journal of clinical neuromuscular disease, 16(1), 25–31.PubMedCrossRef
Gilchrist, G., Dennis, F., Radcliffe, P., Henderson, J., Howard, L. M., & Gadd, D. (2019). The interplay between substance use and intimate partner violence perpetration: A meta-ethnography. International Journal of Drug Policy, 65, 8–23.PubMedCrossRef
Gjestad, R., Franck, J., Lindberg, S., & Haver, B. (2011). Early treatment for women with alcohol addiction (EWA) reduces mortality: A randomized controlled trial with long-term register follow-up. Alcohol and Alcoholism, 46(2), 170–176.PubMedPubMedCentralCrossRef
Glass, J. E., Hamilton, A. M., Powell, B. J., Perron, B. E., Brown, R. T., & Ilgen, M. A. (2015). Specialty substance use disorder services following brief alcohol intervention: a meta-analysis of randomized controlled trials. Addiction, 110(9), 1404–1415.PubMedPubMedCentralCrossRef
Glass, J. E., Hamilton, A. M., Powell, B. J., Perron, B. E., Brown, R. T., & Ilgen, M. A. (2016). Revisiting our review of Screening, Brief Intervention and Referral to Treatment (SBIRT): meta-analytical results still point to no efficacy in increasing the use of substance use disorder services. Addiction, 111(1), 181–183.PubMedCrossRef
van de Glind, G., van den Brink, W., Koeter, M. W., Carpentier, P. J., van Emmerik-van Oortmerssen, K., Kaye, S., et al. (2013). Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug and Alcohol Dependence, 132(3), 587–596.PubMedPubMedCentralCrossRef
van de Glind, G., Konstenius, M., Koeter, M. W., van Emmerik-van Oortmerssen, K., Carpentier, P. J., Kaye, S., et al. (2014). Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug and Alcohol Dependence, 134, 158–166.PubMedCrossRef
Gonzalez, L. P., Veatch, L. M., Ticku, M. K., & Becker, H. C. (2001). Alcohol withdrawal kindling: mechanisms and implications for treatment. Alcoholism: Clinical and Experimental Research, 25, 197S–201S.PubMedCrossRef
Gossop, M., Marsden, J., Stewart, D., & Rolfe, A. (2000). Patterns of drinking and drinking outcomes among drug misusers: 1-year follow-up results. Journal of substance abuse treatment, 19(1), 45–50.PubMedCrossRef
Gossop, M., Neto, D., Radovanovic, M., Batra, A., Toteva, S., Musalek, M., et al. (2007). Physical health problems among patients seeking treatment for alcohol use disorders: a study in six European cities. Addiction Biology., 12(2), 190–196.PubMedCrossRef
Gouzoulis-Mayfrank, E. (2010). Komorbidität von Psychose und Sucht. Psychiatrie und Psychotherapie up2date, 4(02), 81–95.CrossRef
Graeber, D. A., Moyers, T. B., Griffith, G., Guajardo, E., & Tonigan, S. (2003). A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal, 39(3), 189–202.PubMedCrossRef
Graff, F. S., Morgan, T. J., Epstein, E. E., McCrady, B. S., Cook, S. M., Jensen, N. K., & Kelly, S. (2009). Engagement and retention in outpatient alcoholism treatment for women. American Journal on Addictions, 18(4), 277–288.PubMedCrossRef
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 61(8), 807–816.PubMedCrossRef
Grant, B. F., Stinson, F. S., Hasin, D. S., Dawson, D. A., Chou, S. P., Ruan, W., & Huang, B. (2005). Prevalence correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 66(10), 1205–1215.PubMedCrossRef
Grant, K. M., Kelley, S. S., Smith, L. M., Agrawal, S., Meyer, J. R., & Romberger, D. J. (2007). Bupropion and nicotine patch as smoking cessation aids in alcoholics. Alcohol, 41(5), 381–391.PubMedPubMedCentralCrossRef
Grant, T. M., Ernst, C. C., & Streissguth, A. P. (1996). An intervention with high-risk mothers who abuse alcohol and drugs: the Seattle Advocacy Model. American Journal of Public Health, 86(12), 1816–1817.PubMed
Green, A. I., Noordsy, D. L., Brunette, M. F., & O’Keefe, C. (2008). Substance abuse and schizophrenia: pharmacotherapeutic intervention. Journal of substance abuse treatment, 34(1), 61–71.PubMedCrossRef
Green, A. I., Brunette, M. F., Dawson, R., Buckley, P., Wallace, A. E., Hafez, H., et al. (2015). Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder: a randomized trial. The Journal of clinical psychiatry, 76(10), 1359–1365.PubMedCrossRef
Green, R., Bujarski, S., Lim, A. C., Venegas, A., & Ray, L. A. (2019). Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers. Experimental and Clinical Psychopharmacology, 27(3), 257–264.PubMedPubMedCentralCrossRef
Greenfield, S. F. (2016). Treating women with substance use disorders: The women’s recovery group manual. Guilford Publications.
Greenfield, S. F., Trucco, E. M., McHugh, R. K., Lincoln, M., & Gallop, R. J. (2007). The women’s recovery group study: A stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling. Drug and alcohol dependence, 90(1), 39–47.PubMedPubMedCentralCrossRef
Greenfield, S. F., Sugarman, D. E., Freid, C. M., Bailey, G. L., Crisafulli, M. A., Kaufman, J. S., et al. (2014). Group therapy for women with substance use disorders: Results from the Women’s Recovery Group Study. Drug and alcohol dependence, 142, 245–253.PubMedPubMedCentralCrossRef
Gregory, R. J., DeLucia-Deranja, E., & Mogle, J. A. (2010). Dynamic deconstructive psychotherapy versus optimized community care for borderline personality disorder co-occurring with alcohol use disorders: A 30-month follow-up. The Journal of Nervous and Mental Disease, 198(4), 292–298.PubMedCrossRef
Griffin, K. W., Botvin, G. J., Nichols, T. R., & Doyle, M. M. (2003). Effectiveness of a universal drug abuse prevention approach for youth at high risk for substance use initiation. Preventive medicine, 36(1), 1–7.PubMedCrossRef
Groenman, A. P., Schweren, L. J., Weeda, W., Luman, M., Noordermeer, S. D., Heslenfeld, D. J., et al. (2019). Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder. European Child & Adolescent Psychiatry, 28(9), 1213–1222.CrossRef
Gross, G. A. (1982). The use of propranolol as a method to manage acute alcohol detoxification. The Journal of the American Osteopathic Association, 82(3), 206–207.PubMed
Grosshans, M., & Mann, K. (2012). Alkohol. Akuttherapie bei Kindern und Jugendlichen. In A. Batra & O. Bilke-Hentsch (Hrsg.), Praxisbuch Sucht (S. 109). Thieme.
Grothues, J. M., Bischof, G., Reinhardt, S., Meyer, C., John, U., & Rumpf, H. J. (2008). Effectiveness of brief alcohol interventions for general practice patients with problematic drinking behavior and comorbid anxiety or depressive disorders. Drug and alcohol dependence, 94(1–3), 214–220.PubMedCrossRef
Gual, A., Segura, L., Contel, M., Heather, N., & Colom, J. (2002). Audit-3 and audit-4: effectiveness of two short forms of the alcohol use disorders identification test. Alcohol and Alcoholism, 37(6), 591–596.PubMedCrossRef
Gual, A., Balcells, M., Torres, M., Madrigal, M., Diez, T., & Serrano, L. (2003). Sertraline for the prevention of relapse in detoxicated alcohol dependent patients with a comorbid depressive disorder: A randomized controlled trial. Alcohol and Alcoholism, 38(6), 619–625.PubMedCrossRef
Gual, A., He, Y., Torup, L., van den Brink, W., Mann, K., & ESENSE 2 Study Group. (2013). A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. European neuropsychopharmacology, 23(11), 1432–1442.PubMedCrossRef
Gunderson, J. G. (2009). Borderline personality disorder: ontogeny of a diagnosis. American Journal of Psychiatry, 166(5), 530–539.PubMedCrossRef
Guy, N., Newton-Howes, G., Ford, H., Williman, J., & Foulds, J. (2018). The prevalence of comorbid alcohol use disorder in the presence of personality disorder: Systematic review and explanatory modelling. Personality and Mental Health, 12(3), 216–228.PubMedCrossRef
Ham, L. S., Casner, H. G., Bacon, A. K., & Shaver, J. A. (2011). Speeches, strangers, and alcohol use: The role of context in social stress response dampening. Journal of behavior therapy and experimental psychiatry, 42(4), 462–472.PubMedCrossRef
Handmaker, N. S., Miller, W. R., & Manicke, M. (1999). Findings of a pilot study of motivational interviewing with pregnant drinkers. Journal of Studies on Alcohol, 60(2), 285–287.PubMedCrossRef
Harter-Meyer, R. (Hrsg.). (2000). „Wer hier nur Wissen vermitteln will geht baden“: Unterricht an Schulen für Kranke in der Kinder-und Jugendpsychiatrie (Bd. 2). LIT.
Hartzler, B., Donovan, D. M., & Huang, Z. (2010). Comparison of opiate-primary treatment seekers with and without alcohol use disorder. Journal of substance abuse treatment, 39(2), 114–123.PubMedPubMedCentralCrossRef
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthøj, B., Gattaz, W. F., et al. (2015). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia part 3: update 2015 management of special circumstances: depression, suicidality, substance use disorders and pregnancy and lactation. The World Journal of Biological Psychiatry, 16(3), 142–170.PubMedCrossRef
Hasin, D. S., & Grant, B. F. (2015). The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Social psychiatry and psychiatric epidemiology, 50(11), 1609–1640.PubMedPubMedCentralCrossRef
Haug, N. A., Svikis, D. S., & DiClemente, C. (2004). Motivational enhancement therapy for nicotine dependence in methadone-maintained pregnant women. Psychology of Addictive Behaviors, 18(3), 289–292.PubMedCrossRef
Havard, A., Shakeshaft, A., & Sanson-Fisher, R. (2008). Systematic review and meta-analyses of strategies targeting alcohol problems in emergency departments: interventions reduce alcohol-related injuries. Addiction, 103(3), 368–376.PubMedCrossRef
Hawley, R. J., Kurtzke, J. F., Armbrustmacher, V. W., Saini, N., & Manz, H. (1982). The course of alcoholic-nutritional peripheral neuropathy. Acta Neurologica Scandinavica, 66(5), 582–589.PubMedCrossRef
Hayakawa, T., Kondo, T., Shibata, T., Sugimoto, Y., & Kitagawa, M. (1989). Chronic alcoholism and evolution of pain and prognosis in chronic pancreatitis. Digestive diseases and sciences, 34(1), 33–38.PubMedCrossRef
Henggeler, S. W., Borduin, C. M., Melton, G. B., & Mann, B. J. (1991). Effects of multisystemic therapy on drug use and abuse in serious juvenile offenders: a progress report from two outcome studies. Family Dynamics of Addiction Quarterly, 1(3), 40–51.
Henihan, A. M., McCombe, G., Klimas, J., Swan, D., Leahy, D., Anderson, R., et al. (2016). Feasibility of alcohol screening among patients receiving opioid treatment in primary care. BMC Family Practice, 17(1), 153.PubMedPubMedCentralCrossRef
Herman, S. E., Frank, K. A., Mowbray, C. T., Ribisl, K. M., & Davidson, W. S. (2000). Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders. The Journal of Behavioral Health Services & Research, 27(3), 286–302.CrossRef
Herpertz, S. C. (2018). Neue Wege der Klassifikation von Persönlichkeitsstörungen in ICD-11. Fortschritte der Neurologie· Psychiatrie, 86(03), 150–155.PubMedCrossRef
Herpertz, S. C., Zanarini, M., Schulz, C. S., Siever, L., Lieb, K., Möller, H. J., & WFSBP Task Force for Personality Disorders. (2007). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. The World Journal of Biological Psychiatry, 8(4), 212–244.PubMedCrossRef
Hesse, M. (2009). Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry, 9(1), 6.PubMedPubMedCentralCrossRef
Hesse, M., Vanderplasschen, W., Rapp, R., Broekaert, E., & Fridell, M. (2007). Case management for persons with substance use disorders. Cochrane Database of Systematic Reviews, (4).
Heuß, D., Hund, E., & Klehmet, J., Kurth, I., Lehmann, H., & Sommer, C. (2019). Diagnostik bei Polyneuropathien, S1-Leitlinie. In Deutsche Gesellschaft für Neurologie (Hrsg.) Leitlinien für Diagnostik und Therapie in der Neurologie (AWMF-Register-Nr. 030/067). https://​www.​dgn.​org/​leitlinien.
Hien, D. A., Cohen, L. R., Miele, G. M., Litt, L. C., & Capstick, C. (2004). Promising treatments for women with comorbid PTSD and substance use disorders. American journal of Psychiatry, 161(8), 1426–1432.PubMedCrossRef
Hien, D. A., Wells, E. A., Jiang, H., Suarez-Morales, L., Campbell, A. N., Cohen, L. R., et al. (2009). Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. Journal of consulting and clinical psychology, 77(4), 607–619.PubMedPubMedCentralCrossRef
Hien, D. A., Campbell, A. N., Ruglass, L. M., Hu, M. C., & Killeen, T. (2010a). The role of alcohol misuse in PTSD outcomes for women in community treatment: A secondary analysis of NIDA’s Women and Trauma Study. Drug and Alcohol Dependence, 111(1–2), 114–119.PubMedPubMedCentralCrossRef
Hien, D. A., Jiang, H., Campbell, A. N., Hu, M. C., Miele, G. M., Cohen, L. R., et al. (2010b). Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA’s Clinical Trials Network. American Journal of Psychiatry, 167(1), 95–101.PubMedCrossRef
Hien, D. A., Morgan-Lopez, A. A., Campbell, A. N., Saavedra, L. M., Wu, E., Cohen, L., et al. (2012). Attendance and substance use outcomes for the Seeking Safety program: Sometimes less is more. Journal of consulting and clinical psychology, 80(1), 29–42.PubMedCrossRef
Hien, D. A., Campbell, A. N., Ruglass, L. M., Saavedra, L., Mathews, A. G., Kiriakos, G., & Morgan-Lopez, A. (2015a). Maximizing effectiveness trials in PTSD and SUD through secondary analysis: Benefits and limitations using the national institute on drug abuse clinical trials network „Women and Trauma“ study as a case example. Journal of substance abuse treatment, 56, 23–33.PubMedPubMedCentralCrossRef
Hien, D. A., Levin, F. R., Ruglass, L. M., López-Castro, T., Papini, S., Hu, M. C., et al. (2015b). Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial. Journal of consulting and clinical psychology, 83(2), 359–369.PubMedPubMedCentralCrossRef
Hien, D. A., Lopez-Castro, T., Papini, S., Gorman, B., & Ruglass, L. M. (2017). Emotion dysregulation moderates the effect of cognitive behavior therapy with prolonged exposure for co-occurring PTSD and substance use disorders. Journal of anxiety disorders, 52, 53–61.PubMedPubMedCentralCrossRef
Hildebrandt, T., McCrady, B., Epstein, E., Cook, S., & Jensen, N. (2010). When should clinicians switch treatments? An application of signal detection theory to two treatments for women with alcohol use disorders. Behaviour Research and Therapy, 48(6), 524–530.
Hillbom, M., Pieninkeroinen, I., & Leone, M. (2003). Seizures in alcohol-dependent patients. CNS drugs, 17(14), 1013–1030.PubMedCrossRef
Ho, A. P., Tsuang, J. W., Liberman, R. P., Wang, R., Wilkins, J. N., Eckman, T. A., & Shaner, A. L. (1999). Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence. American Journal of Psychiatry, 156(11), 1765–1770.PubMedCrossRef
Hobbs, J. D., Kushner, M. G., Lee, S. S., Reardon, S. M., & Maurer, E. W. (2011). Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence. The American Journal on Addictions, 20(4), 319–329.PubMedPubMedCentralCrossRef
Hock, B., Schwarz, M., Domke, I., Grunert, V. P., Wuertemberger, M., Schiemann, U., et al. (2005). Validity of carbohydrate-deficient transferrin (% CDT), γ-glutamyltransferase (γ-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction, 100(10), 1477–1486.PubMedCrossRef
Hodges, B., & Mazur, J. E. (2004). Intravenous ethanol for the treatment of alcohol withdrawal syndrome in critically ill patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 24(11), 1578–1585.CrossRef
Hoffmann, S., & Mann, K. (2019). Sucht im Alter II – Ergebnissen der Evaluation des Programms. Schriftenreihe der Baden-Württemberg Stiftung.
Hoffmeister, A., Mayerle, J., Beglinger, C., Büchler, M. W., Bufler, P., Dathe, K., et al. (2012). S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS). Zeitschrift für Gastroenterologie, 50(11), 1176–1224.PubMed
Hohmann, L., Bradt, J., Stegemann, T., & Koelsch, S. (2017). Effects of music therapy and music-based interventions in the treatment of substance use disorders: A systematic review. PloS one 12(11): e0187363.
Holder, H. D., & Blose, J. O. (1986). Alcoholism treatment and total health care utilization and costs: A four-year longitudinal analysis of federal employees. Jama, 256(11), 1456–1460.PubMedCrossRef
Hoolahan, B., Kelly, B., Stain, H. J., & Killen, D. (2006). Co-morbid drug and alcohol and mental health issues in a rural New South Wales Area Health Service. Australian Journal of Rural Health, 14(4), 148–153.PubMedCrossRef
Horsfall, J., Cleary, M., Hunt, G. E., & Walter, G. (2009). Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): A review of empirical evidence. Harvard review of psychiatry, 17(1), 24–34.PubMedCrossRef
Hughes, J. R., & Kalman, D. (2006). Do smokers with alcohol problems have more difficulty quitting? Drug and Alcohol Dependence, 82(2), 91–102.PubMedCrossRef
Hulse, G. K., & Tait, R. J. (2002). Six-month outcomes associated with a brief alcohol intervention for adult in-patients with psychiatric disorders. Drug and Alcohol Review, 21(2), 105–112.PubMedCrossRef
Hunt, G. E., Siegfried, N., Morley, K., Sitharthan, T., & Cleary, M. (2013). Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews, (10) CD001088.
Hunt, G. E., Large, M. M., Cleary, M., Lai, H. M. X., & Saunders, J. B. (2018). Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990–2017: Systematic review and meta-analysis. Drug and alcohol dependence, 191, 234–258.PubMedCrossRef
Huntley, Z., Maltezos, S., Williams, C., Morinan, A., Hammon, A., Ball, D., et al. (2012). Rates of undiagnosed attention deficit hyperactivity disorder in London drug and alcohol detoxification units. BMC Psychiatry, 12(1), 223.PubMedPubMedCentralCrossRef
Hurt, R. D., Offord, K. P., Croghan, I. T., Gomez-Dahl, L., Kottke, T. E., Morse, R. M., & Melton, L. J. (1996). Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. JAMA, 275(14), 1097–1103.PubMedCrossRef
Indig, D., Eyeson-Annan, M., Copeland, J., & Conigrave, K. M. (2007). The effects of alcohol consumption, psychological distress and smoking status on emergency department presentations in New South Wales, Australia. BMC Public Health, 7(1), 46.PubMedPubMedCentralCrossRef
Iovieno, N., Tedeschini, E., Bentley, K. H., Evins, A. E., & Papakostas, G. I. (2011). Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. The Journal of Clinical Psychiatry, 72(8), 1144–1151.PubMedCrossRef
Islam, M. M., Day, C. A., Conigrave, K. M., & Topp, L. (2013). Self-perceived problem with alcohol use among opioid substitution treatment clients. Addictive Behaviors, 38(4), 2018–2021.PubMedCrossRef
Jackson, K. M., Sher, K. J., Wood, P. K., & Bucholz, K. K. (2003). Alcohol and tobacco use disorders in a general population: short-term and long-term associations from the St. Louis Epidemiological Catchment Area Study. Drug and Alcohol Dependence, 71(3), 239–253.PubMedPubMedCentralCrossRef
Jackson, R., Johnson, M., Campbell, F., Messina, J., Guillaume, L., Meier, P., et al. (2010). Screening and brief interventions for prevention and early identification of alcohol use disorders in adults and young people. University of Sheffield, School of Health and Related Research (ScHARR) Public Health Collaborating Centre.
Janssens, F., de Suray, N., Piessevaux, H., Horsmans, Y., de Timary, P., & Stärkel, P. (2010). Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study. Journal of clinical gastroenterology, 44(8), 575–582.PubMedCrossRef
Johann, M., Bobbe, G., Putzhammer, A., & Wodarz, N. (2003). Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: Differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor). Alcoholism: Clinical and Experimental Research, 27(10), 1527–1534.PubMedCrossRef
John, U. (2000). Motivationsarbeit mit alkoholabhängigen. Lambertus.
Johnson, C., Dong, H., Ahamad, K., Hayashi, K., Milloy, M. J., Kerr, T., & Wood, E. (2015). Impact of binge alcohol on mortality among people who inject drugs. Addictive behaviors reports, 2, 28–32.PubMedPubMedCentralCrossRef
Johnson, C. D., & Hosking, S. (1991). National statistics for diet, alcohol consumption, and chronic pancreatitis in England and Wales, 1960-88. Gut, 32(11), 1401–1405.PubMedPubMedCentralCrossRef
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., et al. (2014). Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. Jama, 311(18), 1889–1900.PubMedCrossRef
Jones, E. B., & Sharpe, L. (2017). Cognitive bias modification: A review of Metaanalyses. Journal of Affective Disorders, 223, 175–183.PubMedCrossRef
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011). The efficacy of disulfiram for the treatment of alcohol use disorder. Alcoholism: Clinical and Experimental Research, 35(10), 1749–1758.PubMedCrossRef
Jorgensen, L. N., Tonnesen, H., Pedersen, S., Lavrsen, M., Tuxoe, J., Gottrup, F., & Thomsen, C. F. (1998). Reduced amounts of total protein in artificial wounds of alcohol abusers. The British Journal of Surgery-Supplement, 85, 152–153.
Joseph, A. M., Nelson, D. B., Nugent, S. M., & Willenbring, M. L. (2003). Timing of alcohol and smoking cessation (TASC) smoking among substance use patients screened and enrolled in a clinical trial. Journal of Addictive Diseases, 22(4), 87–107.PubMedCrossRef
Joseph, A. M., Willenbring, M. L., Nugent, S. M., & Nelson, D. B. (2004). A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. Journal of Studies on Alcohol, 65(6), 681–691.PubMedCrossRef
Joseph, J., Basu, D., Dandapani, M., & Krishnan, N. (2014). Are nurse-conducted brief interventions (NCBI s) efficacious for hazardous or harmful alcohol use? A systematic review. International nursing review, 61(2), 203–210.PubMedCrossRef
Julian, T., Glascow, N., Syeed, R., & Zis, P. (2018). Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. Journal of neurology, 266(12), 2907–2919.PubMedPubMedCentralCrossRef
Kable, J. A., Coles, C. D., Keen, C. L., Uriu-Adams, J. Y., Jones, K. L., Yevtushok, L., et al. (2015). The impact of micronutrient supplementation in alcohol-exposed pregnancies on information processing skills in Ukrainian infants. Alcohol, 49(7), 647–656.
Kalman, D., Hayes, K., Colby, S. M., Eaton, C. A., Rohsenow, D. J., & Monti, P. M. (2001). Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery: A pilot study. Journal of Substance Abuse Treatment, 20(3), 233–238.PubMedCrossRef
Kalman, D., Kahler, C. W., Tirch, D., Kaschub, C., Penk, W., & Monti, P. M. (2004). Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence. Psychology of Addictive Behaviors, 18(1), 78.PubMedCrossRef
Kalman, D., Morissette, S. B., & George, T. P. (2005). Co-morbidity of smoking in patients with psychiatric and substance use disorders. The American Journal on Addictions, 14(2), 106–123.PubMedPubMedCentralCrossRef
Kalman, D., Kahler, C. W., Garvey, A. J., & Monti, P. M. (2006). High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes. Journal of Substance Abuse Treatment, 30(3), 213–217.PubMedCrossRef
Kalman, D., Kim, S., DiGirolamo, G., Smelson, D., & Ziedonis, D. (2010). Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clinical Psychology Review, 30(1), 12–24.PubMedPubMedCentralCrossRef
Kalman, D., Herz, L., Monti, P., Kahler, C. W., Mooney, M., Rodrigues, S., & O’Connor, K. (2011). Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study. Drug and alcohol dependence, 118(2–3), 111–118.PubMedPubMedCentralCrossRef
Kalyoncu, A., Mırsal, H., Pektaş, Ö., Ünsalan, N., Tan, D., & Beyazyürek, M. (2005). Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect? Journal of Psychopharmacology, 19(3), 301–305.PubMedCrossRef
Kaminer, Y., & Burleson, J. A. (1999). Psychotherapies for adolescent substance abusers: 15-month follow-up of a pilot study. The American Journal on Addictions, 8(2), 114–119.PubMedCrossRef
Kaminer, Y., Burleson, J. A., Blitz, C., Sussman, J., & Rounsaville, B. J. (1998). Psychotherapies for adolescent substance abusers: A pilot study. The Journal of Nervous and Mental Disease, 186(11), 684–690.PubMedCrossRef
Kaminer, Y., Burleson, J. A., & Goldberger, R. (2002). Cognitive-behavioral coping skills and psychoeducation therapies for adolescent substance abuse. The Journal of nervous and mental disease, 190(11), 737–745.PubMedCrossRef
Kaminer, Y., Burleson, J. A., & Burke, R. H. (2008). Efficacy of outpatient aftercare for adolescents with alcohol use disorders: A randomized controlled study. Journal of the American Academy of Child & Adolescent Psychiatry, 47(12), 1405–1412.CrossRef
Kaner, E. F., Beyer, F. R., Garnett, C., Crane, D., Brown, J., Muirhead, C., et al. (2017). Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations. Cochrane Database of Systematic Reviews, (9).
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., et al. (2018). Effectiveness of brief alcohol interventions in primary care populations. Cochrane database of systematic reviews, (2).
Kaner, E. F. S., Beyer, F., Dickinson, H. O., Pienaar, E., Campbell, F., Schlesinger, C., Heather, N., Saunders, J., & Burnand, B. (2007). Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database of Systematic Reviews, (2) CD004148.
Kaoutzanis, C., Kavanagh, C. M., Leichtle, S. W., Welch, K. B., Talsma, A., Vandewarker, J. F., et al. (2015). Chlorhexidine with isopropyl alcohol versus iodine povacrylex with isopropyl alcohol and alcohol-versus nonalcohol-based skin preparations: the incidence of and readmissions for surgical site infections after colorectal operations. Diseases of the Colon & Rectum, 58(6), 588–596.CrossRef
Kartin, D., Grant, T. M., Streissguth, A. P., Sampson, P. D., & Ernst, C. C. (2002). Three-year developmental outcomes in children with prenatal alcohol and drug exposure. Pediatric Physical Therapy, 14(3), 145–153.PubMed
Kaskutas, L. A., Zhang, L., French, M. T., & Witbrodt, J. (2005). Women’s programs versus mixed-gender day treatment: results from a randomized study. Addiction, 100(1), 60–69.PubMedCrossRef
Kavanagh, D. J., Waghorn, G., Jenner, L., Chant, D. C., Carr, V., Evans, M., et al. (2004). Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophrenia Research, 66(2-3), 115–124.PubMedCrossRef
Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., & Carr, V. J. (2009). Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy. Addiction, 104(3), 378–388.PubMedCrossRef
Kay-Lambkin, F. J., Baker, A. L., Kelly, B., & Lewin, T. J. (2011). Clinician-assisted computerised versus therapist-delivered treatment for depressive and addictive disorders: a randomised controlled trial. Medical Journal of Australia, 195, 44–50.CrossRef
Kehlet, H. (1991). The surgical stress response: should it be prevented?. Canadian journal of surgery. Journal canadien de chirurgie, 34(6), 565–567.PubMed
Kelly, S., Olanrewaju, O., Cowan, A., Brayne, C., & Lafortune, L. (2018). Interventions to prevent and reduce excessive alcohol consumption in older people: a systematic review and meta-analysis. Age and ageing, 47(2), 175–184.PubMedCrossRef
Kemp, D. E., Gao, K., Ganocy, S. J., Rapport, D. J., Elhaj, O., Bilali, S., et al. (2009). A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. The Journal of Clinical Psychiatry, 70(1), 113.PubMedCrossRef
Kemp, R., Harris, A., Vurel, E., & Sitharthan, T. (2007). Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry, 15(6), 490–493.PubMedCrossRef
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. American Journal of Orthopsychiatry, 66(1), 17–31.PubMedCrossRef
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627.PubMedPubMedCentralCrossRef
Khadjesari, Z., Murray, E., Hewitt, C., Hartley, S., & Godfrey, C. (2011). Can stand-alone computer-based interventions reduce alcohol consumption? A systematic review. Addiction, 106(2), 267–282.PubMedCrossRef
Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard review of psychiatry, 4(5), 231–244.PubMedCrossRef
Killeen, T., Hien, D., Campbell, A., Brown, C., Hansen, C., Jiang, H., et al. (2008). Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment. Journal of substance abuse treatment, 35(3), 304–311.PubMedPubMedCentralCrossRef
Kim, J. H., Kim, D., & Marder, S. R. (2008). Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(4), 984–988.PubMedCrossRef
Kittel-Schneider, S., Wolff, S., Queiser, K., Wessendorf, L., Meier, A. M., Verdenhalven, M., et al. (2019). Prevalence of ADHD in Accident Victims: Results of the PRADA Study. Journal of Clinical Medicine, 8(10), 1643.PubMedPubMedCentralCrossRef
Klein, M. (1993). Sport-und Bewegungstherapie als integrative Arbeit in der Suchtbehandlung. In Mototherapie mit Erwachsenen. Sport, Spiel und Bewegung in Psychiatrie, Psychosomatik und Suchtbehandlung (S. 81–91). Hofmann.
Klein, W., Missel, P., & Braukmann, W. (1997). Effizienz stationärer Abhängigkeitsrehabilitation: Ergebnisse zum langfristigen sozialmedizinischen Rehabilitationserfolg, Verhaltensmedizin heute. Fortschritte in der Rehabilitation, 7, 47–57.
Klimas, J., Muench, J., Wiest, K., Croff, R., Rieckman, T., & McCarty, D. (2015). Alcohol screening among opioid agonist patients in a primary care clinic and an opioid treatment program. Journal of psychoactive drugs, 47(1), 65–70.PubMedPubMedCentralCrossRef
Klimas, J., Fairgrieve, C., Tobin, H., Field, C. A., O’Gorman, C. S., Glynn, L. G., et al. (2018a). Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. Cochrane Database of Systematic Reviews, (12).
Klimas, J., Wood, E., Nosova, E., Milloy, M. J., Kerr, T., & Hayashi, K. (2018b). Prevalence of heavy alcohol use among people receiving methadone following change to Methadose. Substance use & misuse, 53(2), 270–275.CrossRef
Koethe, D., Juelicher, A., Nolden, B. M., Braunwarth, W. D., Klosterkötter, J., Niklewski, G., et al. (2007). Oxcarbazepine—Efficacy and tolerability during treatment of alcohol withdrawal: A double-blind, randomized, placebo-controlled multicenter pilot study. Alcoholism: Clinical and Experimental Research, 31(7), 1188–1194.PubMedCrossRef
Kofoed, L., Kania, J., Walsh, T., & Atkinson, R. M. (1986). Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders. The American journal of psychiatry, 143(7), 867–872.PubMedCrossRef
Kofoed, L. L., Tolson, R. L., Atkinson, R. M., Toth, R. L., & Turner, J. A. (1987). Treatment compliance of older alcoholics: an elder-specific approach is superior to „mainstreaming“. Journal of Studies on Alcohol, 48(1), 47–51.PubMedCrossRef
Kohler, S., & Hofmann, A. (2015). Can motivational interviewing in emergency care reduce alcohol consumption in young people? A systematic review and meta-analysis. Alcohol and Alcoholism, 50(2), 107–117.PubMedCrossRef
Koike, H., Iijima, M., Sugiura, M., Mori, K., Hattori, N., Ito, H., et al. (2003). Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Annals of neurology, 54(1), 19–29.PubMedCrossRef
Kondo, T., Hayakawa, T., Noda, A., Ito, K., Yamazaki, Y., Iinuma, Y., et al. (1981). Follow-up study of chronic pancreatitis. Gastroenterologia Japonica, 16(1), 46–53.PubMedCrossRef
Konstenius, M., Jayaram-Lindström, N., Beck, O., & Franck, J. (2010). Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug and alcohol dependence, 108(1–2), 130–133.PubMedCrossRef
Konstenius, M., Jayaram-Lindström, N., Guterstam, J., Beck, O., Philips, B., & Franck, J. (2014). Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction, 109(3), 440–449.PubMedCrossRef
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balazs, J., et al. (2019). Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European psychiatry, 56(1), 14–34.PubMedCrossRef
Korcha, R. A., Polcin, D. L., Evans, K., Bond, J. C., & Galloway, G. P. (2014). Intensive motivational interviewing for women with concurrent alcohol problems and methamphetamine dependence. Journal of Substance Abuse Treatment, 46(2), 113–119.PubMedCrossRef
Koskinen, P. (1991). A 4-year prospective follow-up study of the role of alcohol in recurrences of atrial fibrillation. Journal of internal medicine, 230(5), 423–426.PubMedCrossRef
Kraanen, F. L., Vedel, E., Scholing, A., & Emmelkamp, P. M. (2013). The comparative effectiveness of integrated treatment for substance abuse and partner violence (I-StoP) and substance abuse treatment alone: a randomized controlled trial. BMC psychiatry, 13(189).
Kraemer, K. L., Mayo-Smith, M. F., & Calkins, D. R. (2003). Independent clinical correlates of severe alcohol withdrawal. Substance Abuse, 24(4), 197–209.PubMedCrossRef
Krampe, H., & Ehrenreich, H. (2010). Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Current Pharmaceutical Design, 16(19), 2076–2090.PubMedCrossRef
Krampe, H., Wagner, T., Stawicki, S., Bartels, C., Aust, C., Kroener-Herwig, B., et al. (2006). Personality disorder and chronicity of addiction as independent outcomepredictors in alcoholism treatment. Psychiatric Services, 57(5), 708–712.PubMedCrossRef
Kranzler, H. R., Burleson, J. A., Korner, P., Del Boca, F. K., Bohn, M. J., Brown, J., & Liebowitz, N. (1995). Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. The American Journal of Psychiatry, 152(3), 391–397.PubMedCrossRef
Kranzler, H. R., Mueller, T., Cornelius, J., Pettinati, H. M., Moak, D., Martin, P. R., et al. (2006). Sertraline treatment of co-occurring alcohol dependence and major depression. Journal of clinical psychopharmacology, 26(1), 13–20.PubMedCrossRef
Kranzler, H. R., Feinn, R., Morris, P., & Hartwell, E. E. (2019). A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder. Addiction, 114(9), 1547–1555.PubMedPubMedCentralCrossRef
Krupitsky, E. M., Rudenko, A. A., Burakov, A. M., Slavina, T. Y., Grinenko, A. A., Pittman, B., et al. (2007). Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. Alcoholism: Clinical and Experimental Research, 31(4), 604–611.PubMed
Küfner, H. (2010). Epidemiology of substance use and substance use disorders in Germany. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 53(4), 271–283.PubMedCrossRef
Kunz, S., Schulz, M., Lewitzky, M., Driessen, M., & Rau, H. (2007). Ear acupuncture for alcohol withdrawal in comparison with aromatherapy: a randomized-controlled trial. Alcoholism: Clinical and Experimental Research, 31(3), 436–442.PubMedCrossRef
Kushner, M. G., Abrams, K., & Borchardt, C. (2000). The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clinical Psychology Review, 20(2), 149–171.PubMedCrossRef
Landgraf, M., & Heinen, F. (2013). Fetales Alkoholsyndrom: S3-Leitlinie zur Diagnostik. Kohlhammer.
Landy, M. S., Davey, C. J., Quintero, D., Pecora, A., & McShane, K. E. (2016). A systematic review on the effectiveness of brief interventions for alcohol misuse among adults in emergency departments. Journal of substance abuse treatment, 61, 1–12.PubMedCrossRef
Lange, W., Veltrup, C., & Driessen, M. (1999). Entgiftung und qualifizierte Entzugsbehandlung: Kurz-, mittel-und langfristige Katamnesen. Sucht, 45(4), 228–234.
Langeland, W., Draijer, N., & van den Brink, W. (2004). Psychiatric comorbidity in treatment-seeking alcoholics: The role of childhood trauma and perceived parental dysfunction. Alcoholism: Clinical and Experimental Research, 28(3), 441–447.PubMedCrossRef
Lankisch, P. G., Löhr-Happe, A., Otto, J., & Creutzfeldt, W. (1993). Natural course in chronic pancreatitis. Digestion, 54(3), 148–155.PubMedCrossRef
Latimer, W. W., Winters, K. C., D’Zurilla, T., & Nichols, M. (2003). Integrated family and cognitive-behavioral therapy for adolescent substance abusers: A stage I efficacy study. Drug and alcohol dependence, 71(3), 303–317.PubMedCrossRef
Latvala, J., Hietala, J., Koivisto, H., Järvi, K., Anttila, P., & Niemelä, O. (2005). Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease. American Journal of Gastroenterology, 100(6), 1303–1310.PubMedCrossRef
Lechtenberg, R., & Worner, T. M. (1991). Relative kindling effect of detoxification and non-detoxification admissions in alcoholics. Alcohol and Alcoholism, 26(2), 221–225.PubMedCrossRef
Lechtenberg, R., & Worner, T. M. (1992). Total ethanol consumption as a seizure risk factor in alcoholics. Acta neurologica scandinavica, 85(2), 90–94.PubMedCrossRef
Ledgerwood, D. M., & Petry, N. M. (2006). Does contingency management affect motivation to change substance use? Drug and alcohol dependence, 83(1), 65–72.PubMedCrossRef
Lee, H. S., Mericle, A. A., Ayalon, L., & Areán, P. A. (2009). Harm reduction among at-risk elderly drinkers: a site-specific analysis from the multi-site Primary Care Research in Substance Abuse and Mental Health for Elderly (PRISM-E) study. International Journal of Geriatric Psychiatry: A journal of the psychiatry of late life and allied sciences, 24(1), 54–60.CrossRef
Lee, M. T., Horgan, C. M., Garnick, D. W., Acevedo, A., Panas, L., Ritter, G. A., et al. (2014). A performance measure for continuity of care after detoxification: Relationship with outcomes. Journal of substance abuse treatment, 47(2), 130–139.PubMedPubMedCentralCrossRef
Lenz, A. S., Henesy, R., & Callender, K. (2016). Effectiveness of seeking safety for co-occurring posttraumatic stress disorder and substance use. Journal of Counseling & Development, 94(1), 51–61.CrossRef
Lenzenweger, M. F., Lane, M. C., Loranger, A. W., & Kessler, R. C. (2007). DSM-IV personality disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 62(6), 553–564.PubMedPubMedCentralCrossRef
Leone, M. A., Vigna-Taglianti, F., Avanzi, G., Brambilla, R., & Faggiano, F. (2010). Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane database of systematic reviews, (2) CD006266.
Lerner, W. D., & Fallon, H. J. (1985). The alcohol withdrawal syndrome. The new England Journal of Medicine, 951–952.
Levin, F. R., Evans, S. M., Brooks, D. J., Kalbag, A. S., Garawi, F., & Nunes, E. V. (2006). Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug and Alcohol Dependence, 81(2), 137–148.PubMedCrossRef
Levin, F. R., Mariani, J. J., Specker, S., Mooney, M., Mahony, A., Brooks, D. J., et al. (2015). Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit/hyperactivity disorder and cocaine use disorder: a randomized clinical trial. JAMA Psychiatry, 72(6), 593–602.PubMedPubMedCentralCrossRef
Lévy, P., Mathurin, P., Roqueplo, A., Rueff, B., & Bernades, P. (1995). A multidimensional case-control study of dietary, alcohol, and tobacco habits in alcoholic men with chronic pancreatitis. Pancreas, 10(3), 231–238.PubMedCrossRef
Liddle, H. A., Dakof, G. A., Parker, K., Diamond, G. S., Barrett, K., & Tejeda, M. (2001). Multidimensional family therapy for adolescent drug abuse: Results of a randomized clinical trial. The American journal of drug and alcohol abuse, 27(4), 651–688.PubMedCrossRef
Liddle, H. A., Rowe, C. L., Dakof, G. A., Ungaro, R. A., & Henderson, C. (2004). Early intervention for adolescent substance abuse: Pretreatment to posttreatment outcomes of a randomized controlled trial comparing multidimensional family therapy and peer group treatment. Journal of Psychoactive Drugs, 36(1), 2–37.CrossRef
Lieb, B., Rosien, M., Bonnet, U., & Scherbaum, N. (2008). Alkoholbezogene Störungen im Alter-Aktueller Stand zu Diagnostik und Therapie. Fortschritte der Neurologie Psychiatrie, 76(02), 75–83.PubMedCrossRef
Lieber, C. S. (1995). Medical disorders of alcoholism. New England Journal of Medicine, 333(16), 1058–1065.PubMedCrossRef
Lin, Y., Tamakoshi, A., Hayakawa, T., Ogawa, M., Ohno, Y., & Research Committee on Intractable Pancreatic Diseases. (2001). Associations of alcohol drinking and nutrient intake with chronic pancreatitis: findings from a case-control study in Japan. The American journal of gastroenterology, 96(9), 2622–2627.PubMedCrossRef
Linehan, M. M., Schmidt, H., III, Dimeff, L. A., Craft, J. C., Kanter, J., & Comtois, K. A. (1999). Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. The American Journal on Addictions, 8(4), 279–292.PubMedCrossRef
Linehan, M. M., Dimeff, L. A., Reynolds, S. K., Comtois, K. A., Welch, S. S., Heagerty, P., & Kivlahan, D. R. (2002). Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug and Alcohol Dependence, 67(1), 13–26.PubMedCrossRef
Lingford-Hughes, A. R., Welch, S., Peters, L., & Nutt, D. J. (2012). BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology, 26(7), 899–952.PubMedCrossRef
Litt, M. D., Kadden, R. M., & Kabela-Cormier, E. (2009). Individualized assessment and treatment program for alcohol dependence: results of an initial study to train coping skills. Addiction, 104(11), 1837–1838.PubMedPubMedCentralCrossRef
Litten, R. Z., Fertig, J. B., Falk, D. E., Ryan, M. L., Mattson, M. E., Collins, J. F., et al. (2012). A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients. Alcoholism: Clinical and Experimental Research, 36(3), 406–416.PubMedCrossRef
Liu, J., & Wang, L. N. (2019). Baclofen for alcohol withdrawal. Cochrane database of systematic reviews, (11) CD008502.
Liu, S. I., Wu, S. I., Chen, S. C., Huang, H. C., Sun, F. J., Fang, C. K., et al. (2011). Randomized controlled trial of a brief intervention for unhealthy alcohol use in hospitalized Taiwanese men. Addiction, 106(5), 928–940.PubMedCrossRef
Ljung, T., Chen, Q., Lichtenstein, P., & Larsson, H. (2014). Common etiological factors of attention-deficit/hyperactivity disorder and suicidal behavior: a population-based study in Sweden. JAMA Psychiatry, 71(8), 958–964.PubMedCrossRef
LoCastro, J. S., Youngblood, M., Cisler, R. A., Mattson, M. E., Zweben, A., Anton, R. F., & Donovan, D. M. (2009). Alcohol treatment effects on secondary nondrinking outcomes and quality of life: the COMBINE study. Journal of Studies on Alcohol and Drugs, 70(2), 186–197.PubMedPubMedCentralCrossRef
Loeber, S., Kiefer, F., Wagner, F., Mann, K., & Croissant, B. (2009). Treatment outcome after inpatient alcohol withdrawal: impact of motivational interventions: a comparative study. Der Nervenarzt, 80(9), 1085–1092.PubMedCrossRef
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R. W., Lankisch, P. G., Andersen, J. R., et al. (1994). Prognosis of chronic pancreatitis: an international multicenter study. American Journal of Gastroenterology, 89(9), 1467–1471.PubMed
Lucht, M., Kuehn, K. U., Armbruster, J., Abraham, G., Gaensicke, M., Barnow, S., et al. (2003). Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open-label study with tiapride/carbamazepine, clomethiazole and diazepam. Alcohol and Alcoholism, 38(2), 168–175.PubMedCrossRef
Luderer, M., Kaplan-Wickel, N., Richter, A., Reinhard, I., Kiefer, F., & Weber, T. (2018a). Screening for adult attention-deficit/hyperactivity disorder in alcohol dependent patients: Underreporting of ADHD symptoms in self-report scales. Drug Alcohol Dependence, 195, 52–58.PubMedCrossRef
Luderer, M., Sick, C., Kaplan-Wickel, N., Reinhard, I., Richter, A., Kiefer, F., & Weber, T. (2018b). Prevalence estimates of ADHD in a sample of inpatients with alcohol dependence. Journal of Attention Disorders, 0(0), 1087054717750272.
Luderer, M., Kaplan-Wickel, N., Sick, C., Richter, A., Reinhard, I., Kiefer, F., & Weber, T. (2019a). ADHD screening in alcohol dependent subjects : Psychometric characteristics of ADHD self-report scale and Wender Utah Rating Scale short form. Nervenarzt, 90(11), 1156–1161.PubMedCrossRef
Luderer, M., Kiefer, F., Reif, A., & Moggi, F. (2019b). ADHD in adult patients with substance use disorders. Nervenarzt, 90(9), 926–931.PubMedCrossRef
Lui, S., Terplan, M., & Smith, E. J. (2008). Psychosocial interventions for women enrolled in alcohol treatment during pregnancy. Cochrane Database of Systematic Reviews, (3) CD006753.
Lydecker, K. P., Tate, S. R., Cummins, K. M., McQuaid, J., Granholm, E., & Brown, S. A. (2010). Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychology of Addictive Behaviors, 24(3), 453.PubMedPubMedCentralCrossRef
Machielsen, M., Beduin, A. S., Dekker, N., Kahn, R. S., Linszen, D. H., van Os, J., et al. (2012). Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Journal of Psychopharmacology, 26(1), 189–195.PubMedCrossRef
Machielsen, M. W., & de Haan, L. (2009). Differences in efficacy on substance abuse between risperidone and clozapine support the importance of differential modulation of dopaminergic neurotransmission. Psychopharmacology Bulletin, 42(4), 40–52.PubMed
Maejima, S. Y., Kawa, S., Hasebe, O., & Homma, T. (1996). The relationship between drinking status and serial changes of pancreatographic findings in patients with suspected early chronic alcoholic pancreatitis. Pancreas, 13(2), 209–214.PubMedCrossRef
Maisel, N. C., Blodgett, J. C., Wilbourne, P. L., Humphreys, K., & Finney, J. W. (2013). Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction, 108(2), 275–293.PubMedCrossRef
Malcolm, R., Roberts, J. S., Wang, W., Myrick, H., & Anton, R. F. (2000). Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol, 22(3), 159–164.PubMedCrossRef
Malcolm, R., Myrick, H., Brady, K. T., & Ballenger, J. C. (2001). Update on anticonvulsants for the treatment of alcohol withdrawal. The American journal on addictions, 10, 16–23.CrossRef
Malcolm, R., Myrick, H., Roberts, J., Wang, W., Anton, R. F., & Ballenger, J. C. (2002). The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. Journal of general internal medicine, 17(5), 349–355.PubMedPubMedCentralCrossRef
Malcolm, R., Myrick, L. H., Veatch, L. M., Boyle, E., & Randall, P. K. (2007). Reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin. Journal of Clinical Sleep Medicine, 3(1), 24–32.PubMed
Maldonado, A. Q., Tichy, E. M., Rogers, C. C., Campara, M., Ensor, C., Doligalski, C. T., et al. (2015). Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantation. American Journal of Health-System Pharmacy, 72(10), 781–793.PubMedCrossRef
Management of Substance Use Disorders Working Group. (2009). VA/DoD clinical practice guideline for management of substance use disorders (SUD). Department of Defense, Department of Veterans Affairs.
Mandayam, S., Jamal, M. M., & Morgan, T. R. (2004). Epidemiology of alcoholic liver disease. Seminars in Liver Disease, 24(3), 217–232.PubMedCrossRef
Mangrum, L. F., Spence, R. T., & Lopez, M. (2006). Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders. Journal of Substance Abuse Treatment, 30(1), 79–84.PubMedCrossRef
Mann, K., Bladström, A., Torup, L., Gual, A., & van den Brink, W. (2013a). Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biological psychiatry, 73(8), 706–713.PubMedCrossRef
Mann, K., Lemenager, T., Hoffmann, S., Reinhard, I., Hermann, D., Batra, A., et al. (2013b). Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in G ermany and comparison with the US COMBINE study. Addiction Biology, 18(6), 937–946.PubMedCrossRef
Mann, K., Torup, L., Sørensen, P., Gual, A., Swift, R., Walker, B., & van den Brink, W. (2016). Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy. European Neuropsychopharmacology, 26(12), 1941–1949.PubMedCrossRef
Marbet, U. A., Bianchi, L., Meury, U., & Stalder, G. A. (1987). Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. Journal of Hepatology, 4(3), 364–372.PubMedCrossRef
Mariani, J. J., Rosenthal, R. N., Tross, S., Singh, P., & Anand, O. P. (2006). A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. The American journal on addictions, 15(1), 76–84.PubMedCrossRef
Mark, T. L., Vandivort-Warren, R., & Montejano, L. B. (2006). Factors affecting detoxification readmission: Analysis of public sector data from three states. Journal of substance abuse treatment, 31(4), 439–445.PubMedCrossRef
Markowitz, J. C., Kocsis, J. H., Christos, P., Bleiberg, K., & Carlin, A. (2008). Pilot study of interpersonal psychotherapy versus supportive psychotherapy for dysthymic patients with secondary alcohol abuse or dependence. The Journal of nervous and mental disease, 196(6), 468–474.PubMedCrossRef
Martin, R. A., Rohsenow, D. J., MacKinnon, S. V., Abrams, D. B., & Monti, P. M. (2006). Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment. Drug and Alcohol Dependence, 83(1), 73–78.PubMedCrossRef
Martino, S., Carroll, K. M., Nich, C., & Rounsaville, B. J. (2006). A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction, 101(10), 1479–1492.PubMedCrossRef
Martinotti, G., Di Nicola, M., Frustaci, A., Romanelli, R., Tedeschi, D., Guglielmo, R., et al. (2010a). Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. Addiction, 105(2), 288–299.PubMedCrossRef
Martinotti, G., Di Nicola, M., Tedeschi, D., Andreoli, S., Reina, D., Pomponi, M., et al. (2010b). Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial. Journal of Psychopharmacology, 24(9), 1367–1374.PubMedCrossRef
Maruyama, K., & Otsuki, M. (2007). Incidence of alcoholic pancreatitis in Japanese alcoholics: survey of male sobriety association members in Japan. Pancreas, 34(1), 63–65.PubMedCrossRef
Mason, B. J., & Lehert, P. (2010). The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy. The American Journal on Addictions, 19(2), 147–154.PubMedCrossRef
Mason, B. J., Kocsis, J. H., Ritvo, E. C., & Cutler, R. B. (1996). A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA, 275(10), 761–767.PubMedCrossRef
Mason, B. J., Light, J. M., Williams, L. D., & Drobes, D. J. (2009). Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addiction Biology, 14(1), 73–83.PubMedCrossRef
Mason, M., Ola, B., Zaharakis, N., & Zhang, J. (2015). Text messaging interventions for adolescent and young adult substance use: a meta-analysis. Prevention Science, 16(2), 181–188.PubMedCrossRef
Mason, R., & Du Mont, J. (2015). Advancing our knowledge of the complexity and management of intimate partner violence and co-occurring mental health and substance abuse problems in women. F1000prime reports, 7(65).
Mathurin, P., Beuzin, F., Louvet, A., Carrié-Ganne, N., Balian, A., Trinchet, J. C., et al. (2007). Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Alimentary pharmacology & therapeutics, 25(9), 1047–1054.CrossRef
Maxwell, S., & Shinderman, M. S. (2000). Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness. Journal of Addictive Diseases, 19(3), 61–69.PubMedCrossRef
May, P. A., Marais, A. S., Gossage, J. P., Barnard, R., Joubert, B., Cloete, M., et al. (2013). Case management reduces drinking during pregnancy among high risk women. The international journal of alcohol and drug research, 2(3), 61–70.PubMedPubMedCentralCrossRef
Maynié-François, C., Cheng, D. M., Samet, J. H., Lloyd-Travaglini, C., Palfai, T., Bernstein, J., & Saitz, R. (2017). Unhealthy alcohol use in primary care patients who screen positive for drug use. Substance abuse, 38(3), 303–308.PubMedCrossRef
Mayo-Smith, M. F. (1997). Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. Jama, 278(2), 144–151.PubMedCrossRef
Mays, K. L., Clark, D. L., & Gordon, A. J. (2008). Treating addiction with tunes: A systematic review of music therapy for the treatment of patients with addictions. Substance Abuse, 29(4), 51–59.PubMedCrossRef
McCrady, B. S., Epstein, E. E., Cook, S., Jensen, N., & Hildebrandt, T. (2009). A randomized trial of individual and couple behavioral alcohol treatment for women. Journal of consulting and clinical psychology, 77(2), 243–256.PubMedPubMedCentralCrossRef
McCrady, B. S., Epstein, E. E., Hallgren, K. A., Cook, S., & Jensen, N. K. (2016a). Women with alcohol dependence: A randomized trial of couple versus individual plus couple therapy. Psychology of addictive behaviors, 30(3), 287–299.PubMedPubMedCentralCrossRef
McCrady, B. S., Wilson, A. D., Muñoz, R. E., Fink, B. C., Fokas, K., & Borders, A. (2016b). Alcohol-focused behavioral couple therapy. Family process, 55(3), 443–459.PubMedPubMedCentralCrossRef
McGinnes, R. A., Hutton, J. E., Weiland, T. J., Fatovich, D. M., & Egerton-Warburton, D. (2016). Effectiveness of ultra-brief interventions in the emergency department to reduce alcohol consumption: A systematic review. Emergency Medicine Australasia, 28(6), 629–640.PubMedCrossRef
McGovern, M. P., Lambert-Harris, C., Xie, H., Meier, A., McLeman, B., & Saunders, E. (2015). A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction, 110(7), 1194–1204.PubMedPubMedCentralCrossRef
McGrath, P. J., Nunes, E. V., Stewart, J. W., Goldman, D., Agosti, V., Ocepek-Welikson, K., & Quitkin, F. M. (1996). Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Archives of General Psychiatry, 53(3), 232–240.PubMedCrossRef
McQueen, J., Howe, T. E., Allan, L., Mains, D., & Hardy, V. (2011). Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane database of systematic reviews, (8) CD005191.
Mdege, N. D., & Watson, J. (2013b). Predictors of study setting (primary care vs. hospital setting) among studies of the effectiveness of brief interventions among heavy alcohol users: A systematic review. Drug and alcohol review, 32(4), 368–380.PubMedCrossRef
Mdege, N. D., Fayter, D., Watson, J. M., Stirk, L., Sowden, A., & Godfrey, C. (2013a). Interventions for reducing alcohol consumption among general hospital inpatient heavy alcohol users: a systematic review. Drug and Alcohol Dependence, 131(1-2), 1–22.PubMedCrossRef
Mellion, M., Gilchrist, J. M., & De La Monte, S. (2011). Alcohol-related peripheral neuropathy: nutritional, toxic, or both? Muscle & nerve, 43(3), 309–316.CrossRef
Menon, D. K., Harris, M., Sargentoni, J., Taylor-Robinson, S. D., Cox, I. J., & Morgan, M. Y. (1995). In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers. Gastroenterology, 108(3), 776–788.PubMedCrossRef
Mihai, A., Damsa, C., Allen, M., Baleydier, B., Lazignac, C., & Heinz, A. (2007). Viewing videotape of themselves while experiencing delirium tremens could reduce the relapse rate in alcohol-dependent patients. Addiction, 102(2), 226–231.PubMedCrossRef
Miller, W. R., & Rollnick, S. (2015). Motivierende Gesprächsführung: Motivational Interviewing (3. Aufl.). Lambertus.
Miller, W. R., & Wilbourne, P. L. (2002). Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction, 97(3), 265–277.PubMedCrossRef
Miller, W.R., Zweben, A., DiClemente, C., Rychtarik, R.G. (1995) Motivational enhancement therapy manual. National Institute on Alcohol Abuse and Alcoholism.
Milligan, K., Niccols, A., Sword, W., Thabane, L., Henderson, J., Smith, A., & Liu, J. (2010). Maternal substance use and integrated treatment programs for women with substance abuse issues and their children: A meta-analysis. Substance Abuse Treatment, Prevention, and Policy, 5(1), 1–14.
Mills, K. L., Teesson, M., Back, S. E., Brady, K. T., Baker, A. L., Hopwood, S., et al. (2012). Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: A randomized controlled trial. JAMA, 308(7), 690–699.PubMedCrossRef
Minozzi, S., Amato, L., Vecchi, S., & Davoli, M. (2010). Anticonvulsants for alcohol withdrawal. Cochrane database of systematic reviews, (3) CD005064.
Mirin, S. M., Batki, S. L., Bukstein, O., Isbell, P. G., Kleber, H., Schottenfeld, R. S., et al. (1995). Practice guideline for the treatment of patients with substance use disorders-alcohol, cocaine, opioids. American Journal of Psychiatry, 152(11), 4–59.
Missel, P. (2007). Ergebnisqualität in der Rehabilitation Abhängigkeitskranker–Ausgewählte Ergebnisse. Sucht aktuell, 14(1), 16–26.
Missel, P., & Weissinger, V. (2011). Wirksamkeitsstudien zur Suchtrehabilitation Verfahrensweise und Ergebnisse der Einjahreskatamnesen des Fachverbandes Sucht eV zum Entlassjahrgang 2008. Abhängigkeiten, 1(17), 50–68.
Missel, P., Bick, S., Bachmeier, R., Brenner, R., Deller, H., Finkelmeier, B., et al. (2013a). Effektivität der stationären Suchtrehabilitation–FVS-Katamnese des Entlassjahrgangs 2010 von Ambulanzen für Alkohol-und Medikamentenabhängige. Sucht aktuell, 1, 26–34.
Missel, P., Bick, S., Bachmeier, R., Funke, W., Garbe, D., Herder, F., et al. (2013b). Effektivität der stationären Suchtrehabilitation–FVS-Katamnese des Entlassjahrgangs 2010 von Fachkliniken für Alkohol-und Medikamentenabhängige. Sucht aktuell, 1, 13–25.
Miyake, H., Harada, H., Kunichika, K., Ochi, K., & Kimura, I. (1987). Clinical course and prognosis of chronic pancreatitis. Pancreas, 2(4), 378–385.PubMedCrossRef
Miyata, H., Takahashi, M., Murai, Y., Tsuneyoshi, K., Hayashi, T., Meulien, D., et al. (2019). Nalmefene in alcohol-dependent patients with a high drinking risk: Randomized controlled trial. Psychiatry and clinical neurosciences, 73(11), 697–706.PubMedPubMedCentralCrossRef
Moak, D. H., Anton, R. F., Latham, P. K., Voronin, K. E., Waid, R. L., & Durazo-Arvizu, R. (2003). Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. Journal of Clinical Psychopharmacology, 23(6), 553–562.PubMedCrossRef
Mohamed, S., Rosenheck, R. A., Lin, H., Swartz, M., McEvoy, J., & Stroup, S. (2015). Randomized trial of the effect of four second-generation antipsychotics and one first-generation antipsychotic on cigarette smoking, alcohol, and drug use in chronic schizophrenia. The Journal of Nervous and Mental Disease, 203(7), 486–492.PubMedCrossRef
Monforte, R., Estruch, R., Valls-Solé, J., Nicolás, J., Villalta, J., & Urbano-Marquez, A. (1995). Autonomic and peripheral neuropathies in patients with chronic alcoholism: a dose-related toxic effect of alcohol. Archives of neurology, 52(1), 45–51.PubMedCrossRef
Monti, P. M., Colby, S. M., Barnett, N. P., Spirito, A., Rohsenow, D. J., Myers, M., et al. (1999). Brief intervention for harm reduction with alcohol-positive older adolescents in a hospital emergency department. Journal of consulting and clinical psychology, 67(6), 989.PubMedCrossRef
Moore, E., Mancuso, S. G., Slade, T., Galletly, C., & Castle, D. J. (2012). The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis. Australian & New Zealand Journal of Psychiatry, 46(9), 864–878.CrossRef
Moore, R. D., Bone, L. R., Geller, G., Mamon, J. A., Stokes, E. J., & Levine, D. M. (1989). Prevalence, detection, and treatment of alcoholism in hospitalized patients. Jama, 261(3), 403–407.PubMedCrossRef
Moraes, E., Campos, G. M., Figlie, N. B., Laranjeira, R., & Ferraz, M. B. (2010). Cost-effectiveness of home visits in the outpatient treatment of patients with alcohol dependence. European Addiction Research, 16(2), 69–77.PubMedCrossRef
Moreno, C., Mueller, S., & Szabo, G. (2019). Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Journal of hepatology, 70(2), 273–283.PubMedCrossRef
Morley, K. C., Teesson, M., Reid, S. C., Sannibale, C., Thomson, C., Phung, N., et al. (2006). Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. Addiction, 101(10), 1451–1462.PubMedCrossRef
Morris, E. P., Stewart, S. H., & Ham, L. S. (2005). The relationship between social anxiety disorder and alcohol use disorders: A critical review. Clinical Psychology Review, 25(6), 734–760.PubMedCrossRef
Morse, G. A., Calsyn, R. J., Klinkenberg, W. D., Helminiak, T. W., Wolff, N., Drake, R. E., et al. (2006). Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. Community Mental Health Journal, 42(4), 377–404.PubMedCrossRef
Moukhtarian, T. R., Cooper, R. E., Vassos, E., Moran, P., & Asherson, P. (2017). Effects of stimulants and atomoxetine on emotional lability in adults: a systematic review and meta-analysis. European Psychiatry, 44, 198–207.PubMedCrossRef
Moulin, S. R. A., Mill, J. G., Rosa, W. C. M., Hermisdorf, S. R., & da Cruz Caldeira, L. (2015). QT interval prolongation associated with low magnesium in chronic alcoholics. Drug and alcohol dependence, 155, 195–201.PubMedCrossRef
Moussavian, S. N., Becker, R. C., Piepmeyer, J. L., Mezey, E., & Bozian, R. C. (1985). Serum gamma-glutamyl transpeptidase and chronic alcoholism. Digestive diseases and sciences, 30(3), 211–214.PubMedCrossRef
Moy, I., Crome, P., Crome, I., & Fisher, M. (2011). Systematic and narrative review of treatment for older people with substance problems. European Geriatric Medicine, 2(4), 212–236.CrossRef
Moyer, A., Finney, J. W., Swearingen, C. E., & Vergun, P. (2002). Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction, 97(3), 279–292.PubMedCrossRef
Mueller, S. (Hrsg.). (2020). Liver elastography: Clinical Use and Interpretation. Springer International Publishing.
Mueller, S., Millonig, G., Sarovska, L., Friedrich, S., Reimann, F. M., Pritsch, M., et al. (2010). Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World journal of gastroenterology: WJG, 16(8), 966–972.PubMedPubMedCentralCrossRef
Mueller, S., Englert, S., Seitz, H. K., Badea, R. I., Erhardt, A., Bozaari, B., et al. (2015). Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease. Liver International, 35(12), 2514–2521.PubMedCrossRef
Mueller, S. E., Petitjean, S. A., & Wiesbeck, G. A. (2012). Cognitive behavioral smoking cessation during alcohol detoxification treatment: a randomized, controlled trial. Drug and Alcohol Dependence, 126(3), 279–285.PubMedCrossRef
Mueser, K. T., Noordsy, D. L., Fox, L., & Wolfe, R. (2003). Disulfiram treatment for alcoholism in severe mental illness. American Journal on Addictions, 12(3), 242–252.PubMedCrossRef
Muhonen, L. H., Lönnqvist, J., Juva, K., & Alho, H. (2008). Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. The Journal of Clinical Psychiatry, 69(3), 392–399.PubMedCrossRef
Müller, C. A., Schäfer, M., Schneider, S., Heimann, H. M., Hinzpeter, A., Volkmar, K., et al. (2010). Efficacy and safety of levetiracetam for outpatient alcohol detoxification. Pharmacopsychiatry, 43(05), 184–189.PubMedCrossRef
Müller, C. A., Schäfer, M., Banas, R., Heimann, H. M., Volkmar, K., Förg, A., et al. (2011). A combination of levetiracetam and tiapride for outpatient alcohol detoxification: a case series. Journal of addiction medicine, 5(2), 153–156.PubMedCrossRef
Müller-Fahrnow, W., Ilchmann, U., Kühner, S., Spyra, K., & Stoll, S. (2002). Sucht-Rehabilitation in Deutschland: Bestandsaufnahme und Perspektiven. DRV-Schriften, 32, 182.
Murthy, P., Mahadevan, J., & Chand, P. K. (2019). Treatment of substance use disorders with co-occurring severe mental health disorders. Current Opinion in Psychiatry, 32(4), 293–299.PubMedCrossRef
Mutschler, J., Grosshans, M., Koopmann, A., Hermann, D., Diehl, A., Mann, K., & Kiefer, F. (2010a). Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorder—A case series. Alcohol & Alcoholism, 45(2), 146–150.CrossRef
Mutschler, J., Kobiella, A., Grosshans, M., & Kiefer, F. (2010b). Impact of functional social support for abstinence after inpatient detoxification. Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 24(2), 118–124.PubMed
Myrick, H., Anton, R., Voronin, K., Wang, W., & Henderson, S. (2007). A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcoholism: Clinical and Experimental Research, 31(2), 221–227.PubMedCrossRef
Myrick, H., Malcolm, R., Randall, P. K., Boyle, E., Anton, R. F., Becker, H. C., & Randall, C. L. (2009). A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcoholism: Clinical and Experimental Research, 33(9), 1582–1588.PubMedCrossRef
Nadkarni, A., Weiss, H. A., Velleman, R., McCambridge, J., McDaid, D., Park, A. L., et al. (2019). Feasibility, acceptability and cost-effectiveness of a brief, lay counsellor-delivered psychological treatment for men with alcohol dependence in primary care: an exploratory randomized controlled trial. Addiction, 114(7), 1192–1203.PubMedPubMedCentralCrossRef
Naglich, A., Adinoff, B., & Sherwood Brown, E. (2017). Pharmacological treatment of bipolar disorder with comorbid alcohol use disorder. CNS Drugs, 31(8), 665–674.PubMedCrossRef
Nair, N. C., Newton, N., Shakeshaft, A., Wallace, P., & Teesson, M. (2015). A systematic review of digital and computer-based alcohol intervention programs in primary care. Current drug abuse reviews, 8(2), 111–118.PubMedCrossRef
Najavits, L. (2002a). Seeking safety: A treatment manual for PTSD and substance abuse. Guilford Publications.
Najavits, L. M. (2002b). Clinicians’ views on treating posttraumatic stress disorder and substance use disorder. Journal of Substance Abuse Treatment, 22(2), 79–85.PubMedCrossRef
Najavits, L. (2009). Posttraumatische Belastungsstörung und Substanzmissbrauch – Das Therapieprogramm „Sicherheit finden“. (I. Schäfer, M. Stubenvoll, & A. Dilling, Übers.). Hogrefe.
Najavits, L. M., & Schäfer, I. (2008). Posttraumatische Belastungsstörung und Substanzmissbrauch: das Therapieprogramm „Sicherheit finden“. Hogrefe.
Naranjo, C. A., Sellers, E. M., Chater, K., Iversen, P., Roach, C., & Sykora, K. (1983). Nonpharmacologic intervention in acute alcohol withdrawal. Clinical Pharmacology & Therapeutics, 34(2), 214–219.CrossRef
National Institute for Health and Care Excellence (NICE). (2010a). Alcohol-use disorders: preventing the development of hazardous and harmful drinking – public health guidance (PH 24). National Institute for Health and Care Excellence (UK).
National Institute for Health and Care Excellence (NICE). (2019a). 2019 surveillance of alcohol-use disorders (NICE guidelines PH24 and CG115). National Institute for Health and Care Excellence (UK).
Naundorff, J., Kornwald, C., Bosch, A., Hansen, B., & Janßen, H.J. (2018) Statistik 2017 der fünf Sucht-Selbsthilfe und Abstinenzverbände. Deutsche Hauptstelle für Suchtfragen e.V.
Naveau, S., Gaudé, G., Asnacios, A., Agostini, H., Abella, A., Barri-Ova, N., et al. (2009). Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology, 49(1), 97–105.PubMedCrossRef
Nei, J., Matsuda, Y., & Takada, A. (1983). Chronic hepatitis induced by alcohol. Digestive diseases and sciences, 28(3), 207–215.PubMedCrossRef
Neto, D., Lambaz, R., Aguiar, P., & Chick, J. (2008). Effectiveness of sequential combined treatment in comparison with treatment as usual in preventing relapse in alcohol dependence. Alcohol & Alcoholism, 43(6), 661–668.CrossRef
Neumann, E., Bick-Dresen, S., Missel, P., Bachmeier, R., Fölsing, S., Kramer, D., et al. (2019). Effektivität der ambulanten Suchtrehabilitation – FVS-Katamnese des Entlassjahrganges 2016 von Ambulanzen für Alkohol- und Medikamentenabhängige. Sucht Aktuell, 26, 75–83.
New York State Department of Health. (2009). Medical care of HIV-infected substance-using women. New York State Department of Health.
Newton-Howes, G. M., Foulds, J. A., Guy, N. H., Boden, J. M., & Mulder, R. T. (2017). Personality disorder and alcohol treatment outcome: Systematic review and meta-analysis. The British Journal of Psychiatry, 211(1), 22–30.PubMedCrossRef
Nguyen-Khac, E., Chatelain, D., Tramier, B., Decrombecque, C., Robert, B., Joly, J. P., et al. (2008). Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Alimentary pharmacology & therapeutics, 28(10), 1188–1198.CrossRef
Nguyen-Khac, E., Thiele, M., Voican, C., Nahon, P., Moreno, C., Boursier, J., et al. (2018). Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis. The Lancet Gastroenterology & Hepatology, 3(9), 614–625.CrossRef
Nielsen, P., Røjskjær, S., & Hesse, M. (2007). Personality-guided treatment for alcohol dependence: a quasi-randomized experiment. American Journal on Addictions, 16(5), 357–364.PubMedCrossRef
Nieva, G., Ortega, L. L., Mondon, S., Ballbè, M., & Gual, A. (2011). Simultaneous versus delayed treatment of tobacco dependence in alcohol-dependent outpatients. European Addiction Research, 17(1), 1–9.PubMedCrossRef
Nilsen, P., Baird, J., Mello, M. J., Nirenberg, T., Woolard, R., Bendtsen, P., & Longabaugh, R. (2008). A systematic review of emergency care brief alcohol interventions for injury patients. Journal of substance abuse treatment, 35(2), 184–201.PubMedCrossRef
van Nimwegen, L. J., de Haan, L., van Beveren, N. J., van der Helm, M., van den Brink, W., & Linszen, D. (2008). Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial. The Canadian Journal of Psychiatry, 53(6), 400–405.PubMedCrossRef
Nordback, I., Pelli, H., Lappalainen–Lehto, R., Järvinen, S., Räty, S., & Sand, J. (2009). The recurrence of acute alcohol-associated pancreatitis can be reduced: a randomized controlled trial. Gastroenterology, 136(3), 848–855.PubMedCrossRef
Nordholm, D., & Nielsen, B. (2007). Personality disorders among Danish alcoholics attending outpatient treatment. European Addiction Research, 13(4), 222–229.PubMedCrossRef
Norman, S. B., Trim, R., Haller, M., Davis, B. C., Myers, U. S., Colvonen, P. J., et al. (2019). Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA psychiatry, 76(8), 791–799.PubMedPubMedCentralCrossRef
Ntais, C., Pakos, E., Kyzas, P., & Ioannidis, J. P. (2005). Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews, (3).
Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA, 291(15), 1887–1896.PubMedCrossRef
Nyamathi, A., Shoptaw, S., Cohen, A., Greengold, B., Nyamathi, K., Marfisee, M., et al. (2010). Effect of motivational interviewing on reduction of alcohol use. Drug and Alcohol Dependence, 107(1), 23–30.PubMedPubMedCentralCrossRef
Nyhuis, P. W., Niederhofer, E., Scherbaum, N., Schifano, F., Bonnet, U., Dembski, N., et al. (2018). Effectiveness of psychoanalytic-interactional group therapy vs. behavioral group therapy in routine outpatient treatment of alcohol-dependent patients. Substance use & misuse, 53(3), 426–431.CrossRef
O’Connor, E. A., Perdue, L. A., Senger, C. A., Rushkin, M., Patnode, C. D., Bean, S. I., & Jonas, D. E. (2018). Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force. Jama, 320(18), 1910–1928.PubMedCrossRef
O’Connor, M. J., & Whaley, S. E. (2007). Brief intervention for alcohol use by pregnant women. American journal of public health, 97(2), 252–258.PubMedPubMedCentralCrossRef
O’Farrell, T. J., & Clements, K. (2012). Review of outcome research on marital and family therapy in treatment for alcoholism. Journal of Marital and Family Therapy, 38(1), 122–144.PubMedCrossRef
O’Donnell, A., Anderson, P., Newbury-Birch, D., Schulte, B., Schmidt, C., Reimer, J., & Kaner, E. (2014). The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol and Alcoholism, 49(1), 66–78.PubMedCrossRef
O’Farrell, T. J., Schumm, J. A., Dunlap, L. J., Murphy, M. M., & Muchowski, P. (2016). A randomized clinical trial of group versus standard behavioral couples therapy plus individually based treatment for patients with alcohol dependence. Journal of consulting and clinical psychology, 84(6), 497–510.PubMedPubMedCentralCrossRef
Ohlmeier, M. D., Peters, K., Wildt, B. T. T., Zedler, M., Ziegenbein, M., Wiese, B., et al. (2008). Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD). Alcohol & Alcoholism, 43(3), 300–304.CrossRef
Oliver, J. A., Blank, M. D., Van Rensburg, K. J., MacQueen, D. A., Brandon, T. H., & Drobes, D. J. (2013). Nicotine interactions with low-dose alcohol: Pharmacological influences on smoking and drinking motivation. Journal of Abnormal Psychology, 122(4), 1154–1165.PubMedPubMedCentralCrossRef
O’Malley, S. S., Sinha, R., Grilo, C. M., Capone, C., Farren, C. K., McKee, S. A., et al. (2007). Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial. Alcoholism: Clinical and Experimental Research, 31(4), 625–634.PubMed
Ondersma, S. J., Martin, J., Fortson, B., Whitaker, D. J., Self-Brown, S., Beatty, J., et al. (2017). Technology to augment early home visitation for child maltreatment prevention: A pragmatic randomized trial. Child maltreatment, 22(4), 334–343.PubMedPubMedCentralCrossRef
Orr, M. F., Smith, C. L., Finlay, M., Martin, S. C., Brooks, O., Oluwoye, O. A., et al. (2018). Pilot investigation: Randomized controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management. Behavioural Pharmacology, 29(5), 462–468.PubMedPubMedCentralCrossRef
Osiezagha, K., Ali, S., Freeman, C., Barker, N. C., Jabeen, S., Maitra, S., et al. (2013). Thiamine deficiency and delirium. Innovations in Clinical Neuroscience, 10(4), 26.PubMedPubMedCentral
Oslin, D. W. (2005). Treatment of late-life depression complicated by alcohol dependence. The American Journal of Geriatric Psychiatry, 13(6), 491–500.PubMedPubMedCentralCrossRef
Oslin, D. W., Pettinati, H., & Volpicelli, J. R. (2002). Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes. The American Journal of Geriatric Psychiatry, 10(6), 740–747.PubMedCrossRef
Oslin, D. W., Slaymaker, V. J., Blow, F. C., Owen, P. L., & Colleran, C. (2005). Treatment outcomes for alcohol dependence among middle-aged and older adults. Addictive Behaviors, 30(7), 1431–1436.PubMedCrossRef
Oslin, D. W., Grantham, S., Coakley, E., Maxwell, J., Miles, K., Ware, J., et al. (2006). PRISM-E: comparison of integrated care and enhanced specialty referral in managing at-risk alcohol use. Psychiatric Services, 57(7), 954–958.PubMedCrossRef
Oster, J. (2014). Berufsgruppenanalyse Künstlerische Therapeutinnen und Therapeuten (BgA-KT): Ergebnisbericht. Universität Ulm & Nürtingen.
Osterman, R., Lewis, D., & Winhusen, T. (2017). Efficacy of motivational enhancement therapy to decrease alcohol and illicit-drug use in pregnant substance users reporting baseline alcohol use. Journal of Substance Abuse Treatment, 77, 150–155.PubMedPubMedCentralCrossRef
Ouimette, P., Moos, R. H., & Finney, J. W. (2003). PTSD treatment and 5-year remission among patients with substance use and posttraumatic stress disorders. Journal of Consulting and Clinical Psychology, 71(2), 410.PubMedCrossRef
Owens, L., Butcher, G., Gilmore, I., Kolamunnage-Dona, R., Oyee, J., Perkins, L., et al. (2011). A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC). BMC public health, 11(1), 528.PubMedPubMedCentralCrossRef
Palmstierna, T. (2001). A model for predicting alcohol withdrawal delirium. Psychiatric Services, 52(6), 820–823.PubMedCrossRef
Palpacuer, C., Duprez, R., Huneau, A., Locher, C., Boussageon, R., Laviolle, B., & Naudet, F. (2018). Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate. Addiction, 113(2), 220–237.PubMedCrossRef
Pani, P. P., Trogu, E., Pacini, M., & Maremmani, I. (2014). Anticonvulsants for alcohol dependence. Cochrane Database of Systematic Reviews, (2).
Parés, A., Caballería, J., Bruguera, M., Torres, M., & Rodés, J. (1986). Histological course of alcoholic hepatitis: influence of abstinence, sex and extent of hepatic damage. Journal of hepatology, 2(1), 33–42.PubMedCrossRef
Parkinson S, Gunawan A, Lewig K, Flaherty R, Arney F. (2017) Improving service responses to vulnerable families during pregnancy and infancy. A report to the Australian Government, Department of Social Services. Australian Centre for Child Protection/University of South Australia.
Pelli, H., Lappalainen-Lehto, R., Piironen, A., Sand, J., & Nordback, I. (2008). Risk factors for recurrent acute alcohol-associated pancreatitis: a prospective analysis. Scandinavian journal of gastroenterology, 43(5), 614–621.PubMedCrossRef
Pelli, H., Lappalainen-Lehto, R., Piironen, A., Järvinen, S., Sand, J., & Nordback, I. (2009). Pancreatic damage after the first episode of acute alcoholic pancreatitis and its association with the later recurrence rate. Pancreatology, 9(3), 245–251.PubMedCrossRef
Pennay, A., Cameron, J., Reichert, T., Strickland, H., Lee, N. K., Hall, K., & Lubman, D. I. (2011). A systematic review of interventions for co-occurring substance use disorder and borderline personality disorder. Journal of Substance Abuse Treatment, 41(4), 363–373.PubMedCrossRef
Perepletchikova, F., Krystal, J. H., & Kaufman, J. (2008). Practitioner review: adolescent alcohol use disorders: assessment and treatment issues. Journal of Child Psychology and Psychiatry, 49(11), 1131–1154.PubMed
Persson, A., Back, S. E., Killeen, T. K., Brady, K. T., Schwandt, M. L., Heilig, M., & Magnusson, Å. (2017). Concurrent treatment of PTSD and substance use disorders using prolonged exposure (COPE): A pilot study in alcohol-dependent women. Journal of addiction medicine, 11(2), 119–125.PubMedPubMedCentralCrossRef
Peters, T. J., Kotowicz, J., Nyka, W., Kozubski, W., Kuznetsov, V., Vanderbist, F., et al. (2006). Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial. Alcohol and Alcoholism, 41(6), 636–642.PubMedCrossRef
Petrakis, I., Ralevski, E., Nich, C., Levinson, C., Carroll, K., Poling, J., et al. (2007). Naltrexone and disulfiram in patients with alcohol dependence and current depression. Journal of Clinical Psychopharmacology, 27(2), 160–165.PubMedCrossRef
Petrakis, I. L., & Simpson, T. L. (2017). Posttraumatic stress disorder and alcohol use disorder: a critical review of pharmacologic treatments. Alcoholism: Clinical and Experimental Research, 41(2), 226–237.PubMedCrossRef
Petrakis, I. L., O’Malley, S., Rounsaville, B., Poling, J., McHugh-Strong, C., & Krystal, J. H. (2004). Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. Psychopharmacology, 172(3), 291–297.PubMedCrossRef
Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., Rounsaville, B., & VA New England VISN I MIRECC Study Group. (2005). Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biological Psychiatry, 57(10), 1128–1137.PubMedCrossRef
Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., Ralevski, E., & Rounsaville, B. (2006). Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biological Psychiatry, 60(7), 777–783.PubMedCrossRef
Petrakis, I. L., Leslie, D., Finney, J. W., & Rosenheck, R. (2006a). Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia. American Journal on Addictions, 15(1), 44–49.PubMedCrossRef
Petrakis, I. L., Ralevski, E., Desai, N., Trevisan, L., Gueorguieva, R., Rounsaville, B., & Krystal, J. H. (2012). Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology, 37(4), 996–1004.PubMedCrossRef
Pettinati, H. M., Meyers, K., Jensen, J. M., Kaplan, F., & Evans, B. D. (1993). Inpatient vs outpatient treatment for substance dependence revisited. Psychiatric Quarterly, 64(2), 173–182.PubMedCrossRef
Pettinati, H. M., Volpicelli, J. R., Luck, G., Kranzler, H. R., Rukstalis, M. R., & Cnaan, A. (2001). Double-blind clinical trial of sertraline treatment for alcohol dependence. Journal of Clinical Psychopharmacology, 21(2), 143–153.PubMedCrossRef
Pettinati, H. M., Oslin, D. W., Kampman, K. M., Dundon, W. D., Xie, H., Gallis, T. L., et al. (2010). A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. American Journal of Psychiatry, 167(6), 668–675.PubMedCrossRef
Picci, R. L., Vigna-Taglianti, F., Oliva, F., Mathis, F., Salmaso, S., Ostacoli, L., et al. (2012). Personality disorders among patients accessing alcohol detoxification treatment: prevalence and gender differences. Comprehensive Psychiatry, 53(4), 355–363.PubMedCrossRef
Pinto, R. M., Campbell, A. N., Hien, D. A., Yu, G., & Gorroochurn, P. (2011). Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma Study: Implications for posttrial implementation. American Journal of Orthopsychiatry, 81(2), 211–217.PubMedCrossRef
Piontek, D., de Matos, E. G., Atzendorf, J., & Kraus, L. (2017). Substanzkonsum und Hinweise auf klinisch relevanten Konsum in Bayern, Hamburg, Hessen, Nordrhein-Westfalen, Sachsen und Thüringen. Ergebnisse des Epidemiologischen Suchtsurvey 2015 (IFT-Berichte Bd. 189). IFT Institut für Therapieforschung.
Platt, L., Melendez-Torres, G. J., O’Donnell, A., Bradley, J., Newbury-Birch, D., Kaner, E., & Ashton, C. (2016). How effective are brief interventions in reducing alcohol consumption: do the setting, practitioner group and content matter? Findings from a systematic review and metaregression analysis. BMJ open, 6(8), e011473.PubMedPubMedCentralCrossRef
Polycarpou, A., Papanikolau, P., Ioannidis, J. P., & Ioannidis, D. C. (2005). Anticonvulsants for alcohol withdrawal. Cochrane Database of Systematic Reviews, (3) CD005064.
Popova, S., Lange, S., Probst, C., Gmel, G., & Rehm, J. (2017). Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. The Lancet Global Health, 5(3), e290–e299.PubMedCrossRef
Powers, M. B., Vedel, E., & Emmelkamp, P. M. (2008). Behavioral couples therapy (BCT) for alcohol and drug use disorders: A meta-analysis. Clinical psychology review, 28(6), 952–962.PubMedCrossRef
Prendergast, M. L., Messina, N. P., Hall, E. A., & Warda, U. S. (2011). The relative effectiveness of women-only and mixed-gender treatment for substance-abusing women. Journal of substance abuse treatment, 40(4), 336–348.PubMedPubMedCentralCrossRef
Preston, K. L., Jobes, M. L., Phillips, K. A., & Epstein, D. H. (2016). Real-time assessment of alcohol drinking and drug use in opioid-dependent polydrug users. Behavioural pharmacology, 27(7), 579.PubMedPubMedCentralCrossRef
Preuss, U. W. (2008). Abhängigkeitserkrankungen und Psychosen: Erkenntnisse und Kontroversen in Vorbereitung auf neue Klassifikationssysteme. Die Psychiatrie, 2, 61–68.
Preuss, U. W., Koller, G., Barnow, S., Eikmeier, M., & Soyka, M. (2006). Suicidal behavior in alcohol-dependent subjects: The role of personality disorders. Alcoholism: Clinical and Experimental Research, 30(5), 866–877.PubMedCrossRef
Preuss, U. W., Johann, M., Fehr, C., Koller, G., Wodarz, N., Hesselbrock, V., et al. (2009). Personality disorders in alcohol-dependent individuals: Relationship with alcohol dependence severity. European Addiction Research, 15(4), 188–195.PubMedPubMedCentralCrossRef
Prochaska, J. J., Delucchi, K., & Hall, S. M. (2004). A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology, 72(6), 1144–1156.PubMedCrossRef
Project MATCH Research Group. (1997). Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. Journal of Studies on Alcohol, 58(1), 7–29.CrossRef
Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., et al. (2017). ADHD medication and substance-related problems. American Journal of Psychiatry, 174(9), 877–885.PubMedCrossRef
Quinten, C., & Grönle-Jeuck, U. (2002). Die stationäre Behandlung von Alkohol- und Medikamenten-abhängigkeit im höheren Lebensalter: Klinische Erfahrungen und Katamnese. In F. Sucht (Hrsg.), Die Zukunft der Suchtbehandlung: Trends und Prognosen (S. 433–442). Neuland.
Ralevski, E., Ball, S., Nich, C., Limoncelli, D., & Petrakis, I. (2007). The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders. American Journal on Addictions, 16(6), 443–449.PubMedCrossRef
Ralevski, E., O’Brien, E., Jane, J. S., Dean, E., Dwan, R., & Petrakis, I. (2011). Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence. The Journal of Nervous and Mental Disease, 199(7), 499–505.PubMedCrossRef
Ralevski, E., Southwick, S., Jackson, E., Jane, J. S., Russo, M., & Petrakis, I. (2016). Trauma-and stress-induced response in veterans with alcohol dependence and comorbid post-traumatic stress disorder. Alcoholism: Clinical and Experimental Research, 40(8), 1752–1760.PubMedCrossRef
Ramsey, A. T., Satterfield, J. M., Gerke, D. R., & Proctor, E. K. (2019). Technology-based alcohol interventions in primary care: Systematic review. Journal of medical Internet research, 21(4), e10859.PubMedPubMedCentralCrossRef
Ramstedt, M. (2001). Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries. Addiction, 96(1s1), 19–33.CrossRef
Randall, C. L., Thomas, S., & Thevos, A. K. (2001). Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcoholism: Clinical and Experimental Research, 25(2), 210–220.PubMedCrossRef
Rane, A., Church, S., Bhatia, U., Orford, J., Velleman, R., & Nadkarni, A. (2017). Psychosocial interventions for addiction-affected families in Low and Middle Income Countries: A systematic review. Addictive behaviors, 74, 1–8.PubMedCrossRef
Rantala, A., Lehtonen, O. P., & Niinikoski, J. (1997). Alcohol abuse: a risk factor for surgical wound infections? American journal of infection control, 25(5), 381–386.PubMedCrossRef
Rao, R., & Draper, B. (2015). Alcohol-related brain damage in older people. The Lancet Psychiatry, 8(2), 674–675.CrossRef
Raynard, B., Balian, A., Fallik, D., Capron, F., Bedossa, P., Chaput, J. C., & Naveau, S. (2002). Risk factors of fibrosis in alcohol-induced liver disease. Hepatology, 35(3), 635–638.PubMedCrossRef
Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA, 264(19), 2511–2518.PubMedCrossRef
Rehm, J., Taylor, B., & Room, R. (2006). Global burden of disease from alcohol, illicit drugs and tobacco. Drug and Alcohol Review, 25(6), 503–513.PubMedCrossRef
Rehm, J., Taylor, B., Mohapatra, S., Irving, H., Baliunas, D., Patra, J., & Roerecke, M. (2010). Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug and alcohol review, 29(4), 437–445.PubMedCrossRef
Reid, S. C., Teesson, M., Sannibale, C., Matsuda, M., & Haber, P. S. (2005). The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial. Journal of Studies on Alcohol, 66(6), 833–841.PubMedCrossRef
Reker, T., Richter, D., Bätz, B., Luedtke, U., Koritsch, H. D., & Reymann, G. (2004). Short-term effects of acute inpatient treatment of alcoholics. A prospective, multicenter evaluation study. Der Nervenarzt, 75(3), 234–241.PubMed
Resko, S. M., & Mendoza, N. S. (2012). Early attrition from treatment among women with cooccurring substance use disorders and PTSD. Journal of Social Work Practice in the Addictions, 12(4), 348–369.CrossRef
Reyes, M. M., Schneekloth, T. D., Hitschfeld, M. J., Geske, J. R., Atkinson, D. L., & Karpyak, V. M. (2016). The clinical utility of ASRS-v1. 1 for identifying ADHD in alcoholics using PRISM as the reference standard. Journal of Attention Disorders.
Reymann, G., & Danziger, H. J. (2001). Replacing the last week of a motivational inpatient alcohol withdrawal programme by a day-clinic setting. European Addiction Research, 7(2), 56–60.PubMedCrossRef
Reynolds, K. D., Coombs, D. W., Lowe, J. B., Peterson, P. L., & Gayoso, E. (1995). Evaluation of a self-help program to reduce alcohol consumption among pregnant women. International Journal of the Addictions, 30(4), 427–443.PubMedCrossRef
Richter, C., Hinzpeter, A., Schmidt, F., Kienast, T., Preuss, U. W., Plenge, T., et al. (2010). Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial. Journal of clinical psychopharmacology, 30(6), 720–725.PubMedCrossRef
Richter, C., Effenberger, S., Bschor, T., Bonnet, U., Haasen, C., Preuss, U. W., et al. (2012). Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial. Journal of clinical psychopharmacology, 32(4), 558–562.PubMedCrossRef
Ridley, N. J., Draper, B., & Withall, A. (2013). Alcohol-related dementia: an update of the evidence. Alzheimer’s research & therapy, 5(1).
Riedel-Heller, S. G., Gühne, U., Weinmann, S., & Becker, T. (2012). Psychosoziale Therapien bei schweren psychischen Erkrankungen – Die S3-Leitlinie der DGPPN: Stand der Forschung, Behandlungsempfehlungen und Desiderate für die Versorgungsforschung. PPmP-Psychotherapie· Psychosomatik· Medizinische Psychologie, 62(11), 425–428.
Rinck, M., Wiers, R. W., Becker, E. S., & Lindenmeyer, J. (2018). Relapse prevention in abstinent alcoholics by cognitive bias modification: Clinical effects of combining approach bias modification and attention bias modification. Journal of Consulting and Clinical Psychology, 86(12), 1005.PubMedCrossRef
Riper, H., Andersson, G., Hunter, S. B., de Wit, J., Berking, M., & Cuijpers, P. (2014). Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: A meta-analysis. Addiction, 109(3), 394–406.PubMedPubMedCentralCrossRef
Riper, H., Hoogendoorn, A., Cuijpers, P., Karyotaki, E., Boumparis, N., Mira, A., et al. (2018). Effectiveness and treatment moderators of internet interventions for adult problem drinking: An individual patient data meta-analysis of 19 randomised controlled trials. PLoS medicine, 15(12).
Roberts, N. P., Roberts, P. A., Jones, N., & Bisson, J. I. (2015). Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: A systematic review and meta-analysis. Clinical psychology review, 38, 25–38.PubMedCrossRef
Roberts, W., Ralevski, E., Verplaetse, T. L., McKee, S. A., & Petrakis, I. L. (2018). Tobacco use during a clinical trial of mecamylamine for alcohol dependence: Medication effects on smoking and associations with reductions in drinking. Journal of Substance Abuse Treatment, 94, 91–96.PubMedPubMedCentralCrossRef
Robinson, B. J., Robinson, G. M., Maling, T. J. B., & Johnson, R. H. (1989). Is clonidine useful in the treatment of alcohol withdrawal? Alcoholism: Clinical and Experimental Research, 13(1), 95–98.PubMedCrossRef
Roesner, S., Leucht, S., Lehert, P., & Soyka, M. (2008). Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. Journal of Psychopharmacology, 22(1), 11–23.CrossRef
Roesner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010a). Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews, (9) CD004332.
Roesner, S., Hackl-Herrwerth, A., Leucht, S., Vecchi, S., Srisurapanont, M., & Soyka, M. (2010b). Opioid antagonists for alcohol dependence. Cochrane database of systematic reviews, (12) CD001867.
Röjdmark, S., & Brismar, K. (2001). Decreased IGF-I bioavailability after ethanol abuse in alcoholics: partial restitution after short-term abstinence. Journal of endocrinological investigation, 24(7), 476–482.PubMedCrossRef
Rolland, B., Valin, T., Langlois, C., Auffret, M., Gautier, S., Deheul, S., et al. (2015). Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study. International Clinical Psychopharmacology, 30(1), 49–53.PubMedCrossRef
Roncero, C., Ortega, L., Pérez-Pazos, J., Lligoña, A., Abad, A. C., Gual, A., et al. (2015). Psychiatric comorbidity in treatment-seeking alcohol dependence patients with and without ADHD. Journal of Attention Disorders.
Roozen, H. G., De Waart, R., & Van Der Kroft, P. (2010). Community reinforcement and family training: An effective option to engage treatment-resistant substance-abusing individuals in treatment. Addiction, 105(10), 1729–1738.PubMedCrossRef
Roulot, D., Costes, J. L., Buyck, J. F., Warzocha, U., Gambier, N., Czernichow, S., et al. (2011). Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut, 60(7), 977–984.PubMedCrossRef
Roy, A. (1998). Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Biological Psychiatry, 44(7), 633–637.PubMedCrossRef
Royal College of Psychiatrists (RCT). (2018). Our invisible addicts (2. Aufl.). College Report CR211.
Rubio, G., Martínez, I., Ponce, G., Jiménez-Arriero, M. A., López-Muñoz, F., & Álamo, C. (2006). Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity. The Canadian Journal of Psychiatry, 51(8), 531–539.PubMedCrossRef
Rubio, G., López-Muñoz, F., Ponce, G., Pascual, J. M., Martínez-Gras, I., Ferre, F., et al. (2010). Zonisamide versus diazepam in the treatment of alcohol withdrawal syndrome. Pharmacopsychiatry, 43(07), 257–262.PubMedCrossRef
Ruglass, L. M., Miele, G. M., Hien, D. A., Campbell, A. N., Hu, M. C., Caldeira, N., et al. (2012). Helping alliance, retention, and treatment outcomes: A secondary analysis from the NIDA clinical trials network women and trauma study. Substance Use & Misuse, 47(6), 695–707.CrossRef
Ruglass, L. M., Lopez-Castro, T., Papini, S., Killeen, T., Back, S. E., & Hien, D. A. (2017). Concurrent treatment with prolonged exposure for co-occurring full or subthreshold posttraumatic stress disorder and substance use disorders: A randomized clinical trial. Psychotherapy and psychosomatics, 86(3), 150–161.PubMedCrossRef
Ruiz-Goikoetxea, M., Cortese, S., Aznarez-Sanado, M., Magallon, S., Zallo, N. A., Luis, E. O., et al. (2018). Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 84, 63–71.CrossRef
Rümmele, E. (1990). Aspekte der Bewegungspsychotherapie–eine Standortbestimmung. Ders. (Hrsg.): Spektrum der Bewegungspsychotherapie. 1, 1–15.
Rumpf, H. J., & Weyerer, S. (2006). Suchterkrankungen im Alter. Jahrbuch Sucht, Neuland, 189–199.
Rumpf, H. J., John, U., Hapke, U., & Bischof, G. (2009). Möglichkeiten der Intervention bei Alkoholproblemen im höheren Lebensalter. Sucht, 55(5), 303–311.CrossRef
Rupp, C. I., Kemmler, G., Kurz, M., Hinterhuber, H., & Wolfgang Fleischhacker, W. (2012). Cognitive remediation therapy during treatment for alcohol dependence. Journal of Studies on Alcohol and Drugs, 73(4), 625–634.PubMedCrossRef
Rychtarik, R. G., & McGillicuddy, N. B. (2005). Coping skills training and 12-step facilitation for women whose partner has alcoholism: effects on depression, the partner’s drinking, and partner physical violence. Journal of consulting and clinical psychology, 73(2), 249–261.PubMedPubMedCentralCrossRef
Saarto, T., & Wiffen, P. J. (2010). Antidepressants for neuropathic pain: a Cochrane review. Journal of Neurology, Neurosurgery & Psychiatry, 81(12), 1372–1373.CrossRef
Saitz, R. (2010). Alcohol screening and brief intervention in primary care: absence of evidence for efficacy in people with dependence or very heavy drinking. Drug and alcohol review, 29(6), 631–640.PubMedPubMedCentralCrossRef
Saitz, R., Mayo-Smith, M. F., Roberts, M. S., Redmond, H. A., Bernard, D. R., & Calkins, D. R. (1994). Individualized treatment for alcohol withdrawal: a randomized double-blind controlled trial. Jama, 272(7), 519–523.PubMedCrossRef
Salize, H. J., Jacke, C., Kief, S., Franz, M., & Mann, K. (2013). Treating alcoholism reduces financial burden on care-givers and increases quality-adjusted life years. Addiction, 108(1), 62–70.PubMedCrossRef
Salloum, I. M., Cornelius, J. R., Daley, D. C., Kirisci, L., Himmelhoch, J. M., & Thase, M. E. (2005). Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Archives of General Psychiatry, 62(1), 37–45.PubMedCrossRef
Samokhvalov, A. V., Irving, H. M., & Rehm, J. (2010). Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. European Journal of Cardiovascular Prevention & Rehabilitation, 17(6), 706–712.CrossRef
Samson, J. E., & McHugh, R. M. (2019). Brief alcohol interventions for adolescents and young adults in emergency department settings: A descriptive review and meta-analysis. Adolescent Research Review, 4(3), 313–327.CrossRef
Sannibale, C., Teesson, M., Creamer, M., Sitharthan, T., Bryant, R. A., Sutherland, K., et al. (2013). Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction, 108(8), 1397–1410.PubMedCrossRef
Santa Ana, E. J., Wulfert, E., & Nietert, P. J. (2007). Efficacy of group motivational interviewing (GMI) for psychiatric inpatients with chemical dependence. Journal of Consulting and Clinical Psychology, 75(5), 816.PubMedCrossRef
Sarff, M., & Gold, J. A. (2010). Alcohol withdrawal syndromes in the intensive care unit. Critical care medicine, 38(9), S494–S501.PubMedCrossRef
Sarles, H., Cros, R. C., & Bidart, J. M. (1979). A multicenter inquiry into the etiology of pancreatic diseases. Digestion, 19(2), 110–125.PubMedCrossRef
Satre, D. D., Mertens, J., Areán, P. A., & Weisner, C. (2003). Contrasting outcomes of older versus middle-aged and younger adult chemical dependency patients in a managed care program. Journal of Studies on Alcohol, 64(4), 520–530.PubMedCrossRef
Saunders, J. B., Aasland, O. G., Babor, T. F., De la Fuente, J. R., & Grant, M. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction, 88(6), 791–804.PubMedCrossRef
Sawicka, M., & Tracy, D. K. (2017). Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic review. Therapeutic advances in psychopharmacology, 7(8-9), 211–224.PubMedPubMedCentralCrossRef
Scalzo, F., Hulbert, C. A., Betts, J. K., Cotton, S. M., & Chanen, A. M. (2018). Predictors of substance use in youth with borderline personality disorder. Personality Disorders: Theory, Research, and Treatment, 9(4), 390–396.CrossRef
Schadé, A., Marquenie, L. A., van Balkom, A. J., Koeter, M. W., de Beurs, E., van den Brink, W., & van Dyck, R. (2005). The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: A randomized controlled trial. Alcoholism: Clinical and Experimental Research, 29(5), 794–800.PubMedCrossRef
Schadé, A., Marquenie, L. A., Van Balkom, A. J., Koeter, M. W., de Beurs, E., van Dyck, R., & van den Brink, W. (2007). Anxiety disorders: Treatable regardless of the severity of comorbid alcohol dependence. European Addiction Research, 13(2), 109–115.PubMedCrossRef
Schäfer, I., Gast, U., Hofmann, A., Knaevelsrud, C., Lampe, A., Liebermann, P., Lotzin, A., Maercker, A., Rosner, R., & Wöller, W. (Hrsg.). (2019a). S3-Leitlinie Posttraumatische Belastungsstörung. Springer.
Schäfer, I., Lotzin, A., Hiller, P., Sehner, S., Driessen, M., Hillemacher, T., et al. (2019b). A multisite randomized controlled trial of seeking safety vs. Relapse prevention training for women with co-occurring posttraumatic stress disorder and substance use disorders. European journal of psychotraumatology, 10(1), 1–15.CrossRef
Schäufele, M. (2009). Riskanter Alkoholkonsum im höheren Alter: Häufigkeit und Folgen – ein Überblick. Sucht, 55(5), 266–280.CrossRef
Schik, G., Wedegaertner, F. R., Liersch, J., Hoy, L., Emrich, H. M., & Schneider, U. (2005). Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal. Addiction Biology, 10(3), 283–288.PubMedCrossRef
Schippers, G. M., Broekman, T. G., Buchholz, A. (2011) MATE 2.1. Handbuch und Leitfaden. Deutsche Bearbeitung: A. Buchholz, H. Küfner, L. Kraus, F. Rist. : Bêta Boeken.
Schlack, R., Mauz, E., Hebebrand, J., & Hölling, H. (2014). Has the prevalence of parent-reported diagnosis of attention deficit hyperactivity disorder (ADHD) in Germany increased between 2003–2006 and 2009–2012? Results of the KiGGS-study: first follow-up (KiGGS Wave 1). Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 57(7), 820–829.PubMedCrossRef
Schmidt, N. B., Buckner, J. D., & Keough, M. E. (2007). Anxiety sensitivity as a prospective predictor of alcohol use disorders. Behavior modification, 31(2), 202–219.PubMedCrossRef
Schmidt, P., Köhler, J., & Soyka, M. (2008). Evidence-based treatments in the inpatient rehabilitation of alcoholics. Fortschritte der Neurologie-Psychiatrie, 76(2), 86–90.PubMedCrossRef
Schneider, B. C., Moritz, S., Hottenrott, B., Reimer, J., Andreou, C., & Jelinek, L. (2016). Association Splitting: A randomized controlled trial of a new method to reduce craving among inpatients with alcohol dependence. Psychiatry Research, 238, 310–317.PubMedCrossRef
Schneider, U., Altmann, A., Baumann, M., Bernzen, J., Bertz, B., Bimber, U., et al. (2001). Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: The first Multicentre Study in Germany. Alcohol and Alcoholism, 36(3), 219–223.PubMedCrossRef
Schubiner, H., Saules, K. K., Arfken, C. L., Johanson, C. E., Schuster, C. R., Lockhart, N., Edwards, A., Donlin, J., & Pihlgren, E. (2002). Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology, 10(3), 286–294.PubMedCrossRef
Schuckit, M. A., Tipp, J. E., Reich, T., Hesselbrock, V. M., & Bucholz, K. K. (1995). The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects. Addiction, 90(10), 1335–1347.PubMedCrossRef
Schulte, B., O’Donnell, A. J., Kastner, S., Schmidt, C. S., Schäfer, I., & Reimer, J. (2014). Alcohol screening and brief intervention in workplace settings and social services: a comparison of literature. Frontiers in psychiatry, 5, 131.PubMedPubMedCentralCrossRef
Schumm, J. A., O’Farrell, T. J., Murphy, C. M., & Fals-Stewart, W. (2009). Partner violence before and after couples-based alcoholism treatment for female alcoholic patients. Journal of consulting and clinical psychology, 77(6), 1136–1146.PubMedPubMedCentralCrossRef
Schumm, J. A., O’Farrell, T. J., Kahler, C. W., Murphy, M. M., & Muchowski, P. (2014). A randomized clinical trial of behavioral couples therapy versus individually based treatment for women with alcohol dependence. Journal of Consulting and Clinical Psychology, 82(6), 993–1004.PubMedPubMedCentralCrossRef
Sechi, G., & Serra, A. (2007). Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. The Lancet Neurology, 6(5), 442–455.PubMedCrossRef
Seitz, A., Wapp, M., Burren, Y., Stutz, S., Schläfli, K., & Moggi, F. (2013). Association between craving and attention deficit/hyperactivity disorder symptoms among patients with alcohol use disorders. The American Journal on Addictions, 22(3), 292–296.PubMedCrossRef
Seitz, H. K., Bühringer, G., & Mann, K. (2008). Grenzwerte für den Konsum alkoholischer Getränke. In Deutsche Hauptstelle für Suchtfragen (Hrsg.), Jahrbuch Sucht 2008 (S. 205–209). Neuland.
Sernyak, M. J., Glazer, W. M., Heninger, G. R., Charney, D. S., Woods, S. W., Petrakis, I. L., et al. (1998). Naltrexone augmentation of neuroleptics in schizophrenia. Journal of Clinical Psychopharmacology, 18(3), 248–251.PubMedCrossRef
Shah, N. G., Lathrop, S. L., Reichard, R. R., & Landen, M. G. (2008). Unintentional drug overdose death trends in New Mexico, USA, 1990–2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction, 103(1), 126–136.PubMedCrossRef
Shaw, G. K. (1995). Detoxification: the use of benzodiazepines. Alcohol and Alcoholism, 30(6), 765–770.PubMed
Shaw, G. K., Waller, S., Latham, C. J., Dunn, G., & Thomson, A. D. (1998). The Detoxification experience of alcoholic In-patients and predictors of outcome. Alcohol and Alcoholism, 33(3), 291–303.PubMedCrossRef
Shaw, J. M., Kolesar, G. S., Sellers, E. M., Kaplan, H. L., & Sandor, P. A. U. L. (1981). Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care. Journal of Clinical Psychopharmacology, 1(6), 382–389.PubMedCrossRef
Shaw, P., Stringaris, A., Nigg, J., & Leibenluft, E. (2014). Emotion dysregulation in attention deficit hyperactivity disorder. American Journal of Psychiatry, 171(3), 276–293.PubMedCrossRef
Sherwood Brown, E., Beard, L., Dobbs, L., & Rush, A. J. (2006). Naltrexone in patients with bipolar disorder and alcohol dependence. Depression and Anxiety, 23(8), 492–495.PubMedCrossRef
Sherwood Brown, E., Garza, M., & Carmody, T. J. (2008). A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. The Journal of Clinical Psychiatry, 69(5), 701–705.PubMedCrossRef
Sherwood Brown, E., Carmody, T. J., Schmitz, J. M., Caetano, R., Adinoff, B., Swann, A. C., & Rush, A. J. (2009). A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcoholism: Clinical and Experimental Research, 33(11), 1863–1869.PubMedCrossRef
Sherwood Brown, E., Davila, D., Nakamura, A., Carmody, T. J., Rush, A. J., Lo, A., et al. (2014). A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence. Alcoholism: Clinical and Experimental Research, 38(7), 2113–2118.PubMedCrossRef
Shneyderman, Y., & Kiely, M. (2013). Intimate partner violence during pregnancy: victim or perpetrator? Does it make a difference? BJOG: An International Journal of Obstetrics & Gynaecology, 120(11), 1375–1385.CrossRef
Shoptaw, S., Rotheram-Fuller, E., Yang, X., Frosch, D., Nahom, D., Jarvik, M. E., et al. (2002). Smoking cessation in methadone maintenance. Addiction, 97(10), 1317–1328.PubMedCrossRef
Shourie, S., Conigrave, K. M., Proude, E. M., Ward, J. E., Wutzke, S. E., & Haber, P. S. (2006). The effectiveness of a tailored intervention for excessive alcohol consumption prior to elective surgery. Alcohol and Alcoholism, 41(6), 643–649.PubMedCrossRef
Silverman, M. J. (2010). The effect of a lyric analysis intervention on withdrawal symptoms and locus of control in patients on a detoxification unit: A randomized effectiveness study. The Arts in psychotherapy, 37(3), 197–201.CrossRef
Silverman, M. J. (2011). Effects of music therapy on change readiness and craving in patients on a detoxification unit. Journal of Music Therapy, 48(4), 509–531.PubMedCrossRef
Silverman, M. J. (2012). Effects of group songwriting on motivation and readiness for treatment on patients in detoxification: A randomized wait-list effectiveness study. Journal of music therapy, 49(4), 414–429.PubMedCrossRef
Silverman, M. J. (2014). Effects of music therapy on drug avoidance self-efficacy in patients on a detoxification unit: A three-group randomized effectiveness study. Journal of addictions nursing, 25(4), 172–181.PubMedCrossRef
Silverman, M. J. (2015). Effects of lyric analysis interventions on treatment motivation in patients on a detoxification unit: A randomized effectiveness study. Journal of music therapy, 52(1), 117–134.PubMedCrossRef
Silverman, M. J. (2016a). Effects of live and educational music therapy on working alliance and trust with patients on detoxification unit: a four-group cluster-randomized trial. Substance use & misuse, 51(13), 1741–1750.CrossRef
Silverman, M. J. (2016b). Effects of a single lyric analysis intervention on withdrawal and craving with inpatients on a detoxification unit: A cluster-randomized effectiveness study. Substance use & misuse, 51(2), 241–249.CrossRef
Silverman, M. J. (2019). Songwriting to Target State Shame, Guilt, and Pride in Adults with Substance Use Disorder on a Detoxification Unit: A Cluster-Randomized Study. Substance use & misuse, 54(8), 1345–1354.CrossRef
Simioni, N., Cottencin, O., & Rolland, B. (2015). Interventions for increasing subsequent alcohol treatment utilisation among patients with alcohol use disorders from somatic inpatient settings: a systematic review. Alcohol and Alcoholism, 50(4), 420–429.PubMedCrossRef
Simon, V., Czobor, P., Bálint, S., Mészáros, A., & Bitter, I. (2009). Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. The British Journal of Psychiatry, 194(3), 204–211.PubMedCrossRef
Singer, M. V., Pfutzer, R. H., & Kiefer, F. (2009). Striving for abstinence in alcoholic pancreatitis: act of humanity, economic necessity, or flogging a dead horse after all? Gastroenterology., 136(3), 757–760.PubMedCrossRef
Smedslund, G., Berg, R. C., Hammerstrøm, K. T., Steiro, A., Leiknes, K. A., Dahl, H. M., & Karlsen, K. (2011). Motivational interviewing for substance abuse. Cochrane Database of Systematic Reviews, (5) CD008063.
Smith, D. C., Hall, J. A., Williams, J. K., An, H., & Gotman, N. (2006). Comparative efficacy of family and group treatment for adolescent substance abuse. American Journal on Addictions, 15(sup1), 131–136.PubMedCrossRef
Smith, E. J., Lui, S., & Terplan, M. (2009). Pharmacologic interventions for pregnant women enrolled in alcohol treatment. Cochrane Database of Systematic Reviews, (3).
Snead, A. L., Bennett, V. E., & Babcock, J. C. (2018). Treatments that work for intimate partner violence: Beyond the Duluth Model. In New frontiers in offender treatment (S. 269–285). Springer.
Sobell, L. C., Sobell, M. B., & Agrawal, S. (2002). Self-change and dual recoveries among individuals with alcohol and tobacco problems: Current knowledge and future directions. Alcoholism: Clinical and Experimental Research, 26(12), 1936–1938.PubMedCrossRef
Sonne, S. C., & Brady, K. T. (2002). Bipolar disorder and alcoholism. Alcohol Research & Health, 26(2), 103–108.
Sonntag, D., & Künzel, J. (2000). Hat die Therapiedauer bei alkohol-und drogenabhängigen Patienten einen positiven Einfluss auf den Therapieerfolg? Sucht, 46(8), 92–176.CrossRef
Soyka, M. (1995). Die Alkoholkrankheit: Diagnose und Therapie; mit 40 Tabellen. Chapman and Hall.
Soyka, M., & Rösner, S. (2008). Opioid antagonists for pharmacological treatment of alcohol dependence-a critical review. Current drug abuse reviews, 1(3), 280–291.
Soyka, M., Morhart-Klute, V., & Horak, M. (2002). A combination of carbamazepine/tiapride in outpatient alcohol detoxification. European archives of psychiatry and clinical neuroscience, 252(5), 197–200.PubMedCrossRef
Soyka, M., Aichmüller, C., v Bardeleben, U., Beneke, M., Glaser, T., Hornung-Knobel, S., & Wegner, U. (2003). Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study. European Addiction Research, 9(2), 65–72.PubMedCrossRef
Soyka, M., Schmidt, F., & Schmidt, P. (2006). Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence. Pharmacopsychiatry, 39(01), 30–34.PubMedCrossRef
Soyka, M., Kranzler, H. R., Berglund, M., Gorelick, D., Hesselbrock, V., Johnson, B. A., et al. (2008). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of substance use and related disorders, part 1: alcoholism. The World Journal of Biological Psychiatry, 9(1), 6–23.
Soyka, M., Kranzler, H. R., Hesselbrock, V., Kasper, S., Mutschler, J., Moeller, H. J., & WFSBP Task Force on Treatment Guidelines for Substance Use Disorders. (2017). Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision. The World Journal of Biological Psychiatry, 18(2), 86–119.PubMedCrossRef
Spanagel, R., Vengeliene, V., Jandeleit, B., Fischer, W. N., Grindstaff, K., Zhang, X., et al. (2014). Acamprosate produces its anti-relapse effects via calcium. Neuropsychopharmacology, 39(4), 783–791.
Spies, C., Tønnesen, H., Andreasson, S., Helander, A., & Conigrave, K. (2001). Perioperative morbidity and mortality in chronic alcoholic patients. Alcoholism: Clinical and Experimental Research, 25, 164S–170S.PubMedCrossRef
Spirito, A., Sindelar-Manning, H., Colby, S. M., Barnett, N. P., Lewander, W., Rohsenow, D. J., & Monti, P. M. (2011). Individual and family motivational interventions for alcohol-positive adolescents treated in an emergency department: results of a randomized clinical trial. Archives of Pediatrics & Adolescent Medicine, 165(3), 269–274.CrossRef
Spyra, K., & Müller-Fahrnow, W. (1998). Rehabilitanden-Management-Kategorien (RMK’s)–Ein neuer Ansatz zur Fallgruppenbildung in der medizinischen Rehabilitation. Rehabilitation, 37(1), S47–S56.PubMed
St Haxholdt, O., Krintel, J. J., & Johansson, G. (1984). Pre-operative alcohol infusion: The need for analgesic supplementation in chronic alcoholics. Anaesthesia, 39(3), 240–245.PubMedCrossRef
St John, P. D., Snow, W. M., & Tyas, S. L. (2010). Alcohol use among older adults. Reviews in Clinical Gerontology, 20(1), 56–68.CrossRef
Stade, B. C., Bailey, C., Dzendoletas, D., Sgro, M., Dowswell, T., & Bennett, D. (2009). Psychological and/or educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy. Cochrane Database of Systematic Reviews, (2), CD004228.
Staiger, P. K., Richardson, B., Long, C. M., Carr, V., & Marlatt, G. A. (2013). Overlooked and underestimated? Problematic alcohol use in clients recovering from drug dependence. Addiction, 108(7), 1188–1193.
Stappenbeck, C. A., Luterek, J. A., Kaysen, D., Rosenthal, C. F., Gurrad, B., & Simpson, T. L. (2015). A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behaviour Research and Therapy, 66, 8–17.PubMedCrossRef
Stavro, K., Pelletier, J., & Potvin, S. (2013). Widespread and sustained cognitive deficits in alcoholism: a meta-analysis. Addiction Biology, 18(2), 203–213.PubMedCrossRef
Stedman, M., Pettinati, H. M., Sherwood Brown, E., Kotz, M., Calabrese, J. R., & Raines, S. (2010). A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcoholism: Clinical and Experimental Research, 34(10), 1822–1831.PubMedCrossRef
Steele, C. T. (2000). Providing clinical treatment to substance abusing trauma survivors. Alcoholism Treatment Quarterly, 18(3), 71–81.CrossRef
Stein, M. D., Anderson, B., Charuvastra, A., Maksad, J., & Friedmann, P. D. (2002). A brief intervention for hazardous drinkers in a needle exchange program. Journal of Substance Abuse Treatment, 22(1), 23–31.PubMedCrossRef
Steinmetz, S. E., & Gray, M. J. (2018). Utilizing tenets of social cognitive theory to facilitate stay–leave decision making in victims of partner abuse. Partner Abuse, 9(4), 439–454.CrossRef
Stetter, F., & Mann, K. (1997). Dependency outcome of alcohol-dependent patients after inpatient detoxification and motivation treatment. Der Nervenarzt, 68(7), 574–581.PubMedCrossRef
Stewart, S. H., Conrod, P. J., Samoluk, S. B., Pihl, R. O., & Dongier, M. (2000). Posttraumatic stress disorder symptoms and situation-specific drinking in women substance abusers. Alcoholism Treatment Quarterly, 18(3), 31–47.CrossRef
Stewart, S. H., Hutson, A., & Connors, G. J. (2006). Exploration of the relationship between drinking intensity and quality of life. American Journal on Addictions, 15(5), 356–361.PubMedCrossRef
Stigendal, L., & Olsson, R. (1984). Alcohol consumption pattern and serum lipids in alcoholic cirrhosis and pancreatitis: a comparative study. Scandinavian journal of gastroenterology, 19(5), 582–587.PubMedCrossRef
Stockings, E., Hall, W. D., Lynskey, M., Morley, K. I., Reavley, N., Strang, J., et al. (2016). Prevention, early intervention, harm reduction, and treatment of substance use in young people. The Lancet Psychiatry, 3(3), 280–296.PubMedCrossRef
Stolle, M., & Thomasius, R. (2009). Akutbehandlung. Handbuch der Suchtstörungen im Kindes-und Jugendalter (S. 229–244). Schatthauer.
Story, J., & Stark, M. J. (1991). Treating cigarette smoking in methadone maintenance clients. Journal of Psychoactive Drugs, 23(2), 203–215.PubMedCrossRef
Straus, E., Norman, S. B., Haller, M., Southwick, S. M., Hamblen, J. L., & Pietrzak, R. H. (2019). Differences in protective factors among US Veterans with posttraumatic stress disorder, alcohol use disorder, and their comorbidity: Results from the National Health and Resilience in Veterans Study. Drug and alcohol dependence, 194, 6–12.PubMedCrossRef
Strum, W. B. (1995). Abstinence in alcoholic chronic pancreatitis. Effect on pain and outcome. Journal of clinical gastroenterology, 20(1), 37–41.PubMedCrossRef
Sullivan, J. T., Sykora, K., Schneiderman, J., Naranjo, C. A., & Sellers, E. M. (1989). Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). British journal of addiction, 84(11), 1353–1357.PubMedCrossRef
Sun, S., Kuja-Halkola, R., Faraone, S. V., D’Onofrio, B. M., Dalsgaard, S., Chang, Z., & Larsson, H. (2019). Association of psychiatric comorbidity with the risk of premature death among children and adults with attention-deficit/hyperactivity disorder. JAMA Psychiatry, 76(11), 1141–1149.PubMedPubMedCentralCrossRef
Sundström, C., Blankers, M., & Khadjesari, Z. (2017). Computer-based interventions for problematic alcohol use: a review of systematic reviews. International journal of behavioral medicine, 24(5), 646–658.PubMedCrossRef
Süß, H. M. (1995). Zur Wirksamkeit der Therapie bei Alkoholabhängigen: Ergebnisse einer Metaanalyse. Psychologische Rundschau, 46(4), 248–266.
Swanson, J., Van Dorn, R. A., & Swartz, M. S. (2007). Effectiveness of atypical antipsychotics for substance use in schizophrenia patients. Schizophrenia Research, 94(1-3), 114–118.PubMedCrossRef
Sylvia, L. G., Gold, A. K., Stange, J. P., Peckham, A. D., Deckersbach, T., Calabrese, J. R., et al. (2016). A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder. The American Journal on Addictions, 25(2), 94–98.PubMedPubMedCentralCrossRef
Szapocznik, J., Hervis, O., & Schwartz, S. (2003). Brief strategic family therapy for adolescent drug abuse (NIH Publication No. 03-4751). NIDA Therapy Manuals for Drug Addiction. National Institute on Drug Abuse.
Talamini, G., Bassi, C., Falconi, M., Sartori, N., Salvia, R., Rigo, L., et al. (1999). Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Digestive diseases and sciences, 44(7), 1303–1311.PubMedCrossRef
Tammisto, T., & Tigerstedt, I. (1977). The need for fentanyl supplementation of N2O-O2 relaxant anaesthesia in chronic alcoholics. Acta Anaesthesiologica Scandinavica, 21(3), 216–221.PubMedCrossRef
Tanner-Smith, E. E., & Lipsey, M. W. (2015). Brief alcohol interventions for adolescents and young adults: A systematic review and meta-analysis. Journal of substance abuse treatment, 51, 1–18.PubMedCrossRef
Tansil, K. A., Esser, M. B., Sandhu, P., Reynolds, J. A., Elder, R. W., Williamson, R. S., et al. (2016). Alcohol electronic screening and brief intervention: a Community Guide systematic review. American journal of preventive medicine, 51(5), 801–811.PubMedPubMedCentralCrossRef
Taylor, B., & Rehm, J. (2006). When risk factors combine: the interaction between alcohol and smoking for aerodigestive cancer, coronary heart disease, and traffic and fire injury. Addictive Behaviors, 31(9), 1522–1535.PubMedCrossRef
Temmingh, H. S., Williams, T., Siegfried, N., & Stein, D. J. (2018). Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. Cochrane Database of Systematic Reviews, 1.
Templeton, L., Velleman, R., & Russell, C. (2010). Psychological interventions with families of alcohol misusers: A systematic review. Addiction Research & Theory, 18(6), 616–648.CrossRef
Teplin, D., Raz, B., Daiter, J., Varenbut, M., & Plater-Zyberk, C. (2007). Screening for alcohol use patterns among methadone maintenance patients. The American journal of drug and alcohol abuse, 33(1), 179–183.PubMedCrossRef
Terra, M. B., Barros, H. M. T., Stein, A. T., Figueira, I., Athayde, L. D., Spanemberg, L., et al. (2006). Does co-occurring social phobia interfere with alcoholism treatment adherence and relapse? Journal of Substance Abuse Treatment, 31(4), 403–409.PubMedCrossRef
Tevyaw, T. O. L., & Monti, P. M. (2004). Motivational enhancement and other brief interventions for adolescent substance abuse: foundations, applications and evaluations. Addiction, 99, 63–75.PubMedCrossRef
Thibaut, F. (2018). Alert out on tobacco and alcohol consumption in young European women. European Archives of Psychiatry and Clinical Neuroscience, 268, 317–319.PubMedCrossRef
Thibaut, F., Chagraoui, A., Buckley, L., Gressier, F., Labad, J., Lamy, S., et al. (2019). WFSBP and IAWMH guidelines for the treatment of alcohol use disorders in pregnant women. The World Journal of Biological Psychiatry, 20(1), 17–50.PubMedCrossRef
Thiele, M., Rausch, V., Fluhr, G., Kjærgaard, M., Piecha, F., Mueller, J., et al. (2018). Controlled attenuation parameter and alcoholic hepatic steatosis: diagnostic accuracy and role of alcohol detoxification. Journal of hepatology, 68(5), 1025–1032.PubMedCrossRef
Thomas, S. E., Thevos, A. K., & Randall, C. L. (1999). Alcoholics with and without social phobia: A comparison of substance use and psychiatric variables. Journal of Studies on Alcohol, 60(4), 472–479.PubMedCrossRef
Thomas, S. E., Randall, P. K., Book, S. W., & Randall, C. L. (2008). A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking? Alcoholism: Clinical and Experimental Research, 32(1), 77–84.PubMedCrossRef
Thomasius, R. (2008). Suchtstörungen im Kindes-und Jugendalter: Das Handbuch: Grundlagen und Praxis. Schattauer.
Thomson, A. D., Guerrini, I., & Marshall, E. J. (2012). The evolution and treatment of Korsakoff’s syndrome. Neuropsychology review, 22(2), 81–92.PubMedPubMedCentralCrossRef
Thomson, S. J., Westlake, S., Rahman, T. M., Cowan, M. L., Majeed, A., Maxwell, J. D., & Kang, J. Y. (2008). Chronic liver disease – An increasing problem: a study of hospital admission and mortality rates in England, 1979–2005, with particular reference to alcoholic liver disease. Alcohol & Alcoholism, 43(4), 416–422.CrossRef
Thursz, M. R., Richardson, P., Allison, M., Austin, A., Bowers, M., Day, C. P., et al. (2015). Prednisolone or pentoxifylline for alcoholic hepatitis. New England Journal of Medicine, 372(17), 1619–1628.PubMedCrossRef
Tiet, Q. Q., & Mausbach, B. (2007). Treatments for patients with dual diagnosis: a review. Alcoholism: Clinical and Experimental Research, 31(4), 513–536.PubMed
Timko, C., Below, M., Schultz, N. R., Brief, D., & Cucciare, M. A. (2015). Patient and program factors that bridge the detoxification-treatment gap: a structured evidence review. Journal of Substance Abuse Treatment, 52, 31–39.PubMedCrossRef
Tolliver, B. K., DeSantis, S. M., Brown, D. G., Prisciandaro, J. J., & Brady, K. T. (2012). A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report. Bipolar Disorders, 14(1), 54–63.PubMedCrossRef
Toneatto, T. (2005). Cognitive versus behavioral treatment of concurrent alcohol dependence and agoraphobia: a pilot study. Addictive Behaviors, 30(1), 115–125.PubMedCrossRef
Tønnesen, H., & Kehlet, H. (1999). Preoperative alcoholism and postoperative morbidity. British Journal of Surgery, 86(7), 869–874.PubMedCrossRef
Tønnesen, H., Schütten, B. T., & Jørgensen, B. B. (1987). Influence of alcohol on morbidity after colonic surgery. Diseases of the colon & rectum, 30(7), 549–551.CrossRef
Tønneson, H., Petersen, K. R., Nielsen, H. J., Kehlet, H., Højgaard, L., Stokholm, K. H., & Knigge, U. (1992). Postoperative morbidity among symptom-free alcohol misusers. The Lancet, 340(8815), 334–337.CrossRef
Torchalla, I., Nosen, L., Rostam, H., & Allen, P. (2012). Integrated treatment programs for individuals with concurrent substance use disorders and trauma experiences: A systematic review and meta-analysis. Journal of substance abuse treatment, 42(1), 65–77.PubMedCrossRef
Torrens, M., Fonseca, F., Mateu, G., & Farré, M. (2005). Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and meta-analysis. Drug and Alcohol Dependence, 78(1), 1–22.PubMedCrossRef
Trabut, J. B., Thépot, V., Nalpas, B., Lavielle, B., Cosconea, S., Corouge, M., et al. (2012). Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers. Alcoholism: Clinical and Experimental Research, 36(8), 1407–1411.PubMedCrossRef
Tripodi, S. J., Bender, K., Litschge, C., & Vaughn, M. G. (2010). Interventions for reducing adolescent alcohol abuse: A meta-analytic review. Archives of pediatrics & adolescent medicine, 164(1), 85–91.CrossRef
Trull, T. J., Jahng, S., Tomko, R. L., Wood, P. K., & Sher, K. J. (2010). Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. Journal of Personality Disorders, 24(4), 412–426.PubMedPubMedCentralCrossRef
Tsujimoto, T., Kawaratani, H., Yoshiji, H., Uemura, M., & Fukui, H. (2008). Recent developments in the treatment of alcoholic chronic pancreatitis. Current drug abuse reviews, 1(2), 197–202.PubMedCrossRef
Turnbull, C., & Osborn, D. A. (2012). Home visits during pregnancy and after birth for women with an alcohol or drug problem. Cochrane Database of Systematic Reviews, (1), CD004456.
Tzilos, G. K., Sokol, R. J., & Ondersma, S. J. (2011). A randomized phase I trial of a brief computer-delivered intervention for alcohol use during pregnancy. Journal of Women’s Health, 20(10), 1517–1524.PubMedPubMedCentralCrossRef
UKATT Research Team. (2005). Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT). BMJ, 331(7516), 541.CrossRef
Upadhyaya, H., Tanaka, Y., Lipsius, S., Kryzhanovskaya, L. A., Lane, J. R., Escobar, R., et al. (2015). Time-to-onset and-resolution of adverse events before/after atomoxetine discontinuation in adult patients with ADHD. Postgraduate medicine, 127(7), 677–685.PubMedCrossRef
US Burden of Disease Collaborators. (2013). The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA, 310(6), 591–606.PubMedCentralCrossRef
Van den Bosch, L. M., Verheul, R., Schippers, G. M., & van den Brink, W. (2002). Dialectical behavior therapy of borderline patients with and without substance use problems: Implementation and long-term effects. Addictive Behaviors, 27(6), 911–923.PubMedCrossRef
Vasilaki, E. I., Hosier, S. G., & Cox, W. M. (2006). The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review. Alcohol and Alcoholism, 41(3), 328–335.PubMedCrossRef
Vedamurthachar, A., Janakiramaiah, N., Hegde, J. M., Shetty, T. K., Subbakrishna, D. K., Sureshbabu, S. V., & Gangadhar, B. N. (2006). Antidepressant efficacy and hormonal effects of Sudarshana Kriya Yoga (SKY) in alcohol dependent individuals. Journal of affective disorders, 94(1-3), 249–253.PubMedCrossRef
Vege, S. S., Yadav, D., & Chari, S. T. (2007). Pancreatitis. In N. J. Talley, G. R. Locke III, & Y. A. Saito (Hrsg.), GI Epidemiology. Blackwell Publishing.
Victor, M., & Adams, R. D. (1953). The effect of alcohol on the nervous system. Research publications-Association for Research in Nervous and Mental Disease, 32, 526.PubMed
Vittadini, G., Buonocore, M., Colli, G., Terzi, M., Fonte, R., & Biscaldi, G. (2001). Alcoholic polyneuropathy: a clinical and epidemiological study. Alcohol and Alcoholism, 36(5), 393–400.PubMedCrossRef
de Vogel, V., Bouman, Y. H. A., ter Horst, P., Stam, J., & Lancel, M. (2016). Gewalttätige Frauen: eine Multicenter-Studie über Genderunterschiede in der forensischen Psychiatrie. Forensische Psychiatrie Psychotherapie Werkstattschriften, 23(3), 279–302.
Vogelgesang, M. (2011). DGRW-Update: Alkoholabhängigkeit. Die Rehabilitation, 50(05), 292–297.PubMedCrossRef
Vollstädt-Klein, S., Loeber, S., Kirsch, M., Bach, P., Richter, A., Bühler, M., et al. (2011). Effects of cue-exposure treatment on neural cue reactivity in alcohol dependence: a randomized trial. Biological psychiatry, 69(11), 1060–1066.PubMedCrossRef
Wachtel, T., & Staniford, M. (2010). The effectiveness of brief interventions in the clinical setting in reducing alcohol misuse and binge drinking in adolescents: a critical review of the literature. Journal of clinical nursing, 19(5–6), 605–620.PubMedCrossRef
Waern, M., Marlow, T., Morin, J., Östling, S., & Skoog, I. (2014). Secular changes in at-risk drinking in Sweden: birth cohort comparisons in 75-year-old men and women 1976-2006. Age and ageing, 43(2), 228–234.PubMedCrossRef
Waldron, H. B., & Kaminer, Y. (2004). On the learning curve: the emerging evidence supporting cognitive–behavioral therapies for adolescent substance abuse. Addiction, 99, 93–105.PubMedPubMedCentralCrossRef
Waldron, H. B., Slesnick, N. M., Brody, J. L., Turner, C. W., & Peterson, T. R. (2001). Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. Journal of Consulting and Clinical Psychology, 69(5), 802–813.PubMedCrossRef
Waldrop, A. E., Back, S. E., Verduin, M. L., & Brady, K. T. (2007). Triggers for cocaine and alcohol use in the presence and absence of posttraumatic stress disorder. Addictive Behaviors, 32(3), 634–639.PubMedCrossRef
Walter, M., Gunderson, J. G., Zanarini, M. C., Sanislow, C. A., Grilo, C. M., McGlashan, T. H., et al. (2009). New onsets of substance use disorders in borderline personality disorder over 7 years of follow-ups: Findings from the Collaborative Longitudinal Personality Disorders Study. Addiction, 104(1), 97–103.PubMedPubMedCentralCrossRef
Walter, M., Sollberger, D., & Euler, S. (2015). Persönlichkeitsstörungen und Sucht. Kohlhammer.
Walton, M. A., Chermack, S. T., Shope, J. T., Bingham, C. R., Zimmerman, M. A., Blow, F. C., & Cunningham, R. M. (2010). Effects of a brief intervention for reducing violence and alcohol misuse among adolescents: a randomized controlled trial. Jama, 304(5), 527–535.PubMedPubMedCentralCrossRef
Watson, J. M., Crosby, H., Dale, V. M., Tober, G., Wu, Q., Lang, J., et al. (2013). AESOPS: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care. Health technology assessment, 17(25).
Weaver, M. F., Hoffman, H. J., Johnson, R. E., & Mauck, K. (2006). Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. Journal of Addictive Diseases, 25(2), 17–24.PubMedCrossRef
Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., et al. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. The British Journal of Psychiatry, 183(4), 304–313.PubMedCrossRef
Webb, G., Shakeshaft, A., Sanson-Fisher, R., & Havard, A. (2009). A systematic review of work-place interventions for alcohol-related problems. Addiction, 104(3), 365–377.PubMedCrossRef
Weiss, R. D., Griffin, M. L., Kolodziej, M. E., Greenfield, S. F., Najavits, L. M., Daley, D. C., et al. (2007). A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. American Journal of Psychiatry, 164(1), 100–107.PubMedCrossRef
Weissinger, V., & Missel, P. (2012). Leitbild und Positionen zur Suchtkrankenhilfe und -behandlung. Sucht Aktuell – Sonderausgabe, 19(2).
Welch, C., Harrison, D., Short, A., & Rowan, K. (2008). The increasing burden of alcoholic liver disease on United Kingdom critical care units: secondary analysis of a high quality clinical database. Journal of health services research & policy, 13(Suppl 2), 40–44.CrossRef
Welch, K. A. (2011). Neurological complications of alcohol and misuse of drugs. Practical neurology, 11(4), 206–219.PubMedCrossRef
Welte, J. W., & Mirand, A. L. (1995). Drinking, problem drinking and life stressors in the elderly general population. Journal of Studies on Alcohol, 56(1), 67–73.PubMedCrossRef
Wetterling, T., & Veltrup, C. (1997). Diagnostik und Therapie von Alkoholproblemen. Springer.CrossRef
Wetterling, T., Veltrup, C., Driessen, M., & John, U. (1999). Drinking pattern and alcohol-related medical disorders. Alcohol and Alcoholism, 34(3), 330–336.PubMedCrossRef
Wetterling, T., Driessen, M., Kanitz, R. D., & Junghanns, K. (2001). The severity of alcohol withdrawal is not age dependent. Alcohol and Alcoholism, 36(1), 75–78.PubMedCrossRef
Weyerer, S., & Schäufele, M. (2017). Epidemiologie des Alkoholkonsums und alkoholbezogener Störungen im höheren Alter. Sucht, 63(2), 69–80.CrossRef
White, A., Kavanagh, D., Stallman, H., Klein, B., Kay-Lambkin, F., Proudfoot, J., et al. (2010). Online alcohol interventions: a systematic review. Journal of medical Internet research, 12(5), e62.
White, J. M., & Irvine, R. J. (1999). Mechanisms of fatal opioid overdose. Addiction, 94(7), 961–972.PubMedCrossRef
Whitfield, C. L., Thompson, G., Lamb, A., Spencer, V., Pfeifer, M., & Browning-Ferrando, M. (1978). Detoxification of 1,024 alcoholic patients without psychoactive drugs. Jama, 239(14), 1409–1410.PubMedCrossRef
Wieben, E. S., Nielsen, B., Nielsen, A. S., & Andersen, K. (2018). Elderly alcoholics compared to middle-aged alcoholics in outpatient treatment–6-month follow-up. Nordic journal of psychiatry, 72(7), 506–511.PubMedCrossRef
Wiers, R. W., Eberl, C., Rinck, M., Becker, E. S., & Lindenmeyer, J. (2011). Retraining automatic action tendencies changes alcoholic patients’ approach bias for alcohol and improves treatment outcome. Psychological science, 22(4), 490–497.PubMedCrossRef
Wiers, R. W., Boffo, M., & Field, M. (2018). What´s in a trial? On the importance of distinguishing between experimental lab studies and randomized controlled trials: the case of cognitive bias modification and alcohol disorders. Journal of Studies on Alcohol and Drugs, 79(3), 333–343.PubMedCrossRef
Wilens, T. E., Adler, L. A., Weiss, M. D., Michelson, D., Ramsey, J. L., Moore, R. J., et al. (2008). Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug and Alcohol Dependence, 96(1–2), 145–154.PubMedCrossRef
Wilkins, A. J., Jenkins, W. J., & Steiner, J. A. (1983). Efficacy of clonidine in treatment of alcohol withdrawal state. Psychopharmacology, 81(1), 78–80.PubMedCrossRef
Williams, D., & McBride, A. J. (1998). The drug treatment of alcohol withdrawal symptoms: a systematic review. Alcohol and Alcoholism, 33(2), 103–115.PubMedCrossRef
Williams, R. J., & Chang, S. Y. (2000). A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clinical psychology: Science and practice, 7(2), 138–166.
Wilson, I. M., Graham, K., & Taft, A. (2014). Alcohol interventions, alcohol policy and intimate partner violence: a systematic review. BMC public health, 14(1).
Winhusen, T., Kropp, F., Babcock, D., Hague, D., Erickson, S. J., Renz, C., et al. (2008). Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. Journal of substance abuse treatment, 35(2), 161–173.PubMedPubMedCentralCrossRef
Winslow, B. T., Onysko, M., & Hebert, M. (2016). Medications for alcohol use disorder. American Family Physician, 93(6), 457–465.
Witkiewitz, K., & Bowen, S. (2010). Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. Journal of consulting and clinical psychology, 78(3), 362.PubMedPubMedCentralCrossRef
Witkiewitz, K., Votaw, V. R., Vowles, K. E., & Kranzler, H. R. (2018). Opioid misuse as a predictor of alcohol treatment outcomes in the COMBINE study: mediation by medication adherence. Alcoholism: Clinical and Experimental Research, 42(7), 1249–1259.PubMedCrossRef
Wobrock, T., & Soyka, M. (2008). Pharmacotherapy of schizophrenia with comorbid substance use disorder—reviewing the evidence and clinical recommendations. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(6), 1375–1385.PubMedCrossRef
Wodarz, N., Binder, H., Johann, M., & Spiessl, H. (2007). Reducing duration of inpatient treatment results in a higher readmission rate of alcohol addicted patients. Psychiatrische Praxis, 34, S55–S56.CrossRef
Woelk, H., Lehrl, S., Bitsch, R., & Köpcke, W. (1998). Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAP I Study). Alcohol and Alcoholism, 33(6), 631–638.PubMedCrossRef
Wojnar, M., Bizoń, Z., & Wasilewski, D. (1999). Assessment of the role of kindling in the pathogenesis of alcohol withdrawal seizures and delirium tremens. Alcoholism: Clinical and Experimental Research, 23(2), 204–206.PubMedCrossRef
Wölwer, W., Burtscheidt, W., Redner, C., Schwarz, R., & Gaebel, W. (2001). Out-patient behaviour therapy in alcoholism: impact of personality disorders and cognitive impairments. Acta Psychiatrica Scandinavica, 103(1), 30–37.PubMedCrossRef
van der Wulp, N. Y., Hoving, C., Eijmael, K., Candel, M. J., van Dalen, W., & De Vries, H. (2014). Reducing alcohol use during pregnancy via health counseling by midwives and internet-based computer-tailored feedback: a cluster randomized trial. Journal of medical Internet research, 16(12).
Wurst, F. M., Thon, N., Yegles, M., Halter, C., Weinmann, W., Laskowska, B., et al. (2011). Optimizing heroin-assisted treatment (HAT): assessment of the contribution of direct ethanol metabolites in identifying hazardous and harmful alcohol use. Drug and alcohol dependence, 115(1-2), 57–61.PubMedCrossRef
Yang, A. L., Vadhavkar, S., Singh, G., & Omary, M. B. (2008). Epidemiology of alcohol-related liver and pancreatic disease in the United States. Archives of internal medicine, 168(6), 649–656.PubMedCrossRef
Young, S. V., Wood, E., Dong, H., Kerr, T., & Hayashi, K. (2016). Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs. Addiction, 111(8), 1360–1365.PubMedPubMedCentralCrossRef
Yuma-Guerrero, P. J., Lawson, K. A., Velasquez, M. M., Von Sternberg, K., Maxson, T., & Garcia, N. (2012). Screening, brief intervention, and referral for alcohol use in adolescents: a systematic review. Pediatrics, 130(1), 115–122.PubMedCrossRef
Zanjani, F., Zubritsky, C., Mullahy, M., & Oslin, D. (2006). Predictors of adherence within an intervention research study of the at-risk older drinker: PRISM-E. Journal of geriatric psychiatry and neurology, 19(4), 231–238.PubMedCrossRef
Zanjani, F., Mavandadi, S., TenHave, T., Katz, I., Durai, N. B., Krahn, D., et al. (2008). Longitudinal course of substance treatment benefits in older male veteran at-risk drinkers. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 63(1), 98–106.PubMedCrossRef
Zhornitsky, S., Rizkallah, E., Pampoulova, T., Chiasson, J. P., Stip, E., Rompré, P. P., & Potvin, S. (2010). Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis. Journal of Clinical Psychopharmacology, 30(4), 417–424.PubMedCrossRef
Zikos, E., Gill, K. J., & Charney, D. A. (2010). Personality disorders among alcoholic outpatients: prevalence and course in treatment. The Canadian Journal of Psychiatry, 55(2), 65–73.PubMedCrossRef
Zilm, D. H., Sellers, E. M., Macleod, S. M., & Degani, N. (1975). Propranolol effect on tremor in alcoholic withdrawal. Annals of internal medicine, 83(2), 234–235.PubMedCrossRef
Zlotnick, C., Johnson, J., & Najavits, L. M. (2009). Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behavior Therapy, 40(4), 325–336.PubMedCrossRef
Metadaten
Titel
Behandlung von riskantem, schädlichem und abhängigem Alkoholgebrauch
verfasst von
Falk Kiefer
Sabine Hoffmann
Julia Arens
Martin Beutel
Oliver Bilke-Hentsch
Gallus Bischof
Udo Bonnet
Jan Malte Bumb
Ralf Demmel
Silke Diestelkamp
Patric Driessen
Isabel Englert
Ursula Fennen
Heribert Fleischmann
Jennis Freyer-Adam
Wilma Funke
Dieter Geyer
Euphrosyne Gouzoulis-Mayfrank
Renate Hannak-Zeltner
Barbara Hansen
Ursula Havemann-Reinecke
Derik Hermann
Eva Hoch
Werner Höhl
Susann Hößelbarth
Kristin Hupfer
Julia Jückstock
Marianne Klein
Andreas Koch
Joachim Köhler
Michael Köhnke
Anne Koopmann
Oliver Kreh
Monika Krönes
Dietmar Kramer
Georg Kremer
Timo Krüger
Nikolaus Lange
Bodo Lieb
Johannes Lindenmeyer
Mathias Luderer
Karl Mann
Peter Missel
Sebastian Mueller
Michael Müller-Mohnssen
Corinna Nels-Lindemann
Tim Neumann
Thomas Polak
Ulrich W. Preuss
Olaf Reis
Gerhard Reymann
Monika Ridinger
Hans-Jürgen Rumpf
Peter-Michael Sack
Ingo Schäfer
Martin Schäfer
Norbert Scherbaum
Ariane Schulte
Welf Schroeder
Manfred Singer
Michael Soyka
Rainer Thomasius
Clemens Veltrup
Monika Vogelgesang
Irmgard Vogt
Marc Walter
Tillmann Weber
Georg Weil
Bernd Wessel
Tina Wessels
Klaudia Winkler
Nadja Wirth
Arnold Wieczorek
Norbert Wodarz
Dirk Wolter
Copyright-Jahr
2022
Verlag
Springer Berlin Heidelberg
Buch
S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen

Print ISBN: 978-3-662-63676-3

Electronic ISBN: 978-3-662-63677-0

Copyright-Jahr: 2022

DOI
https://doi.org/10.1007/978-3-662-63677-0_3

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Bildnachweise